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SUMMARY 
Tourette syndrome has been reported in most populations throughout the world. 
Overall, there appears to be similar clinical phenomenology and psychopathology, 
which may serve as an indication of the biological nature for the condition. 
The diagnosis of Tourette syndrome represents a challenge for physicians because of 
clinical heterogeneity and often-present comorbidity with other known 
neurobehavioural conditions. Due to these clinical overlaps Tourette syndrome may 
serve as a model disorder for investigating the relationship between various 
neurological and behavioral domains of childhood reflecting either the expression of a 
common biological pathway or a common genetic background. The understanding of 
the genetic basis of Tourette syndrome is therefore of special importance, because it 
may provide useful insights for the study of other developmental disorders. However, 
the lack of objective biological markers of clinical manifestation together with a 
possible high phenocopy rate, unclear mode of inheritance, incomplete penetrance, 
and frequent bilinear transmission of predisposing genes represent major obstacles for 
those attempting to elucidate the genetic basis ofTourette syndrome. 
The research presented in this document is a result of six years' effort of the author 
and her collaborators to generate cytogenetic and molecular genetic data contributing 
to a better understanding of genetic and environmental factors affecting the 
phenotypic expression of Tourette syndrome. Theoretical and experimental results of 
this collaborative effort are assembled in seven articles (four published, three 
currently submitted for a publication) and a general introductory section relating to 
the problems, methods and methodology described and utilized in data collection for 
the individual papers. 
Taken as a whole, while the study of chromosome fragile site expression in Tourette 
syndrome probands yielded equivocal results leading to a number of rather 
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speculative but interesting interpretations, the results of subsequent molecular genetic 
studies are far clearer. 
The three most valuable outcomes of these studies for future genetic investigations in 
Tourette syndrome gene-mapping efforts in the Afrikaner population, and complex 
genetic traits in general, are: 
I. The evidence for association/linkage of at least three genomic regions with 
Tourette syndrome in the Afrikaner population, with two of the regions (11q23 
and 8q22) being suggestively linked to Tourette syndrome by others in different 
populations and employing different analytical methods. 
2. The evidence for extended background linkage disequilibrium in the general 
Afrikaner population (> 5 cM) which further strengthens existing experimental 
data demonstrating the suitability of this popUlation for gene-mapping efforts 
involving complex traits. 
3. The proof based on real rather than computer-simulated data that sequential and 
semiparametric methods of analysis could be sufficiently powerful to generate 
cumulative evidence for positive linkage with the trait in the regions which 
repeatedly yielded both highly significant as well as suggestively significant 
disease-marker associations in the initial set of samples. 
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OPSOMMING 
Tourettesindroom is 'n algemene oorerflike neurobiologiese probleem wat in verskeie 
bevolkingsgroepe vanoor die wereld beskryf is. As gevolg van identiese 
fenomenologie en psigopatologie ten spyte van omgewingsverskille, is dit aanduidend 
van 'n sterk biologiese grondslag vir die toe stand. 
Die teenwoordigheid van kliniese meersoortigheid en die verhoogde voorkoms van 'n 
verskeidenheid komorbiede probleme by 'n subgroep van individue met 
Tourettesindroom, veroorsaak dikwels probleme met die akkurate identifisering 
hiervan. Dit skep egter ook geleenthede vir die bestudering by kinders, van verskeie 
neurologiese en gedragsmanifestasies gebaseer op 'n gemene genetiese substraat. 
Insig in die genetiese-omgewings wisselwerking by Tourettesindroom baan dus die 
weg vir begrip van ander ontwikkelingsprobleme wat ook by kinders aangetref word. 
Die afwesigheid van 'n betroubare biologiese merker of merkers vir hierdie kliniese 
entiteit, die algemene voorkoms van fenokopiee, komplekse oorerwingspatroon, 
onvolledige penetrasie en algemene verskynsel van oorerwing vanaf beide ouers, 
verteenwoordig 'n aantal formidabele struikelblokke ten opsigte van die analise van 
die genetiese basis van Tourettesindroom. 
TS word as een van die komplekse oorerflike toestande beskou, wat beteken dat daar 
duidelike oorerflike faktore by betrokke is, maar dat die oorerwing nie-mendelies van 
aard is. Die gebruiklike reduksionistiese benaderings wat so suksesvol was vir die 
analise van die enkelgeentoestande, werk nie meer onder hierdie omstandighedenie, 
en vir die rede word verskeie nie-parametriese of semiparametriese modelle ingespan. 
Die gedokumenteerde resultate verteenwoordig die navorsing uitgevoer tesame met 
plaaslike en oorsese medewerkers op hierdie gebied gedurende die laaste ses jaar. Die 
teoretiese en eksperimentele resultate word weergegee in sewe publikasies. 
Hiertydens is sitogenetiese en molekulere gegewens versamel in 'n poging om die 
genetiese en omgewingsfaktore onderliggend tot die ekspressie van Tourettesindroom 
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te bepaal. Die teoretiese en eksperimentele resultate van hierdie poging word 
weergegee in sewe publikasies, waarvan vier reeds gepubliseer is, en 'n algemene 
inleidende afdeling wat die probleme en metodes bespreek soos tydens die 
versameling en analise van die data ervaar is. 
Die resultate word in twee afdelings aangebied: eerstens is daar die teoretisering ten 
opsigte van die bevinding van chromosomale breekbaarheid, wat aangedui is om 
verhoog te wees in die Tourette groep. Die betekenis van hierdie bevinding is tans 
nog onduidelik, en as gevolg van resolusieverskille nie direk met die DNA bevindings 
korreleerbaar nie. Hierdie merkerareas moet egter deurgaans in gedagte gehou word 
as moontlik aanwysend van die ligging van kandidaatgene vir Tourettesindroom. 
Die belangrikste gedeelte behandel egter die benadering tot die totale genoomsifiing, 
sowel as die veilgheidsmaatreels ingebou deur die heranalise van verskeie subgroepe 
en gevolglike replisering van resultate. 
Die mees waardevolle implikasies van hierdie navorsing ten opsigte van die 
uitstippeling van die pad vorentoe vir Tourettesindroom geenkartering by die 
Afrikaner, en komplekse oorerflike toestande in die algemeen, sluit die volgende in: 
1. Die bewyse gevind vir die bevestiging van 3 genomiese streke soos 
oorspronklik deur die eerste fase assosiasiestudies aangetoon by die 
manifestering van Tourettesindroom in die Afrikaner, en waar ten minste twee 
van die gebiede (Uq23 en 8q22) ook deur ander navorsers in ander 
bevolkingsgroepe met hierdie toestand gekoppel is; 
2. Die kwantifisering van die stand van koppelings-disekwilibrium by 'n aantal 
lokusse in die Afrikaner genepoel van < ScM. Hierdie gegewens versterk die 
gedagtes met betrekking tot die geskiktheid van hierdie bevolkingsgroep vir 
geenkarteringspogings vir komplekse toestande; 
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3. Die bewys, gebaseer op reele in stede van gemodelleerde data, dat 
opeenvolgende, semiparametriese analisemetodes oor voldoende statistiese 
krag beskik om kumulatiewe getuienis te verskaf vir positiewe koppeling van 
IS met streke wat ook in die oorspronkilke siektemerker assosiasiestudies 
betekenisvolle resultate gelewer het. 
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"The day after I saw Ray, it seemed to me that 
I noticed three Touretters in the street 
downtown New York. I was confounded, for 
Tourette's syndrome was said to be 
excessively rare . 
. . . Was it possible that I had been overlooking 
this all the time, either not seeing such patients 
or vaguely dismissing them as 'nervous', 
'cracked', 'twitchy'? 
The next day, without specially looking, I saw 
another two in the street. At this point I 
conceived a whimsical fantasy or private joke: 
suppose (I said to myself) that Tourette's is 
very common but fails to be recognized but 
once recognized is easily and constantly 
seen. " 
Sacks o. (1987) 
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CHAPTER 1 
General introduction 
1.1. History 
1.11. Recognition and clinical description of Tourette syndrome 
The movement disorder known as Tourette syndrome has been recognized since 1885, 
the year in which Georges Gilles de la Tourette (1857-1904) published a two-part 
article describing the case histories of 9 French men 
and women with the syndrome (Lajonchere et al. 
1996). His description of the disorder, which now 
carries his name, was based on 'the case of the 
cursing marquise' reported by Itard (1825) (MIM 
137580). The marquise's life history was selected by 
Gilles de la Tourette, who himself never examined 
her, as a prototypical example of the syndrome's 
major features such as involuntary movements and 
sounds (Le. barking), markedly enhanced startle 
reactions, coprolalia (inappropriate and involuntary 
swearing), and tendency to repeat both vocalizations (echolalia) and movements 
(echopraxia). In his article, Gilles de la Tourette assumed that the condition manifests 
itself in childhood, and does not affect the senses or intellect. Finally, he considered 
the condition to be hereditary with varying severity throughout a person's life-span 
and incurable. 
Another man, who deserves credit for the description and recognition of the syndrome 
is lean-Martin Charcot (1825-1893), the leading French neurologist of the time and 
Tourette's mentor. He urged Gilles de la Tourette to undertake the task of classifying 
movement disorders, and more importantly, he recognized the disorder, described by 
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his intern, as different from other movement disorders commonly understood at the 
time as "hysteria~'. 
For nearly a century after its original description, Tourette syndrome was considered 
rare with only 485 cases reported worldwide by 1973 (Robertson and Baron-Cohen 
1998). The situation changed dramatically mainly as a result of the work of Shapiro et 
al. (1982, 1989) at the Sinai Medical School in New York, who found, that many 
patients with Tourette-like symptoms responded to treatment with haloperidol, a 
dopamine D2 receptor inhibitor. Today, 'rourette syndrome has become of great 
interest to neurologists and medical professionals in general, which led to the 
realization that the syndrome and related conditions are much more common than had 
previously been considered. 
It is generally accepted that Tourette syndrome can assume many forms. For some 
people it may involve mild facial tics and odd vocalizations. For others it involves 
more dramatic uncontrollable movements, often accompanied by additional problems 
such as hyperactivity, poor attention, obsessions and compulsions (Robertson and 
Baron-Cohen 1998). 
The diagnostic criteria for Tourette syndrome presently included in Diagnostic and 
Statistical Manual of Mental disorders, 4th ed. (DSM-IV) provide a reasonable basis 
for the diagnosis, however, they do not provide an adequate description of the 
numerous symptoms that can co-occur as part of the phenotype. DSM-IV criteria also 
fail to recognize the developmental course of the disorder typically characterized by 
varying severity of expression of multiple symptoms, as well as diminution of the 
symptoms in adolescence (Leckman et al. 1998). 
The initial signs of Tourette syndrome are usually involuntary tic-like movements, 
which may progress in the course of disease to echolalia, grunting, coprolalia, and 
self-mutilation. Earlier studies have found, that self-mutilation symptoms are present 
in -40% of clinic-patient populations (van Woert et al. 1977). Coprolalia, on the other 
hand, previously thought to be one of the most notorious symptoms of the syndrome, 
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occurred less frequently (-10%) in studied patient populations (Goldenberg et al. 
1994) and may be a culturally related phenomenon due to widely different prevalence 
in Japanese and US individuals with Tourette syndrome (Nomura and Segawa 1982, 
Robertson and Stem 1997). 
While the diagnosis of Tourette syndrome is quite straightforward for the physician, 
the degree to which other behaviors are associated and represent the spectrum of 
Tourette symptoms is not clear. In a controversial presidential address. to the 
American Society of Human Genetics, Comings (1989) extended the phenotypic 
range of Tourette syndrome to include attention deficit disorder, conduct disorder, 
major depressive disorder, manic-depressive disorder, panic disorder, schizoid 
disorders, sleep disorders, specific reading disability, stuttering, male type II 
alcoholism and a female type of familial obesity. He suggested that the spectrum of 
behaviors associated with Tourette syndrome could be explained on the basis of a 
gene causing an imbalance of the mesencephalic-meso limbic dopamine pathways, 
resulting in dis-inhibition of the limbic system. 
Pauls et al. (1988) criticized the methods and conclusions of the above· author. In a 
family study of 86 probands the authors found only chronic tics (CT), and obsessive-
compulsive disorder (OCD) with increased frequency in the first degree relatives. 
They did not observe an increased frequency of any other behavipral condition 
suggested by Comings (1989) as part of Tourette syndrome spectrum phenotype by 
comparing the first degree relatives of Tourette index patients with the relatives of 
control subjects. 
Further investigations of these initial observations led to the conclusion that at least 
some forms ofOCD and CT are etiologically related to Tourette syndrome (pauls et al 
1991). The conclusion was also supported by data from families of OCD probands, 
where the rates of Tourette syndrome and CT in the relatives were elevated (Leonard 
et al. 1992, Pauls et al. 1995). In the course of the above studies it became apparent 
that the nature of obsessions and compulsions that occur among the relatives of 
Tourette syndrome probands as well as the treatment responses with respect to OCD 
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are different than those experienced by patients/families with pure OCD (no personal 
or family history of tics) (Eapen et al. 1997, Leckman et al. 1997, Zohar et al. 1997). 
Considerable effort has been made in an attempt to elucidate the relationship between 
Tourette syndrome and attention deficit hyperactivity disorder (ADHD). While 
Comings and Comings (1987) proposed ADHD to be a variant expression of the 
etiologic factors responsible for the manifestation of Tourette syndrome and CT, 
Pauls et al. (1986a, 1993) found no support for such a proposed relationship in their 
studies. They suggested that while it is possible for ADHD to be associated with 
increased clinical severity of Tourette syndrome, it is unlikely that in the absence of 
tics, ADHD was a variant expression of genetic factors underlying Tourette 
syndrome. 
In 1993, Kiessling et al. reported an increase in tic disorder frequency in children 
following a community outbreak of streptococcal infection in Providence, Rhode 
Island. Not only did tics begin abruptly following the infection, antineuronal 
antibodies directed against human caudate were found in 45% of tic cases (n=30), 
compared to 20% of controls. The authors speculated that some cases of Tourette 
syndrome may result from antibodies that cross-react with streptococcal antigens 
mainly in the basal ganglia, in a process similar to Sydenham Chorea (SC). 
In 1995, Allen et al. reported four cases of a new, infection-triggered, autoimmune 
subtype of Tourette syndrome and pediatric OCD, called pediatric autoimmune 
neuropsychiatric disorder associated with streptococcal infections (PANDAS). 
Subsequent reports have indeed suggested that an autoimmune reaction triggered by 
infection and directed against the brain may contribute to the pathogenesis of tics, 
GTS and OCD. Moreover, Swedo et al. (1997) reported that 23 of 27 (85%) 
PANDAS patients, eight of nine (89%) SD patients, and four of 24 (17%) healthy 
children were positive for a B-cell antigen, known as D8/17, an immune marker for 
rheumatic fever (RF). The fmdings were confirmed by Murphy et al. (1997). 
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Finally, an animal model was constructed to support the role. of antibodies 10 
producing tic-like movements and sounds in rats micro-infused with JgG from serum 
derived from Tourette patients. Brain slides of these rats showed preferential staining 
of striatal regions with JgG from Tourette patients but not with JgG from controls 
(Hallett et al. 1996, 1997). 
The precise relationship between the core phenotype of the tic disorder and the 
associated features await the elucidation of the nature of this condition on molecular 
level. 
1.12. The inheritance of Tourette syndrome 
The familial nature of Tourette syndrome was fIrst noted and commented on by de la 
Tourette himself in his 1885 article. 
Since a study of Eisenberger et al. was reported (1959), familial aggregation of the 
syndrome has been confmned in a large number of published and unpublished 
Tourette syndrome pedigrees. The results of most family studies were remarkably 
consistent (for review see Alsbrook and Pauls 1997) with reports of elevated rates of 
Tourette syndrome and CT among fIrst degree relatives when compared to the rates in 
control samples or the general popUlation. 
To prove the existence of genetic factors in the manifestation of the disorder, results 
of family studies were followed by the analysis of concordance rates for the affection 
status in twins. Price et al. (1985) and Hyde et al. (1992) reported signifIcantly higher 
concordance rates among monozygotic (MZ) twins as compared to dizygotic (DZ) 
twins when either Tourette syndrome, CT or OCD were considered as affected. The 
MZ twin data also suggested that non-genetic factors playa role in the manifestation 
of Tourette syndrome, since the concordance rates in affection status were < 1.0, and 
severity of affection status varied. 
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Earlier segregation analyses performed on collected family history data demonstrated 
that a single-major-Iocus hypothesis best explained the patterns of observed Tourette 
syndrome transmission (Comings et al. 1984, Devor et al. 1984, Price et al. 1988) and 
provided strong evidence for an autosomal dominant model of inheritance (pauls and 
Leckman 1986b). 
The results of two more recent segregation analyses (Hasstedt et al. 1995, Walkup et 
al. 1996) provide evidence for a major gene model with a more complex mode of 
inheritance. According to this mixed model of inheritance, it can be predicted that 
0.01 % of individuals in the popUlation are homozygous for the susceptibility allele, 
1.89% are heterozygous, and 98.1 % are homozygous for a normal allele. The 
placement of the threshold for liability indicates that all individuals homozygous for 
the susceptibility allele at the major locus are affected, whereas only 2.2% of males 
and 0.3% of females heterozygous at the major locus are affected. Parameter 
estimates from the mixed model of Tourette syndrome inheritance predict that 38% of 
individuals affected are homozygous for the major locus, whereas 62% of affected 
individuals have only one copy of the susceptibility allele. The contribution of the 
multifactorial background accounts for an estimated 40%-45% of the phenotypic 
variance (Walkup et al. 1996). 
While the mode of inheritance is not simple, it is clear that Tourette syndrome has a 
significant genetic basis and that some individuals with Tourette syndrome, CT and . 
OCD manifest variant expression of the same genetic susceptibility factors. The 
localization and characterization of genetic factors responsible for the expression of 
Tourette syndrome is of major importance for our understanding of the pathogenesis 
of this disorder. 
Attempts to localize the responsible gene(s) have thus far not yielded consistent 
positive results. Linkage analysis of data from series of mUltiply affected families 
resulted in the exclusion of> 90% of the genome (see Barr and Shandor 1998 for 
review). These analyses were completed assuming a dominant mode of inheritance 
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and locus heterogeneity for Tourette syndrome and spectrum disorders, which could 
have led to false exclusion of relevant genomic region(s). 
1.2. The aims of the study 
To elucidate the genetic basis of Tourette syndrome, different methods were 
employed during the course of the study: 
1. Increased expression of chromosomal fragile sites has been documented for 
several psychiatric and neurological disorders including schizophrenia and 
bipolar disorder. In order to systematically search for subtle chromosomal 
abnormalities and/or Tourette syndrome specific fragile site expression, 
cytogenetic investigations have been initiated in a random group of Tourette 
syndrome index cases. The initial study (Chapter 2) involved the evaluation of 
spontaneous, rare-folate sensitive and BrDU-inducible FS expression in the 
Tourette syndrome males as opposed to age-matched controls. 
2. Because the rare-folate sensitive and BrDU-inducible fragile sites represent only 
a small fraction of all fragile sites inducible on human chromosomes, a second 
study was initiated in order to investigate the expression of common fragile sites 
in the Tourette syndrome index cases as opposed to the controls (Chapter 3). The 
aim of this study was to defme those common fragile sites, which could serve as 
discriminatory cytogenetic markers for Tourette syndrome. 
3. The overvIew of literature, spannmg two decades of fragility studies was 
condensed and published with the intention to provide a theoretical background 
for our chromosomal fragility fmdings in association with the Tourette syndrome 
phenotype, as well as the identification of a new group of common aphidicolin-
inducible fragile sites, not previously reported (Chapter 4). 
4. Our initial idea to follow up a particular subgroup of chromosomal regions 
characterized by increased fragility in the Afrikaner Tourette syndrome 
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individuals on the molecular level was eventually substituted by a different 
method. The new strategy, which ·represents a unique approach to mapping a 
common complex trait, consisted of several subsequent steps. The whole genome 
search for marker-disease association was performed using pooled DNA samples 
genotyped with > 1,000 genetic markers distributed throughout the genome. 
Markers with differences in allelic distributions between case and control pools 
were then subjected to individual typings in two non-overlapping sets of case-
control samples and subsequently to the statistical evaluation of marker allele 
distributions. The published results of the work (Chapter 5) represent an 
important contribution to current Tourette syndrome gene-mapping efforts. 
5. The Afrikaner population of South Africa is regarded as genetic isolate suitable 
for gene-mapping efforts, particularly because a strong founder effect has been 
repeatedly documented for several monogenic traits with an increased prevalence 
rate in the population. For a number of these disorders, extensive haplotype 
sharing was documented among affected individuals at or near the disease loci. 
However, until recently no investigations were performed in order to examine the 
background linkage disequilibrium (LD) distribution in the general Afrikaner 
population. Our preliminary investigation of the extent of background LD 
distribution (Chapter 6) represents an important step in paving the way for 
utilizing the Afrikaner population in whole genome association studies. 
6. Significant case-control association fmdings, even when achieved in young 
genetically isolated population, may still be a result of population stratification, 
therefore all association fmdings require to be confirmed by nuclear-family-based 
linkage methods such as the transmission disequilibrium test (TDT) and/or 
haplotype relative risk method (HRR). The results of our marker-disease 
association fmdings for Tourette syndrome are regarded as preliminary, until 
confirmed by semiparametric linkagelLD methods using nuclear-family 
genotyping data in genomic regions of interest (Chapter 7). 
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1.3. Introduction to the methods utilized to investigate the genetics of 
Tourette syndrome during the present study 
1.31. Fragile sites on human chromosomes 
Agents known to inhibit DNA replication induce the expression of chromosomal 
fragile sites (FS), which appear as gaps, breaks, or discontinuities in chromosome 
structure. When examined in metaphase preparations, it is not possible to distinguish 
between a random gap or break in chromosomal structure and chromosomal FS. Only 
statistically significant recurrence of gaps, breaks, or lesions at the same chromosomal 
band (region) and under the same culture conditions delineates FS (Sutherland and 
Richards 1999). 
The majority of culture conditions resulting in FS expression cause inhibition of DNA 
repair or replication, either due to nutrient deprivation (e.g. perturbed nucleotide 
pools) or inhibition of DNA replication enzymes (e.g. DNA polymerase alpha). As a 
consequence, under-replicated DNA sequences, primarily at FS (Hansen et al. 1997, 
Le Beau et al. 1998) do not package completely before the G2 phase and manifest as 
discontinuities in chromosomal structure. 
1.311. Rare fragile sites 
FS were initially chissified according to the methods of their induction (Sutherland et 
al. 1998). The two main classes were "rare" and "common" FS. The common FS 
appear to be part of normal chromosome structure and are present at all common FS 
loci in every individual. The frequency of their expression differs among the 
individuals and is modulated by factors like age, sex, and hormonal status (Tedeschi 
et al. 1992). 
The most widely studied subgroup of the rare FS are so called rare-folate sensitive 
sites, induced by folic acid and thymidine deprivation in the cell culture media. The 
frequencies of their expression are relatively low (in -4%-20% investigated 
UNNERSI1EIT STELLENBOSCH 
B/BUOTEEK 
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metaphases) and also the population frequency of individuals carrying one of these 
sites is low (- 5%). 
Rare folate-sensitive FS comprise the most studied class of FS at the molecular level 
and their relationship with tandemly repeated sequences of varying complexity has 
been well established. The ftrst cloned FS site was FRAXA, a rare-folate sensitive FS 
at the chromosome Xq28 region, cytogenetically expressed in association with the 
most common form of male mental retardation called Fragile X syndrome. The DNA 
sequence at the FRAXA locus is characterized by tandemly repeated CCG units with 
interspersed CCT repeat units (Hirst et al. 1994). Due to increased copy numbers of 
CCG units alone (>55 repeat units), the sequence becomes prone to the expansion and 
subsequently a full fragile X mutation. A common haplotype of surrounding 
sequences has recently been characterized, which can be used to predict which alleles 
at FRAXA locus are likely to proceed to expansion (Gunter et al. 1998). 
Four other rare FS have been cloned: FRAXE and FRAXF at Xq28, FRAIIB at 
llq23.3 chromosomal region and FRA16A at 16q22. All of these sites are associated 
with (CCG)I(CGG)n triplet repeat expansions which become hyper-methylated 
beyond a critical size/number of repeats. Three of them are associated with clinical 
problems and in two cases, gene responsible for disease state was identifted: FMRI in 
FRAXA (MIM 309550) and CBL2 (MIM 165360) in FRAIIB. FRAXE has also been 
associated with a mild form of mental retardation, expansion of (CCG)n arrays (>200 
repeats) and hypepermethylation of a CpG island adjacent to a gene called FMR2 
(MIM 309548)(Gecz et al. 1996). 
FRA16A is characterized by longer CCG repeat units that lack CCT interruptions and 
are more prone to expansion (Nancarrow et al. 1994, 1995). FRAllB was found in a 
mother and brother of a child with Jacobsen syndrome, suggesting that the breakage 
in FS during early development could have resulted in a chromosome deletion in the 
patient. This FS has been assigned to an interval of approximately 100 kb containing 
the 5' end of the CBL2 gene, which includes a CCG trinucleotide repeat. The 
chromosomal deletion breakpoint in the patient was mapped within the same interval 
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(Jones et al. 1994). In later reports the association of the Ilq23.3 deletions with eeG 
expansions in CEL2 and FRAllB expression was not confmned (Michaelis et al. 
1998). 
1.312. Common fragile sites 
A large number of common FS are expressed as a result of aphidicolin (APe) 
treatment of cell cultures 24 hours before harvesting. The most frequently observed 
(-70% - 80% metaphases) in all individuals is FRA3B, the FS on chromosome 
3p14.2. The second most frequently expressed is FRAI6B, the FS on chromosome 
16q23. The frequencies of expression differ in various reports and are mainly due to 
different culture conditions and also to APe being dissolved in dimethyl sulphoxide 
(DMSO) (resulting in lower expression rates at most FS), or in ethanol. This enhances 
overall fragility caused by APe, even though ethanol itself does not induce FS 
expression and has no clastogenic effects. The rank orders of expressed FS per 
metaphase remain relatively consistent between different studies. 
Although they comprise the vast majority of fragile sites, much less is known at the 
molecular level about the "common" fragile sites. These FS sites are seen as a 
constant feature of all chromosomes and have been shown to display a number of 
characteristics of unstable, highly recombinogenic DNA in vitro, including 
chromosome rearrangements, sister chromatid exchange and, more recently, 
intrachromosomal gene amplification (Glover 1998). 
Only one such fragile site, FRA3B at 3pI4.2, has been extensively investigated at the 
molecular level. It extends over a broad region of about 500 kb, and no trinucleotide 
or other simple repeat motifs have been identified in the region. The FS lies within the 
FHIT gene locus (MIM 601153), which is unstable in a number of tumors and tumor 
cell lines (Heubner et al. 1997, 1998). It thus appears that genomic instability at 
common fragile regions has a potential to facilitate chromosome rearrangements 
associated with cancers (popescu et al. 1990, Paz-y-Mino et al. 1992, Popescu et al. 
1994, Wilke et al. 1996, Huang et al. 1998, Smith et al. 1998, Huang et al. 1999). The 
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co-occurrence of oncogenes and cancer suppressor genes at the same chromosomal 
bands as common FS has long been recognized, but only recently, studies of 
environmental and genetic factors that influence FS expression and instability became 
an important field of research aiming towards a better understanding of malignancy. 
FRAI6B, the FS on chromosome 16q23 induced by DNA minor groove-binding 
agents such as distamycin A and berenil, and FRAlOB, induced by BrdU and/or 
BrdC, have also been cloned (Yu et al. 1997, Hewett et al. 1998). Both FS are caused 
by highly expanded (up to several thousand copies to yield a fragile site) AT-rich 
microsatellite repeats, which vary in size and composition due to somatic and 
intergenerational instability. 
Different aspects of chromosomal fragility currently under investigation are: the 
potential of certain viruses to induce specific FS expression in infected cells (Li et al. 
1998) and the association of common fragility with early events of DNA 
amplification leading to acquired resistance to drugs (Kuo et al. 1998). Both types of 
observation suggest that high local levels of transcription can interfere with 
metaphase chromatin packaging and are sufficient to generate fragile chromosome 
areas. The fact that common FS could represent the cytogenetic expression of 
transcriptionally active regions was also supported by Sbrana et al (1998) in their 
study of FS expression modulation by camptothecin, a specific inhibitor of 
\ 
topoisomerase I. 
1.32. Genetic mapping 
1.321. The principles 
Genetic mapping in principle means comparing the inheritance pattern of disease 
traits with the co-inheritance pattern of certain chromosomal regions. Mendel's laws 
of genetic inheritance, and mathematical formulae developed by J. B. S. Haldane that 
relates map distances to recombination frequencies provided the key elements in early 
systematic searches for disease-causing genes in experimental crosses. After the 
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recognition of naturally-occurring DNA sequence variations as a source of genetic 
markers, it became possible to trace the Inheritance in human pedigrees. 
The aim of genetic mapping therefore, is to evaluate how often two loci (e.g. disease-
marker locus, marker-marker locus) are separated by meiotic recombination. Three 
conimon but distinct measures of the separation ofloci are used in the process: 
11 Recombination fraction, e, the probaB,ility that two loci will be separated by 
recombination at meiosis. 
2/ Map distance, measured in centimofgans, cM, named after the American 
3/ 
geneticist . Thomas Hunt Morgan, ~epresents the expected number of 
I 
recombinations occurring between tWo loci at meiosis. 1 cM equals a 
I 
crossover value of 1 %. i 
Physical distance, measured in base pairs, bps, of DNA. 
A single recombination event during meiotic ciell division produces two recombinant 
and two non-recombinant chromatids (progeny). If two loci under investigation are on 
i 
different chromosomes, they will segregate independently and the chance that a 
daughter cell will be recombinant or non-recrmbinant for these loci on particular 
chromosomes is 50%. In average, two loci cannot produce more than 50% 
recombinants, not even in the case of tlouble or triple crossover events. 
Recombination will rarely separate loci, wrich lie very close together on a 
chromosome, because only a crossover located precisely in the small space between 
I 
the two loci will create recombinants. The: further apart two loci are on the 
chromosome, the more likely it is that a cro;ssover will separate them. Thus the 
I 
recombination fraction is a measure of genetic distance between the two loci. 
I 
I 
The relationship between the recombination I fraction, genetic map distance and 
physical distance is non-linear and variable it). different parts of the genome and 
! 
between the sexes. For small distances there is ah approximate equivalence between e 
= 0.01, map distance = 1 cM and physical dis~ce = 106 bp (one Megabase). The 
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haploid human genome comprises approximately 109 Mb and has a sex-averaged map 
length of approximately 3,300 cM. 
The only possible way to recognize recombinants from non-recombinants at two 
genetic loci is to use loci with more than one sequence variant (allele) in the human 
population. Such allelic sequence variation is described as a DNA polymorphism if 
more than one variant at a locus occurs with a' frequency greater than 0.01 in a human 
population. It has been calculated that DNA polymorphisms occur approximately in 11 
, 
250 to 11 300 bases in human genomic DNA. 
The identification of different types of DN~ polymorphisms made it possible to 
develop different sets of polymorphic genetic! markers. The flrst generation of DNA 
markers, were called restriction fragment length polymorphisms (RFLPs), owing their 
1 
nomenclature to the existence of restriction site polymorphisms. They had only two 
alleles (the restriction site was either present or absent), which made most of the 
meioses uninformative for the RFLPs (the recombinants could not be distinguished 
from non-recombinants). Minisatellite (VNTR) markers were a great improvement, 
since large number of alleles became available for which most meioses were 
, 
informative. Classical minisatellites, however, have been difficult to handle with 
standard PCR techniques, because they span a large area and often fail to amplify. In 
addition, they seem to cluster in subtelomeric regions of chromosomes. 
The standard tools in current genetic mapping' efforts are microsatellites, which are 
moderately sized arrays of tandemly repeated DNA sequences, highly polymorphic 
and dispersed over considerable portions of the nuclear genome. The bulk of them are 
(CA)n repeats (Genethon). The disadvantage of markers based on dinucleotide repeat 
sequences for large-scale genotyping is that they are prone to replication slippage 
during PCR amplification. This means, each allele gives a ladder of 'stutter bands' on 
a gel, which makes genotyping results difficult to read. Tri- and tetranucleotide 
repeats usually give clearer results with a single band from each allele and are 
gradually replacing dinucleotide repeats as the markers of choice. Much effort is 
being devoted to producing compatible sets of microsatellite markers which can be 
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amplified together in a multiplex PCR reaction, and have allele sizes which allow 
them to be run in the same gel lane without producing overlapping bands (Center for 
Medical Genetics, Marshfield). 
Typing suitable families with highly polymorphic genetic markers equally spaced 
throughout the genome and scoring of the genotypes is usually followed by statistical 
evaluation of the likelihood that disease and marker loci are linked. When large and 
sufficiently informative families are used in gene mapping efforts, such an analysis is 
relatively simple. Usually, however, only imperfect family data are available and 
recombinants cannot be identified unambiguously. Computer-generated lod score 
methods subsequently have to be applied for extracting linkage information from such 
'imperfect' families. 
The lod score, Z, is the logarithm of the odds that two loci are linked (with 
recombination fraction 9) rather than unlinke~ (recombination fraction 0.5). The lod 
scores are calculated for a range of e values by looking at each meiosis, marker after 
marker (two-point linkage analysis), or by analyzing genotyping data for more than 
two markers simultaneously (multipoint linkage analysis). Alliod scores are zero at 
9=0.5 since they measure the ratio of two independent probabilities. If there are no 
recombinants between the disease and mar~er locus, the lod score will reach a 
maximum at 9=0. If there are recombinants, the thresholds for a single test are Z=3.0 
and Z= -2.0. The threshold for accepting linkage, with a 5% chance of error is Z=3.0 
or 1000: 1 odds. Linkage can be rejected if Z<-2.0. 
Values of Z between -2.0 and 3.0 are inconclusive when applying multiple marker 
typings (e.g. in whole genome searches) since t;he chances of spurious positive results 
, , 
are greater when compared to a situation where only one marker was typed. The 
threshold lod score for a study using n markers:would then be 3 + log(n). In practice, 
lod scores below 5, whether with one marker or many are regarded as provisional and 
require to be followed up by confirmatory studies (Ott 1991, Terwilliger and Ott 
1994). 
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Standard lod score analysis is a tremendously powerful method for scanning the 
genome in 20-30 Mb segments to locate disease genes. Unfortunately, it has some 
drawbacks, in that it can be effectively applied only for Mendelian monogenic 
disorders: 
• Standard lod score analysis requires specification of a precise genetic model, 
including the mode of inheritance, the gene frequency and a penetrance of 
I 
each genotype. 
• It has limits with respect to the achievable resolution - not < than 1 Mb - an 
uncomfortably large genetic region for positional cloning of an unknown 
disease gene. 
, 
• Locus heterogeneity (the disease phe~otype is produced by mutations in two 
or more unlinked genes) can cause a failure to identify linkage in either of the 
regIOns. 
Not all of the 65,000 - 80,000 human genes will be identified as disease-causing 
genes. Those genes, which are indispensable to embryonic development, where 
mutations are mostly lethal, will remain unre~orded in humans. Out of the currently 
listed 5,000 Mendelian traits, about 1I1Oth have been placed on the human genome 
map and only about 1I100th of the disease gen~s were identified by positional cloning 
(OMIM). 
1.322. Gene mapping strategies for:complex traits 
The term 'complex trait' refers to any phenotype that does not exhibit classic 
Mendelian recessive or dominant inheritance ;attributable to a single gene locus. In 
general, complexities arise when the simple 90rrespondence between genotype and 
phenotype breaks down, either because the same genotype results in different 
phenotypes (due to the effects of chance, environment, or interaction with other 
genes) or different genotypes result in the same phenotype. Most common traits of 
medical relevance belong to this category, including those responsible for 
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susceptibility to heart disease, hypertension, diabetes, cancer, infectious diseases, and 
the majority of neuropsychiatric disorders (Lander and Schork 1994). 
After impressive successes in mapping single gene disorders, the attention of many 
investigators is turning to more challengin$ problems of the genetic dissection of 
complex traits. The majority of these 'gene-hunting' efforts were, however, hampered 
by a fundamental genetic complication such as the 'imperfect co-segregation' of 
genetic markers with complex traits caused by: 
I 
11 Incomplete penetrance and high phenocopy rate, which means that the 
I 
genotype at a given locus may affecf the probability of the disease, but not 
fully determine the outcome. The predisposing allele may than be present in 
! 
some unaffected individuals and abse~t in some affected individuals. 
21 Genetic (locus) heterogeneity, implying that mutations in anyone of several 
I 
genes at different chromosomal lqci may result in identical disease 
phenotypes. One of the chromosomal loci will then co-segregate with a 
disease in some families but not in others. Genetic heterogeneity is different 
, I 
from allelic heterogeneity, in which one fmds multiple disease-causing 
I 
mutations at a single gene locus. Allelic heterogeneity tends not to interfere 
with gene mapping. 
3/ Polygenic inheritance, ( refer to those, traits which require the simultaneous 
presence of several mutations at multiple loci. Polygenic traits can be 
classified as discrete traits, measured by a specific outcome, or quantitative 
traits, measured by a continuous variable. Polygenic inheritance complicates 
genetic mapping, because no single lbcus is strictly required to produce a 
discrete trait or a high value of a quantitative trait. 
4/ High frequency of disease-causing alleles in the popUlation, often resulting in 
bilineal transmission of disease allele~ in affected pedigrees. This interferes 
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with traditional linkage analysis and becomes an even greater problem if 
, 
combined with genetic heterogeneity.l 
I 
The flrst challenge in the genetic dissestion of a complex phenotype is the 
identiflcation of a candidate map location of the genes underlying 
I 
susceptibility/resistance to the trait via cpnducting a genome-wide search for 
linked/associated genetic loci. The second cHallenge is the fme-structure localization 
, I 
I 
of any component gene to physical segments small enough to facilitate positional 
, 
cloning or recognition of candidate genes (Deylin and Risch 1995). 
I 
The methods available for genetic dissection of complex traits fall into four 
I 
categories: linkage analysis, allele-sharing methods, association studies in human 
population, and genetic analysis of large crosses in model organisms such as the 
mouse and rat. The latter will not be discussed in this thesis. 
Linkage analysis 
If a limited number of loci are major determinants of susceptibility to a complex trait, 
it should be possible to map such loci by linkage analysis (Risch 1990). Large 
pedigrees typically contain a broad spectrum of phenotypes for a complex disease, 
therefore, only families characterized by a strong history of disease, with ostensible 
mendelian inheritance can be chosen for analysis. This approach has been 
successfully applied to mapping and later identiflcation of the BRCAl (MIM 113705) 
breast cancer susceptibility gene on chromosome 17, when using age of disease onset 
as a quantitative trait (QT). By examining the inheritance pattern of pairs of regions, 
multiple sclerosis has been mapped in large Finnish kindreds to both HLA (MIM 
142830) on chromosome 6p21.3 and the gene for myelin basic protein on 
chromosome 18 (Tienari et al. 1992). 
Like any model-based method, linkage analysis can be very powerful, if the correct 
genetic model has been specifled. The use of a wrong model, however, can lead to 
misspeciflcation of true linkages or accepting false ones. For some psychiatric 
disorders this approach has been a source of false positive fmdings, e.g. in mapping 
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schizophrenia to a locus on chromosome 5 (Kennedy et al. 1995), particularly because 
the model requires persons to be classified clearly as affected or unaffected. Such a 
classification depends mainly on the age of onset of the disease, on the diagnostic 
criteria used and their reliability, and also on the validity of diagnostic categories for 
genetic research (Farmer et al. 1994). For these and other difficulties, model-free, 
non-parametric methods are preferred in psychiatric genetics. These methods ignore 
unaffected people, but look for shared chromosomal segments in affected individuals. 
Allele sharing methods 
Shared segment methods can be used in nuclear families, e.g. sib pair analysis (Fulker 
and Cardon 1994), within known extended families, or in populations that are 
descended from a small founder group (Holmas 1993, Holmans and Craddock 1995, 
Houwen et al. 1994). Pairs of sibs are expected to share 0,1 or 2 parental haplotypes 
with a frequency of Y4, Y2 and Y4, respectively. If both sibs are affected by a genetic 
disease, they will share a chromosomal region carrying the disease locus with higher 
frequency than predicted by random segregation. Sib-pair studies require no prior 
assumptions about parameters such as mode of inheritance, penetrance, phenocopy 
rate, and disease allele frequency (Kruglyak and Lander 1995a). 
The affected sib pair approach has been successfully applied to mapping the non-HLA 
susceptibility locus for type 1 diabetes on chromosome 11 (Davies et al. 1994), and is 
strongly pursued with other complex diseases, including schizophrenia, manic 
depression, alcoholism, and Tourette syndrome (The International Tourette Syndrome 
Genetic Linkage Consortium). 
Because allele-sharing methods are non-parametric (that is, they assume no model for 
the inheritance of the trait), they tend to be more robust but less powerful than a 
correctly specified linkage model. The power of allele-sharing methods to 
demonstrate linkage for a complex trait depends on a number of factors: number of 
sibships (trios, case-control individuals), degree of genetic heterogeneity, risk ratio for 
the sibs versus population prevalence, and informativeness of the marker (Goring and 
Ott 1997). In the next couple of years, the application of non-parametric methods in 
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genetic mapping is expected to produce a large number of susceptibility loci, with 
many false positive fmdings as a tradeoff. The true susceptibility loci will then have 
to be sorted out by well-designed confmnatory studies. 
An important difference between linkage mapping of single and complex disorders is 
that, whereas for single gene diseases recombination events can defme an exact 
interval in which the disease gene must lie, in complex diseases recombination events 
, 
can only alter the probability that the susceptibility locus is localized within a 
particular interval. Fine linkage mapping for complex traits, therefore, requires very 
large samples. For example, localizing a susceptibility gene to a 1 cM interval 
requires a median of 200 sib pairs for a locus causing a fivefold increased risk to a 
first degree relative and 700 sib pairs for a locus causing a 2-fold increased risk. To 
narrow the candidate chromosomal regions defmed by allele-sharing methods, 
population-based linkage disequilibrium or candidate gene approaches may be applied 
(Craddock and Owen, 1996). 
1.323. Population association studies in mapping susceptibility loci 
An alternative to linkage mapping in families is to look for statistical association 
between a disease and some marker genotype at the population level (Owen and 
McGuffm 1993, Risch and Merikangas 1996). While linkage implies a relationship 
between loci, association represents a relationship between alleles, meaning that 
unrelated people across the whole population, who have a certain allele at one locus 
have a statistically more than random chance of having some particular allele at a 
second locus. Linkage is usually necessary, but never sufficient, for allelic association 
(Hodge 1993). 
Diseas(}'-marker association studies are based on a comparison of unrelated affected 
(case) and unaffected (control) individuals with the same population background. The 
marker-allele at a particular locus of interest is associated with the disease trait if it 
occurs at a significantly higher frequency in affected as compared to control 
individuals. In the case of a positive association fmding, the associated allele may 
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directly cause susceptibility to the trait and will be associated with the disease in 
every human population. Alternatively, a particular marker is in a close proximity to 
the disease gene, which means that the allele is in linkage disequilibrium (LO) with 
the disease-causing mutation (Greenberg 1993, Hodge et al. 1981, Hodge 1994, Jorde 
1995). 
Positive association can also arise as an artifact of population admixture, meaning that 
affected and control individuals originate predominantly from ethnically different 
populations with different marker-allele frequencies (Kidd 1993). To prevent spurious 
association arising from population admixture, association studies should be 
performed within genetically homogeneous populations or by using 'internal controls' 
for marker-allele frequencies: a study of affected individuals and their parents, such as 
the haplotype relative risk method (HRR) (Falk and Rubinstein 1987, Terwilliger and 
Ott 1992), and transmission disequilibrium test (TOT) (Spielman et al. 1993, 
Spielman and Ewens 1996). 
Genomic searches for association are most meaningful if performed in young, 
genetically isolated populations in which LO extends over greater genetic distances, 
and the number of disease-causing mutations is likely to be fewer. Suitability of a 
population for the localization of disease genes by disequilibrium mapping is usually 
assessed from the demographic history of particular population,and from the 
existence of a founder effect for the disease under the study in particular population 
(Laan and Paabo 1997). 
When positive association fmdings are reported, various research groups attempt to 
replicate the original fmdings in independent studies (Sobell et al. 1993). Each of such 
conftrmatory studies, however, might slightly differ from the original design, e.g. by 
revising the defmition of the disorder. This raises a question, whether each 
conftrmatory step is in fact a valid attempt to replicate the original fmding, or whether 
each step should rather be considered an exploratory analysis generating new 
hypotheses after failing to support the original hypothesis. 
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Such 'defmition drift' can be minimized if a single group of investigators attempts to 
replicate their initial positive fmdings on discrete subsamples using uniform 
diagnostic criteria and laboratory procedures. Such a sequential approach to the study 
design and analysis of case-control data includes a reduction of the number· of 
candidates investigated (genomic areas, candidate genes, genetic markers) by testing 
(analyzing, genotyping) them subsequently and separately on several independent 
subsamples (discrete or cumulative sample approach). After each stage, significant 
candidates are tested further, until only true associations are likely to be retained. If 
1,000 candidates were tested initially, then only 1 false "positive" result is expected 
after 3 stages of testing, which minimizes the chance of a type 1 statistical error 
without seriously decreasing the power of the study (Schaid and Sommer 1994, Sham 
1994). 
Typing hundreds of markers in order to achieve sufficient coverage of the genome for 
LD studies, apart from the amount of labor and cost of genotyping, raises a serious 
problem of multiple hypothesis testing. The threshold for the genome-wide (multiple 
hypothesis testing) significance is set at p=0.05/n, where n is the number of 
independent potential associations checked (Kruglyak and Lander 1995b, Lander and 
Kruglyak 1995, Morton 1998, Kruglyak 1999). Such correction of statistical 
significance may cause important findings to be missed, because only extraordinarily 
strong association fmdings would remain significant after the correction (Curtis 1996, 
Witte et al. 1996). Having to deal with the statistical complications and with high 
false positive rates, have led most researchers to accept consistent replication as the 
best evidence for a true association. It is therefore recommended by many, that even 
the fmdings which did not produce assigned genome-wise significance, and only 
achieved point-wise significance level should be followed up in a multiple testing 
manner. 
1.324. DNA pooling and case-control association stUdies 
Determination of genotypes at several hundred polymorphic loci in hundreds of 
individuals is required for mapping complex traits. The idea of using pooled DNA 
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samples to reduce the burden of labor and cost intensive genotyping was ftrst 
suggested by Arnheim et al. (1985) in the context of case-control studies. This author 
argued that alleles in LD with a disease would be enriched (or deftcient) in a pooled 
DNA sample of affected individuals in comparison with a pooled control DNA 
sample. 
Initially, the pooled DNA sample approach has been applied as a genetic mapping 
tool in isolated populations with reduced allelic diversity, e.g. in mapping the gene for 
Bardet-Biedl syndrome (Sheffield et al. 1994), cerebellar ataxia (Nystuen et al. 1996), 
and autosomal recessive non-syndromic hearing loss (Scott et al. 1996). In all the 
above studies it was expected that affected individuals would be homozygous for a 
single marker allele at a locus closely linked to the disease gene. Thus the markers 
were identiftable by visual examination of either silver-stained or radioactively 
labeled markers. 
For complex phenotypes it is inevitable to quantify the marker allele frequencies, 
since the prevalence of individuals homozygous for a marker allele linked to the 
disease locus will not reach or be close to 100%. The quantification of marker allele 
frequencies is only possible by direct genotyping, but can also be estimated from 
pooled PCR products (Graff et al. 1997). It has been well documented that the allele 
frequencies estimated from pooled DNA samples show a correlation with allele 
frequencies obtained by direct genotyping. Estimations were mostly made using 
GENES CAN software for quantifying allele ampliftcation at polymorphic markers 
using 5' fluorescently labeled forward PCR primers. 
A good correspondence of the PCR products from the pooled samples with those 
obtained by direct genotyping was also achieved for shorter alleles, even though it is 
well known that PCR may be biased towards greater efficiency of ampliftcation of 
shorter, rather than longer, DNA templates. The trend of frequencies from smaller 
alleles to be overestimated and larger alleles to be underestimated in pooled PCR 
products is, however, minor and does not appear to signiftcantly affect overall allele 
frequency estimations (pacek et al. 1993, Shaw et al. 1998a). 
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DNA pooling can be efficiently used as an initial searching tool for a candidate map 
location of susceptibility/protective genes via a genome-wide screen. The method can 
also be employed to follow up and confIrm regions identified in linkage studies or to 
investigate candidate disease loci. The experimental designs using a pooled DNA 
approach should also include application of correction methods for stutter artifact and 
preferential ampli~cation (Barcellos et al. 1997, Daniels et al. 1998). 
When initial identification of relevant loci is followed by individual genotyping, the 
estimation of actual allele frequencies in pooled samples is not crucial. Rather it is 
important to recognize the variance in allele distributions between applicable DNA . 
pools at a large number of loci. It is expected, that by employing such a research 
strategy, subtle differences in allele distributions could be missed in the initial screen 
without any major consequences, since they are not important and will not give rise to 
statistically significant differences between case and control groups following 
genotyping of individual DNA samples. The visual examination of radioactively 
labeled peR products is therefore expected to be sufficiently powerful to recognize 
significant differences between applicable DNA pools. 
1.325. Linkage disequilibrium mapping 
It has long been recognized that classical linkage methods which had been 
successfully used for mapping genes with major effects have limited power to detect 
genes of modest effect, which are more likely to be responsible for complex traits 
(Risch and Merikangas 1996). Gene-mapping efforts have therefore been redirected 
towards linkage disequilibrium (LD) mapping which relies on the assumption that a 
single ancestral mutation is responsible for a large proportion of disease cases in a 
present day popUlation. Such a mutation is considered to have arisen originally in a 
chromosomal region carrying a particular set of marker alleles.,.. the ancestral 
haplotype (Kruglyak 1997). 
The size of the preserved original ancestral haplotype in the present day population 
largely depends on the number of generations since the introduction of the mutation 
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into the population, and the recombination frequency between loci at a particular 
chromosome region. The detection of identity by descent (IBD) region (ancestral 
haplotype) among affected individuals on a population level provides a strong 
evidence for the presence of a relevant disease gene in the region. 
Formal analysis of IBD in population samples is usually based on the evaluation of 
LD - that is, non-random association between individual marker and disease alleles 
(Service et al 1999). Associations between any flanking marker alleles in general, can 
be produced by several factors: recent mutation at one of the loci; population founder 
effect; admixture between populations with different allele frequencies at the loci; 
selection; or demographic history of the popUlation (Luo 1998). The magnitude ofLD 
is maintained by the recombination frequency between the loci and dissipates more 
rapidly with physical distance in telomeric regions of the chromosomes than in 
centromeric regions (Watkins et al. 1994). 
In the human genome, LD has been studied mainly in genetic regions surrounding 
disease genes on affected chromosomes. LD has been successfully applied for the ftrst 
time in cloning the cystic ftbrosis gene (Riordan et al. 1989) and since then widely 
used for the fme-mapping stage of the localization of disease genes in single founder 
popUlations (Devlin and Risch 1995, Jorde 1995, Peterson et al. 1995), because it 
incorporates information on recombinations that have occurred during the entire 
period from the mutational event to the present time (de la Chapelle and Wright 
1998). 
Although there is growing interest in the employment of LD for initial genome-
screening studies of complex diseases, the use of the method has been limited until 
recently to the mapping of rare monogenic diseases in genetic isolates (Friedman et al. 
'. 1995, Houwen et al. 1994, Newport et al. 1996). This limitation has mainly been 
technological, since in most populations, LD extends over very small genetic 
distances and to identify shared segments or disease associated genetic regions on the 
population level requires typing of an impractically dense set of genetic markers. 
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For example, in mixed populations, such as the American population, LD is not 
expected to exceed ~ cM, in which case at least 6,000 markers would be required to 
examine disease-marker associations. The exception are young, genetically isolated 
populations in which LD extends over greater genetic distances (Peltonen 1996). In 
these populations, LD is expected to stretch a distance of up to 3 cM around disease 
loci, in which case testing of 1,100 evenly spaced genetic markers is required for a 
genome-wide LD study. 
Today, the problems with utilization of LD are no longer technological. The key 
issues are analysis and interpretation of large-scale genotyping data. There is a 
growing consensus among geneticists that full utilization of current and forthcoming 
technological tools will require a better understanding of population genetics and the 
distribution ofLD across the human genome (Freimer et al. 1997). 
It has been speculated that genes for rare monogenic traits are caused by relatively 
recent mutations, which are more likely detectable in populations with 'star-like' 
genealogies and so called founder effects. The reverse situation would prevail in the 
case of alleles involved in complex traits. Such alleles, which are generally common 
in the population, are likely to be old. According to computer simulation studies, a 
large area of LD in populations with a constant size will surround such an old 
mutation, whereas in recently expanded populations, the area will display very little 
LD (Slatkin 1994, Terwilliger et al. 1998). Consequently, there is a substantial 
probability of obtaining significant nonrandom associations between closely spaced 
neutral loci in populations with a constant size (at equilibrium under mutation and 
genetic drift), while there is a very little chance of fmding nonrandom associations 
even between completely linked loci if the population growth has been sufficiently 
rapid. 
The conclusions achieved by computer simulations have been supported by studies of 
Laan and PiUibo (1997) in populations of Saami, Swedish, Finnish and Estonian 
males. Finns and Saami (formerly known as Lapps) are two populations living in 
close geographical proximity, but with a completely different demographic history. 
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While the Finnish population expanded rapidly in the last few thousand years, the 
Saami do not present evidence of any such expansion. The authors established their 
genotyping results from 7 dinucleotide repeat loci spanning a region of about 4 cM 
on chromosome Xq13. While several pairs of loci in the Saami contributed to the 
fmding of non-random allelic associations in the region, only one pair of closely 
spaced loci displayed significant LD level in the Finish population. This pair of loci 
shows strong association in two admixed populations from Fenno-Scandinavian 
region (Swedish and Estonian) used for comparison purposes under the same study 
circumstances (cryptic duplicate markers? - Center for Medical Genetics, Marshfield). 
On the contrary, Peterson et al. (1995), who studied background LD distribution in 
Finns over several regions on chromosome 4, detected LD between· a number of loci 
separated by more than 1 cM. Freimer et al. (1997) argues that the divergent fmdings 
of the two studies are probably caused by two factors, which have been proven to 
influence the ability to detect LD: variable genomic regions and marker 
heterozygosity. Freimer et al. (1997) also criticized the conclusion, that rapidly 
expanding popUlations will not be useful for mapping genes that contribute to disease 
susceptibility, mainly because of a difference between methods for quantifying 
background LD and those that search for LD around a disease locus. 
1.325. Linkage analysis in nuclear families. 
It has long been recognized that combining association and linkage strategies in 
mapping genes for complex diseases is inevitable (Rutter 1994). The two methods 
have different advantages and disadvantages. While the strength of linkage studies has 
been proven by mapping large number of rare monogenic mendelian disorders, the 
great strength of association studies lies in their power to detect genes of very small 
effect not detectable by classical linkage methods (a crucial asset When studying a 
multiple gene disorder). 
The power of association studies is, however, compromised by numerous weaknesses. 
Firstly they are successful only if the marker itself is of pathological importance, or it 
/ 
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is very close to a susceptibility locus, which usually means impractically dense 
marker maps have to be typed in order to detect genome-wide associations. Secondly, 
, 
the use of anonymous markers for association studies is limited by the fact, that if 
linkage exists between an anonymous marker and a disease locus, yet the alleles at 
both loci are in linkage equilibrium, then an association between them will not be 
detected (Schaid and Sommer 1993). Third, an important weakness of conventional 
association studies is a high rate of spurious associations resulting from inadequate 
matching of cases and controls, especially when there is ethnic heterogeneity within 
sampled populations. 
The development of family-based association methods helped to overcome high rates 
of false positive association findings by allowing an artificial well-matched control 
sample to be constructed from marker data generated from family members of 
probands in the same study (Craddock and Owen 1996). 
Rubinstein et al. (1981) and Falk and Rubinstein (1987) recommended using the 
affected offspring's genotype (made up of alleles transmitted from parents to the 
affected child) at the marker locus as the 'case' sample, and an artificial genotype 
made up of the alleles not transmitted to the child from its parents as the 'control' 
sample in an association test. This method is sometimes called the affected family-
based control or haplotype relative risk (HRR) method and can be applied either to 
genotypes or alleles. Statistically, HRR is a weighted average of two odds ratios: (1) 
the odds of the presence of a particular marker among either of the two alleles 
transmitted to the affected child are divided by the odds (2) that the marker is among 
either of the two non-transmitted alleles (Schaid and Sommer 1993). The validity of 
HRR methods as tests for association or linkage depends on the structures of the 
pedigrees (i.e., simplex or mUltiplex pedigrees) as well as the popUlations to which 
they are applied (Spielman and Ewens 1996). 
Ott (1989) and Terwilliger and Ott (1992) further dermed the statistical properties of 
the HRR for diseases with a recessive-like mode of inheritance. They developed a 
haplotype-based haplotype relative risk method (HHRR) in order to make a better use 
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of all the information present in the nuclear family data via discrimination between 
parental homozygotes and heterozygotes for a particular allele. Genotype-based HRR 
(GHRR) of Falk and Rubinstein (1987) does not treat each of the two parental 
genotypes as independent observations, which makes the HHRR method more 
powerful for mapping complex traits with recessive-like inheritance. In the case of a 
dominant disease with reduced penetrance, it is better not to distinguish between 
parental homo- and heterozygotes for associated alleles. In this case GHRR is more 
powerful as a gene-mapping tool. 
As an alternative to the HRR method of analysis, Spielman et al. (1993)· proposed the 
transmission/disequilibrium testing (TDT) as means to test for linkage in the presence 
of association. The TDT method evaluates whether the frequency of transmission of 
alleles from heterozygous parents to their affected children deviates from 50%, the 
expected; mendelian frequency when there is no linkage. The TDT method can be 
applied to large pedigrees with many affected subjects as well as to a single disease 
case per family (simplex family), provided that genotypes for both parents of the 
affected subjects are available (Schaid. 1998). However, a simplex family is 
informative for linkage only when linkage disequilibrium exists - that is, when the 
likelihood of the coupling and repulsion linkage phases in the parents are not equal 
(Spielman et al. 1994). 
The TDT methods allow computation of P values by means of the "I} distribution, 
which is valid only when the number of informative (i.e., heterozygous) parents in the 
study is large. Although designed as a linkage test, the TDT is also valid as a test of 
association in simplex families, even in the presence of admixed population structure. 
The TDT is not valid as a test for association if the families are multiplex (contain 
affected sibs) or have affected members in multiple generations (Spielman and Ewens 
1996). The reason is that any "I} test assumes independent observations for the data, 
and marker data sampled from related affected individuals are not necessarily 
independent, even when association is absent (i.e., under the null hypothesis for tests 
of association). 
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When the TDT is. used to test for linkage, it is valid to use all affected subjects who 
have parental data: The false positive rate for linkage is not inflated, even if subjects 
are genetically related, because under the null hypothesis of no linkage, the 
transmission of parental marker alleles follows Mendel's law of transmission, so that 
sibs are independent (Spielman and Ewens 1996). 
Shortly after the introduction ofTDT, the intended use was as a test for linkage with a 
particular marker - for example, at or very near a candidate gene. Since then, the TDT 
has also been used as a screening test and applied to data from many markers 
throughout the genome. This is usually associated with a large increase in type I error 
(false-positive) rate and as a result of that, for each individual marker, a significance 
level smaller (more extreme) than the nominal level should be required. While for 
standard lod score analysis or the affected sib-pair method the maximum lod scores 
are considered statistically significant if > 3 (which approximately translates to 
P=.0001), the TDT method is often claimed to be statistically significant if P<.05. 
Even though stringent, the suggested per-locus significance levels are still achievable 
) 
when standard lod score analysis, or affected sib-pair methods are used, because there 
is a high correlation with the evidence for linkage at closely linked markers. In the 
case of TDT, scores for closely spaced markers do not necessarily exhibit high 
correlation (Spielman and Ewens 1996). Therefore, in order to achi,eve a specific 
genome-wide significance level, the per-locus significance level must be essentially 
equal to the genome-wide rate divided by the number of marker loci (standard 
correction for multiple independent tests derived from the Bonferroni inequalities). 
In general, TDT has greater power to detect linkage for a genetic trait with a 
recessive-type inheritance model than for a dominant-type model. Its power is also 
higher when there is a greater difference in marker allele frequency between disease 
and normal chromosomes (the presence of association). On the other hand, factors 
like increased recombination rate, decreased penetrance, recurrent mutation at the 
marker or at the disease locus, older age of the mutant disease allele, and incomplete 
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initial LD between marker and disease locus (Xiong and Guo 1998), all negatively 
influence the power ofTDT. 
Apart from the above reasons, collecting DNA from parents of affected probands is 
also useful for the construction of multimarker haplotypes, which can be much more 
informative for mapping disease genes than to study single markers at a time (Lander 
and Schork 1994). As was discussed in the previous chapter (1.324), associations are 
preserved between alleles at tightly linked loci under conditions of LD. This means 
that LD can be evaluated through identification of conserved haplotypes among 
affected individuals, rather than with statistical tests of association (Houwen et al. 
1994). The detection ofIBD-shared haplotypes (chromosome segments) in the case of 
rare recessive conditions is possible from marker analysis of a handful of disease 
chromosomes, provided patients are distantly related. In the case of dominant traits, 
the search for shared chromosome segments is only feasible with a larger sample size, 
depending on disease penetrance, and disease heterogeneity (either allelic, locus, or 
etiological). 
In order to distinguish haplotypes 'identical-by- state' (IBS) from those 'identical-by-
descent' (IBD), dense maps of highly informative markers have to be typed spanning 
existing regions of interest. The probability of IBD haplotype sharing among affected 
individuals on the population level at or near non-disease loci is very small. Such 
sharing may, however, occur as a result of a background kinship - that is, individuals 
share an IBD haplotype for a different reason than a common affected ancestor. In 
heterogeneous populations, the extent of background kinship is very small; 
characterized by a kinship coefficient < .0001. In isolated popUlations, on the other 
hand, the kinship I coefficient increases dramatically, as a result of higher 
consanguinity rates, and is often> .01 (Kruglyak 1997). 
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CHAPTER 2. 
American Journal of Medical Genetics (Neuropsychiatric Genetics) 60:444-447 (1995) 
Increased Chromosomal Breakage in Tourette syndrome 
Predicts the Possibility of Variable Multiple Gene Involvement 
in Spectrum Phenotypes: Preliminary Findings and Hypothesis 
George S. Gericke*, Ingrid Simonic*, Elma Cloete*, Cecile Buckle*, and Piet J. 
Becker** 
*Department of Human Genetics and Developmental Biology, University of Pretoria, and **Center for 
Epidemiological Research in Southern Africa, MRC, Pretoria, South Africa 
Increased chromosomal breakage was found in 12 patients with DSM-IV 
Tourette syndrome (TS) as compared with 10 non-TS control individuals with 
respect to untreated, modified RPMI, and BrdU treated lymphocyte cultures 
(P<O.OOI in each category). A hypothesis is proposed that a major TS gene is 
probably connected to genetic instability, and associated chromosomal marker 
sites may be indicative of the localization of secondary genes whose altered 
expression could be responsible for associated comorbid conditions. This concept 
implies that genes influencing higher brain functions may be situated at or near 
highly recombinogenic areas allowing enhanced amplification, duplication and 
recombination following chromosomal strand breakage. Further studies on a 
larger sample size are required to confirm the findings relating to chromosomal 
breakage and to analyze the possible implications for a paradigmatic shift in 
linkage strategy for complex disorders by focusing on areas at or near unstable 
chromosomal marker sites. 
KEYWORDS: 
© 1995 Wiley-Liss, Inc. 
Tourette syndrome, chromosomal instability, spectrum 
disorder, behavioral genetics, brain evolution 
Stellenbosch University  https://scholar.sun.ac.za
33 
The extent of comorbid behavioral abnormalities described in association with 
Tourette syndrome (TS) and related tic disorders (Singer and Rosenberg 1989, 
Trimble 1989, Sverd 1991, Comings and Comings 1993) complicates both diagnostic 
precision as well as optimal research design as required for demonstration of linkage 
or significant association with a defmed marker. 
While most pedigree analyses predict TS to be due to a single autosomal gene 
disorder (Baron et al. 1981, Kidd and Pauls 1982, Comings et al. 1984, Devor 1984, 
Pauls and Leckman 1986) almost the whole autosomal genome has now been 
screened without linkage being demonstrated (Heutink et al. 1993). The possibility of 
heterogeneity has been invoked to explain the inability to reproduce linkage fmdings. 
Both linkage and association studies have failed to yield the expected insight into 
many complex neurobehavioral disorders (Crowe 1993, Kidd 1993). 
In this paper we suggest another approach based on the fmding of increased 
spontaneous and chemically induced chromosomal instability in TS patients which 
could possibly supply marker sites for identification of the genes involved in the 
heterogeneous presentation of this, and possibly other neurobehavioral spectrum 
disorders. 
The study was initiated because of the fmding of increased fragility observed during a 
fra-X cytogenetic workup of a retarded nondysmorphic male with tics where 14 
percent of metaphases showed chromosome breakage at 3p13 and expression of an 
Xq26 fragile site; and the presence of a 46,XY, t(7;12)(q22q24.1) karyotype in 
another mildly retarded child with tics and self-injurious behavior. The breakpoint at 
7q22 in this patient was similar to that described in several relatives in a TS kindred: 
46,XX/XY, t(7;18)(q22;q22.1) by Comings et al. (1986). 
Spontaneous, modified RPMI (modRPMI)(lrvine Scientific) and BrdU(Sigma) 
inducible breaks (Sutherland and Ledbetter 1989, Sutherland 1991) were studied in 12 
males with DSMIV Tourette syndrome (7 children, 5 adults) and 10 unaffected junior 
male students. Blood samples were collected after informed consent was obtained. 
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For patient and control subjects three lymphocyte cultures were set up simultaneously. 
Investigator who treated the cultures, and analyzed all slides, was blind to the 
affection status of the individual cases. RPMI 1640 (Highveld Biological) medium 
supplemented with 10% fetal calf serum (SteriLab) was used in two cultures, and mod 
RPMI (folic acid and thymidine deficient medium) with the fetal calf serum 
supplement reduced to 5% was used to establish a third culture. Cultures were 
maintained for 72 hours. 40mg/L BrdU was added for the last 16 h to one of the 
cultures growing in RPMI 1640 medium. Colcemid (0.2/..lg/ml) was added to all 
cultures 35 min prior to harvesting. Chromosome spreads were obtained according to 
the standard procedure: 0.075M KCI for 10 min, methanol:acetic acid 3:1 fixation. 
For the analysis of breakage rate and the location of breakpoints, 100 G-banded 
metaphases at 400-band level from the spontaneous (untreated) cultures and 50 
metaphases from mod RPMI and BrdU-treated cultures were scored for each 
individual. Chromatid and/or chromosome breaks were assigned as a single event; the 
few chromatid type of exchanges were considered as double events. After testing for 
equality of variance in the TS and control groups, these groups were compared with 
respect to the mean number of aberrations per cell using the appropriate two-sided 
Student t-test at the 0.05 level of significance. In view of the small sample size, the 
results from the t-test were confirmed employing non-paramatric Mann-Whitney test. 
The only specific rare folate-sensitive fragile site induced in TS cells was 
fra(10)(q25). For each of the 3 categories-untreated, mod RPMI-, and BrdU-treated 
categories - the TS and control groups differed significantly (P<0.001 in each 
category) with respect to the mean number of aberrations per cell (Table 1). These 
results indicate that TS cells manifest chromosomal instability in this preliminary 
study. 
Although an analysis of the relevance of particular breakpoints has not been possible 
due to the small sample size, breakage sites observed in our patients may be of 
pathogenetic importance because some of them appear to be at areas previously 
implicated in linkage studies for neurobehavioral disorders. Some interesting 
differences in this preliminary study were fragility at 22q 12-q 13 in all TS patients and 
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none in the controls; this area has recently been considered with regard to potential 
linkage with schizophrenia (Pulver etal. 1994); involvement of 18q22 previously 
considered to be associated with TS (Comings et al. 1986; Donnai 1987) and 
Xp221Y q 11-12 homologous areas implicated frequently in TS patients indicating a 
possible involvement of pseudo-autosomal genes. 
TABLE 1 
Mean number of aberrations per cell for the TS and control groups 
No. of cells 
Treatment analyzed 
Category per patient 
Untreated 100 
ModRPMI 50 
BrdU 50 
Mean (sd) no. 
of aberrations/cell 
Patients Controls 
(n=12) (n=lO) 
0.121 0.052 
(0.034) (0.026) 
0.255 0.086 
(0.074) (0.044) 
0.163 0.092 
(0.050) (0.033) 
P-values 
t-test 
<0.001 
<0.001 
<0.001 
Mann-
Whitney 
test 
<0.001 
<0.001 
=0.0024 
In addition one patient with TS and 47, XXY with paternal pseudoautosomal 
nondisjunction as a possible mechanism being responsible for the 47, XXY karyotype 
and two with fragility at Xq27.3 in association with TS were observed before 
initiating the study protocol as reported here. 
Barletta et al. (1991) reported the association of other fragile sites in three families 
with the fragile X-syndrome and considered the existence of some underlying genetic 
mechanism in both autosomal fragile sites and fragile X-syndrome. The degree of 
fragility in obliga~e female carriers of the fragile X chromosome was found to be a 
potentially important predictor of psychopathology among women with normal IQ 
(Freund et al. 1992). Women with positive fragility scored highest on the "odd 
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communication" and "peculiar mannerisms" (?tics) items. Increased fragility was 
found to be associated with schizotypal· features. The authors stated that a need exists 
to clarify the nature of the association between the clinical neuropsychiatric 
phenotype and fragile site expression. 
Garofalo et al. (1992) found increased fragility in association with schizophrenia and 
considered the possibility that this fmding may be useful for the search for the 
location of major genes for that disease. The existence of significant overlap between 
schizophrenia and severe TS has been documented (Comings 1990). 
Several investigators have published reports of an association between TSand 
chromosomal abnormalities. At the Sixth Genetic Workshop on TS in the Netherlands 
in 1990, case studies were reported with TS like symptoms and changes in 
chromosomes 3, 8, 9, and 13. TS phenotype co-segregating in two instances with an 
18q22.1 abnormality was reported by Comings et al. (1986) and Donnai (1987). Co-
occurrence of TS with FRAXA (Kerbeshian et al. 1984), trisomy 21 (Barabas et al. 
1986), karyotype 47, XYY (Marskey, 1974),47, XXX and 9p monosomy (Singh et al. 
1982), and 9p monosomy alone (Taylor et al. 1991) were also reported. 
The high prevalence for tic related disorders could indicate an evolutionary 
advantage, and a proportion of any population would harbor this "instability" 
phenomenon and benefit from it by increased recombination, preventing inbreeding 
depression of genes coding for higher brain functions. In this regard, the term 
"recombination-enhancing areas" may be more appropriate than the negative 
connotation ascribed to "instability". Models have been proposed (Windle et al. 1991, 
Kimmel et al. 1992) indicating the possible importance of chromosome breakage and 
subsequent gene deletion resulting from resection of broken chromosome ends, as 
initial events in gene amplification. Are we witnessing genetic changes relevant to the 
evolution of a more complex nervous system? Although instability makes the genome 
more sensitive to environmental input, this may, however, render it more vulnerable 
to injury, for which certain mental disorders could represent the penalty. 
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Phenotypic heterogeneity could result from environmentally precipitated genetic 
instability in susceptible individuals, varying degrees of which might predict severity 
of behavioral dysfunction in TS gene carriers. 
Over time, a complex and expanded list of behavioral and medical problems could 
presumably result from the same underlying phenomenon. In this regard, it would be 
interesting to consider the possibility of a fundamental interrelationship between TS 
and other conditions such as fra-X and auto-immune problems, all recorded as 
problems with an increased prevalence in inbred old Colony Mennonites (Jaworski et 
al. 1989). This may be informative for the study of possible pathogenic relationships . 
between such conditions in larger outbreed populations. 
TS appears to represent a condition where more comorbid disorders cosegregate, and 
as proposed here, more genes be differently expressed than would be expected in 
circumscribed psychiatric syndromes. If confIrmed, this phenomenon may allow 
multiple gene involvement in TS to be used as an entry to identification of major 
genes for other disorders not manifesting as spectrum conditions, but which are 
usually expressed as comorbid disorders in TS pedigrees. 
The need for a heuristic model in complex multifactorial neurobehavioral disorders is 
evident. In this regard, comments concerning studies on alcoholism, (Devor 1993) 
may be considered relevant for the study of TS as well; namely, that a paradigmatic 
shift in linkage strategy away from the search for the gene should be redirected 
towards fmding regions of interest that can be more fully explored by other molecular 
techniques. It is not (yet) possible to make this assumption, and for this reason a 
further study on a larger patient sample is in progress. 
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CHAPTER 3 
American Journal of Medical Genetics (Neuropsychiatric Genetics) 67:25-30 (1996) 
Increased Expression of Aphidicolin-Induced Common Fragile 
Sites in Tourette Syndrome: The Key to Understand the 
Genetics of Comorbid Phenotypes? 
George S. Gericke*, Ingrid Simonic*, Elma eloete*, and Piet J. Becker** 
* Department of Human Genetics and Developmetal Biology, University of Pretoria, and 
** Center for Epidemiological Research in Southern Africa (CERSA), Medical Research Council, 
Pretoria, South Africa 
In a comparison of 80 common aphidicolin-inducible fragile sites (FS) between 
26 DSM-IV Tourette syndrome (TS) and 24 control individuals, the mean of the 
summed break frequencies following mild aphidicolin pretreatment was 
significantly higher in TS individuals than in controls (P<O.OOI). Other 
breakpoints encountered during this study, i.e., random breaks, breaks 
corresponding to rare FS, and breakpoints recorded by others but not listed as 
common FS according to the Chromosome Coordinating Meeting (1992) were 
listed as category II breakpoints. By using the most significantly different mean 
FS breakage figures !between TS and control individuals, further stepwise 
discriminant analysis allowed identification of TS individuals from only a few 
sites in both the common FS and category II breakpoint groups. Future research 
needs to focus on confirmation of altered common fragile site expression in 
association with behavioral variation, whether expression of certain 
discriminatory sites concurs with specific comorbid disorder expression; the 
nature of the molecular alterations at these FS and the implications of a genomic 
instability phenotype for the mapping of a primary TS gene or genes. 
© 1996 Wiley-Liss, Inc. 
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Tourette syndrome, aphidicolin, common fragile sites, gene 
mapping, tandem repeat sequences 
Tourette syndrome (TS) is a common, heritable tic disorder associated with obsessive 
compulsive behavior and attention deficit-hyperactivity which are regarded as integral 
components of the phenotype (KurIan et al. 1994), while the relationship to a wide 
range of additional reported comorbid problems (Comings and Comings 1993) 
remains controversial. Most research fmdings indicate that TS is due to the effect of a 
single major autosomal gene (Baron et aL 1981, Kidd and Pauls 1982, Comings et aL 
1984, Devor 1984, Pauls and Leckman 1986), which is supported by genealogical 
research indicating a gene founder effect in South Africa (Torrington and Gericke, 
unpublished data). Alternatively, the complex spectrum of manifestations suggested 
to others the possibility of polygenic inheritance (Comings 1994). 
The recent observation of increased chromosomal breakage in TS has been proposed 
as a basis for the consideration of variable multiple secondary gene involvement at 
chromosomal fragile sites in complex behavioral disorders (Gericke et aL 1995). 
Fragile sites (FS) are nonrandom heritable sites on chromosomes that can be induced 
to form gaps, breaks, and rearrangements under specific conditions (Jordan et al. 
1990). Both rare and common FS are expressed in culture under conditions which 
inhibit DNA synthesis. FS may represent "active genomic sites that are vulnerable to 
physiological and environmental disturbance" (Yunis and Hoffinan 1989). Because 
the different classes of FS reveal cross induction (Yunis et al. 1987, Hecht et al. 
1988), it was suggested that FS may be indicative of areas of shared molecular 
homology in the sequence composition of nonrandom chromosomal DNA (Stopera 
1989), and that such sites can be general targets of mutagenic action. 
Since aphidicolin-induced common FS have been postulated to be of pathologic 
importance (Hecht 1991), we decided to investigate whether increased fragility of 
these sites are present in TS individuals, and whether any specific aphidicolin-induced 
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breakpoints could be demonstrated to be characteristically associated with TS clinical 
diagnosis. 
Material and methods 
Five to ten milliliters of heparinized blood for chromosome culturing was collected 
from individuals after informed consent was obtained. 
Patients 
This group of young adult Caucasians included 15 males and 11 females. All of these 
26 individuals had mild, though clearly recognizable motor and/or vocal tics, but were 
moderately to severely handicapped by associated obsessive-compulsive disorder, 
residual learning problems, or conduct disorders. Nineteen relatives from 6 families 
were included in this group. They were diagnosed as having TS by means of DSM-IV 
criteria, had positive family histories of a tic disorder in all instances, and were 
selected according to whether their clinic visits coincided with days that were 
convenient to the laboratory, whether they gave informed consent to participate in the 
study and whether matched controls were available. The choice of this age cohort 
allowed a clear retrospective evaluation of the longitudinal patient histories and 
permitted exclusion of other potentially confounding psychiatric or neurologic 
differential diagnoses. 
Controls 
Twenty-four randomly selected emotionally stable Caucasian medical students 
volunteers consisting of 14 males and 10 females. There were no significant 
differences in the mean age between patients and controls, and in the mean age of 
males and females within the groups. 
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Procedure 
Coded blood specimens from both patients and controls arrived simultaneously to the 
laboratory in batches of varying sizes. Patient and control specimens were thus 
handled together, and culture preparation and analysis of slides were performed by a 
single investigator who had no knowledge of the clinical status of the individuals 
being tested. 
Cell cultures 
Phytohemagglutinin (PHA) stimulated blood lymphocytes were cultured in RPMI 
1640 medium (Highveld) supplemented with 10% fetal calf serum (GIBCO) for 72 
hours at 37°C. Twenty-four hours prior to harvesting, aphidicolin dissolved in 70% 
ethanol (MERCK) was added to each 10 ml culture to obtain a fmal concentration of 
O.1J.lM. Colcemid (0.2 ml)(SIGMA) was added for the last 35 minutes. Cells were 
then treated with a hypotonic 0.075 M KCI solution for 12 minutes and ftxed in 
methanol: acetic acid ftxative. Slides were made, air dried and GTG banded. 
Analysis 
Three to four slides from each individual were analyzed, and for each patient one 
hundred complete metaphases were assessed at 350-400 band level. Aberrations (gaps 
and breaks) were counted as single event at the band(s) involved. In some 
metaphases, it was not possible to identify the individual chromosomes and 
chromosome bands because of the extent of breakage. Such pulverized cells were not 
included in the analysis. 
All events on the band were recorded, i.e. chromatid gap or break, chromosome gap 
or break, or chromatid exchange. In case a gap or break occurred on both homologues 
in the same band, it was counted as two events. 
Frequencies of 80 common aphidicolin-inducible FS were evaluated according to 
criteria formulated by the Chromosome Coordinating Meeting (CCM) (1992). (Table 
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1) All other breakpoints, including rare FS, breaks reported by others but not listed by 
the CCM 1992 as common fragile sites, and all breakpoints regarded as random, were 
listed separately. (Table 2) These sites included only those breakpoints from the 
group, which occurred in most of the individuals in low frequencies, or which 
occurred in only some of the samples, but in higher frequencies, comparable to those 
of common FS, in both TS and non-TS groups. 
Results 
The differences in the mean number of aberrations per cell between TS and controls 
for known aphidicolin-inducible FS, and for breakpoints, not listed as common FS by 
CCM 1992 are shown in Tables 1 and 2. 
In order to develop a classification function for characterization of TS patients, a 
stepwise discriminant analysis was utilized. The sample size was not adequate to 
include all the sites into the analysis. Hence to decide which sites to include, the two 
groups were compared with respect to the mean percentage of breaks at each site, 
using the appropriate t-test after comparing the groups for equal variance using 
Levene's test. Those sites for which the two groups were significantly different 
(P<O.05) with regard to the mean percentage of breakages, and who additionally 
displayed mean differences >5% between patients and controls were subsequently 
included into a further stepwise discriminant analysis. 
Standard Aphidicolin-Inducible Sites (Table1) 
From the sites, Ip21, lq44, 3p14, 6q26, 7p22, 7q31, 7q32, llpl4, llql4, 16q23, 
22q 12, Xp22, and Xq22, utilization of stepwise discriminant analysis indicated 
optimum standardized coefficients for the sites lq44, 16q23, and 22q12 which were 
used in the classification function: 
TS: y = -16.922 + O.934(lq44) + 0.395(16q23) + 0.321(22qI2) 
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Non-TS: y = -5.085 + 0.295(lq44) + 0.245(16q23) + 0.133(22qI2) 
This could be simplified to the single function: 0.639(lq44) + 0.150(16q23) + 
0.188(22qI2). With all controls scoring less than 11.837, this function indicated 100% 
specificity (all controls can be assigned to non-TS group by means of these three FS 
expression frequencies), and 88% sensitivity (88% of clinically diagnosed TS 
individuals can be assigned to TS group by means of above three FS expression 
frequencies/cell) under these study circumstances. 
Category II Sites (Table 2) (Fig. 1) 
It was decided to keep the analyses separate for the two categories of sites defined in 
this article. The overall difference in category II sites between TS and control 
individuals were significant (p=O.OO 1). By including sites 3p26, 3q 13, lOp 11.2, 
12qI2-q13, 14qI2-q13, and Xq13, utilization of stepwise discriminant analysis 
indicated optimum standardized coefficients for the sites lOpl1.2, 14q13, and 3q13. 
Employing these sites in an analysis similar to the one performed for group I FS, 
73.1% of clinically diagnosed TS patients were assigned to the affected group by 
means of FS expression (sensitivity), as was the case for 79.2% of controls 
(specificity). 
The classification function for category II sites was: 
TS: 
Non-TS: 
y = -5.810 + 0.888(10pl1.2) + 1.184(14qI2-q13) + 
0.766(3q13) 
y = -1.812 + 0.346(10pl1.2) + 0.623(14qI2-q13) + 
0.336(3qI3) 
This could be reduced to the single classification function: 
0.542(lOpl1.2) + 0.561(14qI2-q13) + 0.430(3q13), 
meaning that an individual could be classified as TS if the observed value of this 
function for above three sites was more than 4. 
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Mean (SO) percentage of common aphidicolin-inducible breaks at different sites for TS and control individuals 
TS TS Control TS TS Control 
Site Mean SO Mean SO t-test Site Mean SO Mean SO t-test 
1p36 2.69 1.57 1.42 1.25 0.003 7q21 4.31 2.15 2.42 1.72 0.001 
1p32 5.00 2.95 2.83 1.61 0.002 7q22 2.85 1.89 1.33 1.24 0.002 
1p31 4.65 3.15 2.00 1.22 0.001 7q31 12.62 4.93 6.83 2.97 0.000 
1p22 0.77 1.07 0.75 1.03 0.949 7q32 17.38 5.26 9.29 3.22 0.000 
1p21 14.42 5.12 7.83 3.20 0.000 7q36 1.35 1.13 0.46 0.59 0.001 
1q21 1.42 1.33 0.67 0.92 0.025 Sq22 5.38 2.97 3.29 1.99 0.005 
1q25 6.19 3.15 2.63 1.79 0.000 Sq24.1 3.08 2.28 1.88 1.73 0.042 
1q31 1.50 1.24 0.75 0.85 0.016 Sq24.3 2.15 1.54 1.13 0.99 0.007 
1q42 0.73 1.28 0.67 0.96 0.844 9p21 1.31 1.38 0.54 0.78 0.019 
1q44 9.85 0.67 3.96 2.03 0.000 9q12 0.85 0.88 0.54 1.18 0.303 
2p24 9.96 4.27 6.04 2.97 0.001 9q22 3.27 1.89 2.08 1.47 0.017 
2p16 6.77 2.57 3.92 1.95 0.000 9q32 12.73 4.88 8.04 3.26 0.000 
2p13 6.96 2.86 3.50 1.79 0.000 10q21 0.73 0.96 0.46 0.78 0.279 
2q21 6.58 2.91 2.71 1.78 0.000 10q22 3.00 1.96 1.58 1.32 0.005 
2q31 5.96 4.15 2.04 1.70 0.000 10q25 3.08 2.33 1.25 1.07 0.001 
2q32 7.77 3.66 5.79 2.20 0.025 10q26 6.50 2.94 4.29 2.89 0.010 
2q33 5.69 3.21 2.21 1.47 0.000 11p15 3.62 1.94 2.42 1.18 0.011 
2q37 8.12 3.70 4.42 2.70 0.000 11p14 10.38 4.01 5.08 2.93 0.000 
3p24 7.19 4.07 4.67 2.58 0.012 11p13 9.27 3.64 5.92 3.60 0.002 
3p14 58.50 13.64 38.42 9.10 0.000 11q14 10.19 4.38 5.75 2.66 0.000 
3q25 4.00 2.48 2.71 2.81 0.091 11q23 0.85 0.83 0.54 0.72 0.175 
3q27 3.73 2.22 2.25 1.65 0.011 12q21 4.00 2.51 2.13 1.60 0.003 
4p16 2.85 1.85 2.21 1.35 0.173 12q24 2.65 1.92 1.92 1.35 0.121 
4p15 2.92 1.90 2.46 1.64 0.361 13q13 8.50 3.71 4.29 2.37 0.000 
4q21 3.19 2.47 1.96 1.71 0.047 13q21 1.35 1.44 1.17 1.37 0.655 
4q31 12.19 3.90 8.17 3.13 0.000 13q32 2.65 1.72 1.21 1.25 0.002 
5q31 2.04 1.40 0.96 0.86 0.002 16q23 49.62 10.18 27.92 9.49 0.000 
6p25 6.62 3.58 3.42 1.74 0.000 17q23 2.88 1.99 0.63 0.65 0.000 ~ 
6p22 1.08 1.23 0.67 0.92 0.191 1Sq12 5.85 2.65 3.08 1.77 0.000 ~ 
--1 
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Table 1 Continued 
TS TS Control TS TS Control 
Site Mean SO Mean SO t-test Site Mean SO Mean SO t-test 
6q15 1.58 1.45 1.46 1.06 0.744 1Sq21 1.65 1.47 1.08 1.25 0.147 
6q21 3.23 1.75 2.29 1.57 0.052 19q13.1 1.50 1.50 1.17 1.43 0.427 
6q26 12.15 4.86 7.13 2.91 0.000 20p12 5.73 3.21 3.33 2.04 0.003 
7p22 9.23 3.87 4.13 2.89 0.000 22q12 10.48 4.35 5.83 3.38 0.000 
7p14 1.96 1.48 0.54 0.83 0.000 Xp22.3 23;00 8.60 14.96 6.84 0~001 
7p13 11.85 4.22 6.04 3.64 0.000 Xq22 15.46 6.41 9.22 3.68 0.000 
7q11 4.62 2.14 3.00 1.82 0.006 Xq27 2.27 1.97 1.21 1.28 0.028 
Table 2 
Mean (SO) percentage of other breaks for TS patients and controls 
TS TS Control Control TS TS Control Control 
Site Mean SO Mean SO t-test Site Mean SO Mean SO t-test 
3p268 2.42 2.32 1.21 1.32 0.027 13q348 0.42 0.81 0.46 0.66 0.867 
3q138 3.73 2.44 1.63 1.17 0 14q13 3.92 1.94 2 1.38 0 
4q238 0.65 0.94 0.25 0.53 0.065 15q13-q14 0.5 0.65 0.67 0.82 0.426 
4q278 0.69 1.09 0.5 0.72 0.469 1Sp11.2 1.15 1.35 0.96 1.27 0.6 
4q34-q35 1 1.26 0.63 1.01 0.256 1Sq22 0.96 1.08 0.46 0.88 0.079 
5q13 1.38 1.27 0.67 0.82 0.022 20q11.2 0.73 0.78 0.5 0.72 0.283 
5q33-q34 2.15 1.8 1.42 1.5 0.125 21q22 0.92 0.8 0.46 0.66 0.03 
Sp21 0.62 0.75 0.33 0.56 0.139 22q13b 0.42 0.75 0.08 0.28 0.041 
Sq11.2 0.35 1.02 0.46 0.98 0.693 Xp22.1 0.96 1.15 0.29 0.55 0.012 
10p13 1.19 1.3 1.96 1.49 0.583 Xq13 2.08 1.38 0.96 1.04 0.002 
10p11.2 3.08 1.72 1.29 1.27 0 Xq24 0.58 0.76 0.29 0.69 0.172 
10q11.2 0.12 0.33 0.21 0.41 0.381 Xq26 0.62 0.9 0.5 0.72 0.621 
12p12 0.77 0.82 0.75 0.79 0.933 Xq27.3b 0.04 0.2 0.13 0.34 0.28 
12q13b 1.23 1.21 0.38 0.65 0.003 
a Breakpoints detected in our study and reported by others, but not listed in CCM92 ~ 
b Breakpoints considered as rare folate-sensitive FS 00 
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Figure 1 
Examples of some category II breaks in TS patients: A. 3q13; B. 4q33-q34; C. 
5q13; D. 10p13; E. 10p11.2; F. 14q13; G. 1Sq13-q14; H. 18p11.2-p11.3; I. 
18q22;J.21q22; L.Xq13. 
A B c o 
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In six instances, similarly affected family members of index cases with TS formed 
part of the study. The sites recurring within these families include: 
family lea male and a female): lSqlS in 2/2 family members; 
family 2 (three females and a male): 3q2l in 4/4 cases and 6q23 in 3/4 cases; 
family 3 (three males and a female): l7p12 in 3/4 cases and Yqll-ql2 in 2/3 
males; 
family 4 (three males and a female): 1 7p 12 in 4/4 cases and Y q ll-q 12 in all 
males; 
family S(a male and two females): 8p23 in 2/3 cases. 
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In family 6, in two females, there was no concordance with regard to any FS 
, 
expression. Y q ll":q 12 fragile site was expressed in 7/8 males from the above family 
groups. Some of these breaks are not reflected in Table I or II because they do not 
qualify for inclusion according to the criteria mentioned in the methods section of this 
paper. 
Discussion 
This paper reports increased aphidicolin induced common fragile sites (FS) 
expression associated with Tourette syndrome (TS), as well as the possible existence 
of discriminatory FS with regard to TS patients. The particular sites found to be 
indicative of TS during this early study may be altered during subsequent research. 
ConfIrmation of increased aphidicolin-induced FS expression in TS needs to take into 
account the large number of conditions which may influence chromosome breakage 
(Craig-Holmes et al. 1987, Chudley et al. 1990, Smeets and Merkx 1990, Tedeschi et 
al. 1992), including tissue specifIcity ofFS expression (Morgan et al. 1988, Murano et 
al. 1989), culture conditions such as ethanol concentration (Kuwano and Kajii 1987), 
menstrual stage cycle in females (Furuya et al. 1991 ), and knowledge of the 
population background with regard to common aphidicolin-induced FS (Rao et al. 
1988). Although our study could be criticized for not adequately evaluating the role of 
such variables, the differences between TS and control individuals were consistently 
distinct to such a marked degree that it was considered worthwhile to open this 
avenue of research to the widest possible scrutiny. 
A major question arises whether increased expression of aphidicolin-induced FS in 
individuals with TS could be potentially informative for the molecular analysis of 
genes involved in the expression of a TS spectrum disorder. The future isolation and 
cloning of the DNA sequences involved at some of these sites might show that they 
are polymorphic regions and targeted association studies could potentially be applied 
to examine their role in TS as well as other neuropsychiatric disorders. 
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A number of reports correlating behavioral alteration with chromosomal breakage 
have already been published and include schizophrenia (Delisi et al. 1988, Garofalo 
et al. 1992), the psychopathology found in obligate fra-X female carriers (Freund et 
al. 1992), and Rett syndrome (Telvi et al. 1994). 
To our knowledge, the only published fmding relating chromosomal fragility to TS by 
another author can be found in an article on Huntington disease and childhood-onset 
Tourette syndrome (Kerbeshian et al. 1991), where the karyotype 46, XY / 46, XY, 
fra(16)(q22) was found in 12% of cells. The authors stated that the clinical 
significance of FS in phenotypically normal individuals is unknown. 
In addition to being considered genetically active areas (Yunis et al. 1987, Hecht et al. 
1988, Hecht and Hecht 1991, Austin et al. 1992), FS may represent regions of DNA 
repeat sequences (Sutherland et al. 1985). Organized repetitive DNA sequences in the 
genome are considered to bear a relationship to a highly conserved chromatin folding 
code (Vogt 1990) and may predispose these areas to selective forces such as 
environmentally induced breakage. 
Individuals expressing the rare folate-sensitive sites FRAXA and FRAXE have 
unstable expanded CCG repeats and methylation of adjacent CpG islands. An 
explanation has been proposed according to which GCC and CGG repeat sequences 
lead to delayed replication because they form unusual DNA structures that present a 
block for the replication apparatus (Knight et al. 1993). Chromatin is subsequently 
rendered fragile through late replication following failure to erase an imprinted X-
inactivation signal in these instances (Laird et al. 1987). 
In addition, the molecular basis ofFRAI6A, another autosomally located, rare folate 
sensitive fragile site, was found to be expansion of a normally polymorphic p(CCG)n 
repeat (Richards et al. 1994). It is not clear whether one is allowed to extrapolate from 
these fmdings concerning rare fragile sites. Molecular analysis of a 4.5kB fragment 
containing 6 of 13 aphidicolin-induced breakpoints at constitutive fragile site 3p14.2 
failed to identify traditional motifs, such as a trinucleotide repeat sequence to explain 
fragility (Paradee et al. 1994). However, in a cell line with a reciprocal translocation 
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between human chromosome 3 (with breakpoint at 3pI4.2) and a hamster 
chromosome, the fragile site was expressed on both derivative chromosomes, 
suggesting in this instance that the fragile site represents a repeated sequence (Glover 
and Stein 1988). 
If multiple genes, acting either independently (genetic heterogeneity), additively 
(polygenic inheritance), or epistatically are required for expression of a 
neurobehavioral spectrum phenotype, this will create obstacles for linkage detection 
of a major gene by the standard lod score method (Crowe 1993). Nonparametric 
linkage analyses, such as the affected sib-pair method, which is useful for the analysis 
of multifactorial disorders, and which was suggested as the next step in TS-gene 
linkage at the Tenth Genetic Workshop on Tourette syndrome held during August 
1994 in Toronto (personal communication, J. Weber) is less powerful to detect 
linkage and cannot satisfactorily address a situation where multiple genes may be 
operative, which is what our fragility studies could suggest. 
For TS, a dual situation may exist, according to which various associated phenotypes 
may arise through modified gene activity at fragile sites ("the component factors of 
multidimensional phenotypes"){Cloninger 1994), but the primary phenotype for 
which the TS gene is responsible may actually be chromosomal instability. 
A heritability estimate of 0.88 for aphidicolin-inducible common FS expression in a 
twin study indicated that fragility could be considered to represent the secondary 
expression of a more fundamental mechanism operative within the genome (Austin et 
al. 1992). Similarly, a basic genetic mechanism was proposed for the concurrent 
expression of both autosomal FS and fragile-X sites in individuals from three families 
with the fra-X syndrome (Barletta et al. 1991). This concept was also discussed by 
other groups (Amarose et al. 1987, Smeets and Ares 1990). 
Since individuals with TS are usually phenotypically normal, an association between 
FS and neurobehavioral characteristics (rather than with dysmorphic or disease-
related phenomena) may easily have been overlooked during earlier popUlation based 
surveys of common FS. The quotation by Roger KurIan that" ... there is at least a little 
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bit ofTS in us all" (KurIan 1993) seems entirely appropriate in view of the population 
frequency of expression of common FS and the proposed role of some change at these 
sites being associated with neurobehavioral alteration. 
In conclusion, if differential expression of certain fragile sites can be conftrmed to be 
associated with variant behavior, and these FS can also be demonstrated to show a 
consistent relationship with certain classes of repeat sequences, such sites may be 
important with regard to both normal evolutionary processes (King 1994), as well as 
having the potential to be involved in potentially deleterious dynamic mutations. 
As indicated, these fmdings do not rule out the need to search for a major TS gene, 
which may however not be as strongly linked to any of the behavioral phenotypical 
features as to the chromosomal phenotype which is described in this paper. 
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Abstract 
One hundred and fifty breakpoint sites were recorded during an analysis of 
aphidicolin-ethanol inducible fragile sites (FS) in 56 blood samples and 13 amniocyte 
cultures and were classified according to the criteria formulated by the Chromosome 
Coordinating Meeting. The fmding of previously unlisted FS in this sample, the 
altered expression of FS in conditions not usually associated with chromosomal 
abnormalities and the apparent lack of tissue specificity indicate the importance of 
one or more fundamental mechanisms operating to produce the diverse associated 
clinical phenotypes, with the chromosomal fragility representing an intermediate 
phenotype. Several lines of evidence converge towards the conclusion that FS are a 
manifestation of an altered state of genetic activity at areas associated with 
transcriptional regulation, because of their concordance with CpG islands, nuclease 
sensitive sites, replication origins, zinc fmger protein domains and viral integration 
sites. An investigation is required whether this phenomenon could contribute both to 
evolutionary diversity through increased recombination, the formation of unstable 
repeat sequences and variable methylation, and to the expression of multigene disease 
processes resulting in the production of variable and complex phenotypes, even within 
families. 
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Introduction 
The basic biology and evolutionary significance of chromosomal fragile sites (FS) 
remain enigmatic. FS on human chromosomes can be defmed as vulnerable regions 
where lesions occur spontaneously or after induction with certain break-inducing 
agents (Smeets and Merkx 1990). These sites have been divided into two main 
groups, viz. "rare" and "common" FS (Hecht 1986). Those present in less than 2.5% 
of the population are considered to be rare (Berger et al. 1985), whereas common FS 
are considered to be present in more than 50% of the population (Hecht 1986) or in 
almost every individual (Samadder et al. 1993). 
Aphidicolin-inducible common FS appear to be Ubiquitous in humans and other 
mammals. The estimated high degree of genetic determination for pooled FS 
frequencies suggests that these sites result from a common process that is under 
stringent genetic control (Austin et al. 1992). Aphidicolin-induced common FS have 
been considered as candidates of pathological importance (Hecht 1991). 
We have documented the increased expression of these common FS in individuals 
with Gilles de la Tourette syndrome (TS), a complex neurobehavioural spectrum 
disorder (Gericke et al. 1995, 1996). This fmding has raised questions concerning 
possible relationship between FS and gene activity and suggests an underlying role for 
these genomic areas with regard to the pattern of expression of co-morbid disorders in 
TS. If FS expression reflects altered transcriptional activity at multiple sites, common 
FS may playa role in the expression of polygenic disorders in general. 
Materials and methods 
Specimens from 21 Caucasians (4 females and 17 males) diagnosed as having TS by 
means of DSM IV criteria, were analysed as one group. These criteria require the 
presence of both motor and one or more vocal tics, occurring many times a day for 
more than 1 year with onset before age 18, causing significant social and occupational 
impairment and are not due to the effects of a medical condition or substance use 
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(American Psychiatric Association 1994). A separate group consisted of randomly 
chosen Caucasian blood samples referred to our laboratory for chromosomal analysis, 
viz. Five for fragile X (fra-X) screening, one patient with velocardiofacial 
(Shprintzen) syndrome together with blood samples from non-affected sibling and 
both parents, two patients with Duchenne muscular dystrophy, two patients with 
Cornelia de Lange syndrome and a patient with Russel-Silver syndrome, two couples 
with a history of recurrent fetal loss and three healthy males referred for chromosomal 
damage screening after being exposed to ethylene dioxide together with matching 
control blood specimens. The remainder included blood samples of newborn children 
with dysmorphic features where a syndromic diagnosis had not been made. The 
number of patients included in the second group consisted of 13 females and 22 
males. All individuals included in the study had normal karyotypes, according to 
standard banded chromosome analyses and no cytogenetic evidence was found for 
any of the suspected fra-X cases having increased breakage at Xp27.3 in folate-
deficient culture media. 
In total, 56 blood samples were aphidicolin treated. Thirteen amniocyte cultures, 
reported to be "well growing", 48 h before harvesting, were also included on a 
random basis. 
Two phytohaemaglutinin (PHA)-stimulated lymphocyte cultures were established for 
each individual by using 0.5ml whole blood in RPMI-1650 medium supplemented 
with 10% fetal bovine serum (FBS). After 48 h, aphidicolin dissolved in 70% ethanol 
was added (24 h treatment) to each 10 ml culture to obtain a final concentration of 
0.1 JlM. Standard cytogenetic techniques were used for harvesting and slide 
preparation. 
Complete metaphase spreads (n=50) for each culture (100 per individual) were 
assessed at the 350-400 band level. All types of aberrations (gaps, breaks, chromatid 
exchanges) were scored as single events at the band(s) involved. 
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Fibroblasts derived from amniotic fluid were maintained and subcultured in Ham's 
FlO medium and 20% FBS. Aphidicolin dissolved in 70% ethanol was added to 
obtain a fmal concentration of O.IIlM, 25h prior to harvesting. Cultures were treated 
with colcemid for the last three hours. Cells were processed in the standard manner 
for the preparation of chromosomes. Cultured amniocytes were shown to be 
extremely sensitive to aphidicolin-ethanol treatment and the mitotic index in most 
samples was low. However it was decided to evaluate all available complete 
metaphases for the distribution of gaps and breakpoints. 
Results 
In total, 150 breakpoint sites were recorded. These site were grouped and evaluated 
separately according to their status as common FS, rare FS (Chromosome 
Coordinating Meeting 1992), breakpoints recorded by others, but not . listed as 
common FS (Table 1), and so-called random breakpoints (Tables 2, 3). All sites 
reported as being tissue-specific for other tissues were also found in T-Iympocyte 
cultures. It was therefore decided to include the analysis of 576 metaphases from 13 
amniocyte cultures to observe differences in their expression when compared with 
lymphocytes. A breakpoint was counted as "one" when occurring on one of the 
chromosomes, and as "two" when occurring on both homologues. 
There was no intention, from the beginning of the study, to make any statistical 
comparison of FS expression between samples from different groups of patients. Our 
only interest was to screen for the frequencies of random breaks. As a much higher 
expression at most sites assessed as random breakpoints was found in patients with 
TS, we decided to evaluate FS expression in this group separately. 
The computed means per 100 cells of common FS in T -lymphocyte cultures of both 
investigated groups of patients are summarized in Table 1. Despite the observation 
that the rank orders of most expressed sites differed between the two groups (TS and 
non-TS) in agreement with previous fmdings (Gericke et al. 1995, 1996), we found 
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the sites 3p14, 16q23 and Xp22.3 as being the most prevalent in both groups. The 
hierarchy of the remaining sites in the TS group was: lq44, 7q32, Xq22, 14q24, Ip21, 
7p22, 7p13, 6q26, 2p24, 4q31, llp13, 8q22, 2q32, 9q32, 22q12, 2q37, etc. The 
hierarchy of these sites in the non-TS group was: 7q32, lq44, Xq22, 14q24, Ip21, 
7p21,6q26, 7q31, 2p24, 4q31, 7p13,2q32, Ilp13,9q32,8q22,22q12,etc. 
Some 22 breakpoints are listed according to their frequencies of occurrence in Table 
2. All of these are expressed at least in one subject in 4% or more of the metaphase 
spreads, which is a cut-off frequency necessary to cytogenetically classify an 
individuals as fra-X positive (Jacobs et al. 1980). The rank orders of the means for the 
above ~escribed group of aphidicolin-inducible FS were found to be different between 
the patient groups, viz. for the TS group: 10p12-p13, lOp 1 1.2, 14q13, 6p21.1, Xq13, 
18pl1.2, 6q23, Xp22.l, 17q25, 8ql1.2, 4q34-q35, 15qI2-q13, Xq12, 21q22, 9q34, 
4q31, 3p13, 5qI2-q13, 15qI4-qI5, 18pl1.3, 5q34, 20q11.2; and for the non-TS 
group: lOpI2-p13, 18pl1.3, lOp 1 1.2, Xp22.l, 5q12-q13, 6q23, Xq13, 14q13, 
18pl1.2, 4q34-q35, 6p21.1, 8ql1.2, 15q14-q15, 15q12-q13, Xq12, 20ql1.2, 9q34, 
5q34, 14q31, 17q25,21q22,3p13. 
The means for the listed group of breakpoints is in most cases approximately twice as 
high in the TS group. The insufficient scope of the study and the lack of complete 
clinical data for non-TS individuals, especially with regard to their neurobehavioral 
status, do not allow defmite conclusions to be made from the observed differences in 
this study. 
The localization of all other breakpoints repeatedly found in our study is given in 
Table 3. According to the most widely used criteria discussed in Jordan et al. (1990), 
they cannot be assigned as FS. These sites can only be recognized as being fragile 
based on Craig-Holmes et al. (1987) approach, where the site is scored as positive if it 
is expressed at least once in two or more subjects. 
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Table 1 
Mean frequency (%) of common aphidicolin-inducible fragile sites 
for TS and non-TS patients. 
TS TS non-TS non-TS TS TS non-TS non-TS 
Site (mean) (SO) (mean) (SO) Site (mean) (SO) (mean) (SO) 
ip36 2.43 1.37 1.54 1.25 Sq24.3 4.19 2.7 2.29 1.28 
ip32 3.29 1.58 2.86 1.99 9p2i 1.24 1.34 0.8 0.91 
1p3i 3.19 2.04 2.94 3.08 9q12 0.86 0.89 0.49 0.79 
ip22 0.62 0.72 0.77 0.88 9q22 0.9 1.11 0.71 0.8 
ip2i 15.86 5.37 10.8 4.45 9q32 9.33 5.15 7.03 3.91 
iq21 0.52 0.66 0.63 0.88 9q34 1.24 1.44 0.66 1.12 
1q25 6.57 2.95 3.94 1.82 i0p13 5.81 3.25 3.31 2.55 
iq3i 0.9 0.75 0.97 0.96 i0p11.2 3.43 1.99 1.2 1.24 
1q42 1.48 1.18 0.69 0.87 10q2i 0.67 1.21 0.89 0.87 
iq44 22.9 5.66 15.86 7.72 10q22 1.81 1.1 1.77 1.56 
2p24 11.81 3.02 9.4 4.87 i0q23b 0.52 0.66 0.49 0.72 
2p16 3.57 1.73 2.89 2.31 10q25 2.81 2.28 1.83 2.06 
2p13 4.67 2.83 3.69 2.02 10q26 6.1 3.19 5.06 3.06 
2q13b 1.05 0.95 0.83 1.21 11p15 3.14 1.39 2.77 1.9 
2q21 6.1 4.87 3.71 2.71 11p14 4.05 2.95 2.91 1.69 
2q31 2.67 1.83 2.4 2.06 11p13 10.95 4.25 7.54 3.02 
2q32 9.81 3.2 7.54 2.86 iiqi3 0.62 0.65 0.2 0.4 
2q33 5.1 2.86 3.91 2.27 1iqi4 6.57 2.84 5.03 3.3 
2q37 8.29 5.03 5.43 3.06 11q23 0.81 1.1 0.63 0.92 
3p36a 5.76 2.67 3.23 2.16 12q13b 1.19 1.53 0.8 1.02 
3p24 3.76 1.9 2.74 2.4 12q21 3.81 2.11 2.54 1.6 
3p21a 2.1 1.27 0.89 0.87 i2q24 2.67 2.1 1.86 1.51 
3p14 59.05 9.51 52.31 12.82 13q13 7.24 4.46 4.94 2.32 
3pi3 1.19 1.1 0.54 0.69 i3q2i 0.95 1.05 1.2 1.15 
3q13a 4.71 2.6 2.74 1.85 13q32 1.86 1.64 1.06 0.78 
3q21 8 1.1 1.06 0.71 0.84 13q34a 1.57 1.22 0.89 1.15 
3q25 2.19 1.82 1.4 0.95 14q13 3.48 1.99 1.2 1.24 
3q27 5.1 2.16 3.29 2.13 14q23 2.86 1.96 1.86 1.55 
4p16 3.52 2.77 2.49 2.24 14q24 16.14 4.33 11.83 4.37 
4p15 3.67 2.51 2.29 1.89 14q31 1.24 1.19 0.63 0.96 
4q21 1.24 1.41 1.26 1.01 i5q12-13 1.57 1.26 0.74 0.81 
4q23a 1.9 1.51 1.83 1.36 15q14-15 0.97 1.09 0.86 0.83 
4q2r 1 1.02 0.66 0.66 i5q22 1 1.02 0.57 0.86 
4q31 11.24 3.83 8.29 3.3 16p13b 1.1 1.06 0.46 0.76 
4q35 1.62 1.86 0.97 1.16 16q22 4.67 5.54 1.89 1.74 
5p14 3.29 3.47 2.83 2.6 16q23 49.9 10.88 41.71 10.19 
5p13 2.14 1.73 1.69 1.45 17p12b 1.14 0.99 0.17 0.37 
5qi3 1.14 1.28 1.34 1.37 17q23 1.62 1.81 1.23 1.06 
5q15 5.43 1.84 4.54 2.7 17q25 2.14 1.93 0.63 1.07 
5q21 2 1.88 1.14 1.18 1Sp11.3 0.48 1.01 2.2 3.62 
5q31 0.81 0.85 0.77 0.75 1Sp11.2 2.52 1.79 1 1.33 
6p25 12.29 4.24 7.31 3.84 1Sq12 5.24 3.04 4.49 2.91 
6p22 2.29 1.61 1.26 1.66 1Sq2i 1.38 1.17 0.71 0.93 
6p21.i 3.05 2.17 0.91 0.94 1Sq22 1.62 1.33 0.74 0.76 
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Table 1 
Continued 
T8 T8 non-T8 non-T8 T8 T8 non-T8 non-T8 
8ite (mean) (SO) (mean) (SO) 8ite (mean) (SO) (mean) (SO) 
6q15 1.81 1.56 1.03 0.83 19q13.1 2.43 1.73 1.46 1.36 
6q21 3.71 1.86 3.66 2.28 20p12 6.81 3.22 4.69 2.16 
6q25 2.29 1.93 1.23 1.12 20q11.2 0.76 0.87 0.49 0.82 
6q26 11.1 5.31 10.14 3.79 20q13.2 0.33 0.47 0.23 0.59 
7p22 15.57 5.96 10.51 4.03 21q21 0.14 0.35 0.11 0.4 
7p14 1.05 1.17 0.66 0.78 21q22 1.43 1 0.63 1.15 
7p13 12.43 3.49 8.17 4.62 22q11.2 0.67 0.94 0.49 0.73 
7q11 3.71 1.86 3.74 2.53 22q12 9.24 4.56 5.71 3.15 
7q21 2.81 1.68 2.29 1.91 22q13b 0.67 0.84 0.49 0.72 
7q22 0.71 0.7 0.91 0.92 Xp22.3 31.05 12.27 15.8 10.19 
7q31 11.33 3.68 10.03 4.62 Xp22.1 2.24 1.41 1.69 1.41 
7q32 21.33 5.19 15.94 5.62 Xq13 2.52 1.99 1.23 1.53 
7q36 0.9 0.97 0.86 1 Xq22 17.05 5.35 13.89 6.27 
8p21 1.05 0.79 0.6 0.73 Xq26 0.38 0.65 0.23 0.42 
8q11.2 2.05 1.86 0.89 1.04 Xq27 1 1.2 0.71 0.9 
8q21 b 0.24 0.43 0.09 0.28 Yq11 0.71 1.39 0.34 0.75 
8q22 10.19 2.91 5.83 2.93 Yq12 0.48 0.73 0.2 0.58 
8q24.1 4.38 2.68 2.74 1.95 
a Breakpoints detected in our study and reported by others but not listed 
as common FS in Chromosome Coordinating Meeting (1992) 
b Breakpoints considered as rare folate-sensitive FS 
Table 2 
Mean frequency (%) of non-specific aphidicolin-inducible breakpoints 
for TS and non-TS groups 
T8 T8 non-T8 non-T8 T8 T8 non-T8 non-T8 
8ite (mean) (SO) (mean) (SO) 8ite (mean) (SO) (mean) (SO) 
3p13 1.19 1.1 0.54 0.69 14q31 1.24 1.19 0.63 0.96 
4q35 1.62 1.86 0.97 1.16 15q12-13 1.57 1.26 0.74 0.81 
5q13 1.14 1.28 1.34 1.37 15q14-15 0.97 1.09 0.86 0.83 
6p21.1 3.05 2.17 0.91 0.94 17q25 2.14 1.93 0.63 1.07 
6q25 2.29 1.93 1.23 1.12 18p11.3 0.48 1.01 2.2 3.62 
8p21 1.05 0.79 0.6 0.73 18p11.2 2.52 1.79 1 1.33 
8q11.2 2.05 1.86 0.89 1.04 18q22 1.62 1.33 0.74 0.76 
9q34 1.24 1.44 0.66 1.12 21q22 1.43 1 0.63 1.15 
10p13 5.81 3.25 3.31 2.55 Xp22.1 2.24 1.41 1.69 1.41 
10p11.2 4.1 2.24 2.03 1.78 Xq11-12 1.52 1.74 0.74 1.02 
14q13 3.48 1.99 1.2 1.24 Xq13 2.52 1.99 1.99 1.53 
Stellenbosch University  https://scholar.sun.ac.za
64 
Table 3 
Mean frequency (%) of sporadically occurring aphidicolin-inducible breakpoints 
for TS and non-TS groups 
15 15 non-15 non-TS 15 15 non-1S non-1S 
Site (mean) (SO) (mean) (SO) Site (mean) (SO) (mean) (SO) 
2p12 0.48 0.91 0.17 0.51 17q21 0.52 0.73 0.4 0.73 
4q12 0.33 0.47 0.37 0.59 19q13.3 0.62 0.72 0.29 0.78 
5q33 0.76 1.06 0.66 0.79 20q11.2 0.76 0.87 0.49 0.82 
Sp25 0.62 0.79 0.31 0.52 20q13.2 0.33 0.47 0.23 0.59 
9p24 0.62 0.84 0.46 0.65 21q21 0.14 0.35 0.11 0.4 
10p14-15 0.38 0.58 0.23 0.48 22q11.2 0.67 0.94 0.49 0.73 
10q11.2 0.76 1.11 0.34 0.58 Xp21 0.1 0.29 0.03 0.17 
12p12 0.67 0.71 0.74 0.73 Xp11.4 0.14 0.35 0.34 0.58 
12q12 0.48 0.66 0.03 0.17 Xp11.2 0.29 0.55 0.11 0.32 
12q24.3 0.29 0.63 0.09 0.28 Xq21 0.19 0.39 0.03 0.23 
14q12 0.67 0.99 0.66 0.79 Xq24 0.24 0.53 0.31 0.62 
14q32 0.52 1.14 0.2 0.47 Xq26 0.38 0.65 0.23 0.42 
16p11.2 0.24 0.68 0.17 0.38 Yq11 0.71 1.39 0.34 0.75 
16q12 0.24 0.43 0.11 0.32 Yq12 0.48 0.73 0.2 0.58 
16q21 0.57 0.73 0.37 0.48 
Table 4 
Mean frequency (%) of aphidicolin-inducible breakpoints 
in cultured amniocytes 
Site Mean Site Mean Site Mean Site Mean 
1p31 14.93 3q13 2.6 7q21 1.22 15q22 1.39 
1q25 1.04 3q27 7.81 7q31 2.08 16q23 15.1 
1q44 1.39 4q23 2.26 7q32 1.04 1Sq12 1.39 
2q21 2.26 4q31 1.04 10q11.2 4.69 1Sq21 4.86 
2q32 1.04 4q35 1.04 10q26 1.22 19q13.1 1.91 
2q33 1.04 5q13 2.97 11q14 1.74 20q12 2.6 
3p26 2.26 6q26 2.43 12p13 1.39 22q12 1.57 
3p21 1.04 7p22 1.04 13q32 3.47 Xq12 1.04 
3p14 14.1 7q11 9.9 14q24 1.39 Xq22 1.74 
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Figure 1 
Examples of some breakpoints (arrows) included in Tables 2 and 3, and breakpoint 
Xq28 included in Table 1. A. 4q35, B. 5q13, C. 5q34, D. 6p21.1, E. 6q25, F. 8p25, O. 
8ql1.2, H. lOp13, 1. lOpl1.2, 1. 10ql1.2, K. 14q13, L. 15q14-q15, M. 17q25, N. 
18pl1.2, O. 18q22, P. lOql1.2, Q. 21.q22, R. Xp22.1, S. Xpl1.2, T. Xq12, U. Xq13, 
V. Xq26, W. Xq28 
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Breakpoints expressed in cultured amniocytes (Table 4) usually corresponded to those 
frequently found in skin fibroblasts from normal individuals (Murano et al. 1989a). 
The average number of FS induced in amniocytes was low compared with PHA '" 
stimulated T -lymphocytes, and because there was a strong inhibition of cell division, 
a comparison of induced frequencies between these cell types was meaningless. 
Whereas fragile sites at 16q23 and 3p 14 were again most frequent, Xp22.3 expression 
was low. In addition, sites at Ip31, 7ql1, 3q27 (probably described as 3q26.2 in the 
above mentioned study), 10ql1.2, 18q21, 13q32, 5q13, 3p26, 20p12.1 or 2q21 were 
not the most frequently seen in cultured T-Iymphocytes. 
Sites at the 4q23 and 7q 1 i.2 bands were previously regarded as bone-marrow-specific 
(Morgan et al. 1988) and but were subsequently found in B lymphocytes and skin 
fibroblasts by Murano et al. (1989a) together with the site at 1 Oq 11.2. These sites 
were also observed in cultured amniocytes and a low level of their expression 
compared with other common FS was found in T lymphocytes. This fmding appears 
to support our conclusion that aphidicolin-induced FS is not as tissue-specific as 
suggested. It remains to be seen whether the differences in cell-type-dependent 
frequency of expression are attributable to either different replication rates or the 
sequence of DNA replication, differences in gene activity, or tissue sensitivity to 
aphidicolin treatment (Murano et al. 1989b). Most of the sites included in Table 2 
were also sporadically found in cultured amniocytes. 
It was not possible to localize all "new" breakpoints at the sub-band level because of 
differences in chromosomal resolution (Fig. 1). In some cases, involved areas 
coincided with cancer chromosome breakpoints (Hecht 1988): 5q13, 5q35, 9q34, 
14q32, 18ql1.2, 20q13, 21q22, 22ql1.2, Xpl1.2. The breakpoint in 14q13 was 
reported in patients with possible acquired chromosomal instability (Tedeschi et al. 
1987). 
Sites at 5q13, 17q21, 20ql1.2, 20q13.3, 2Iq22, 22qI1.2, Xq13 were recognized as 
common chromosome breaks (not FS) by Michels (1985) and Xq26 as a FS by the 
same author. The breakpoint at 6p21, discussed by Tedeschi et al. (1992) as being a 
common FS, is not listed as such by the Chromosome Coordinating Meeting (1992). 
Stellenbosch University  https://scholar.sun.ac.za
67 
The 18pll.3 breakpoint reported to be associated with· translocation and heritable FS 
at 2q13 and fetal demise at 10 weeks of gestation (Jacky et al. 1995) was expressed, 
respectively, in 14% and 16% of cells in patients with Cornelia de Lange and Russel-
Silver syndromes. 
Discussion 
In this paper, we report FS expression phenomena in a wide range of genetically 
compromised individuals. The fmding of previously unlisted FS in this sample, the 
altered expression of FS in conditions not usually associated with chromosomal 
fragility and the apparent lack of tissue specificity indicate the importance of one or 
more fundamental mechanisms operating to produce the diverse associated 
phenotypes recorded here, with the chromosomal fragility representing an 
intermediate phenotype. In this regard, the comment by Hecht (1991) that common FS 
can be classified by means of chemical inductive methods, with a large currently 
unclassified group representing a "wastepaper basket", could perhaps be 
reinvestigated by ascertainment of the type of individuals in which their expression is 
altered. 
It will be of interesting to see whether groups of common FS exist that are over- or 
underexpressed in specified groups of patients. The high frequency of breakpoints in 
18pl1.3 in the patients with Cornelia de Lange syndrome and Russel Silver syndrome 
as included in our study; or the overall higher expression of breakpoints as 
summarized in Table 2 in TS patients may serve as examples of the sofar unknown 
importance of "fragile" chromosome areas or the specific regulatory mechanisms 
involved in their expression. 
Aphidicolin, an inhibitor of DNA polymerase alpha (Glover et al. 1984), may alter 
DNA synthesis in specific regions that concur with FS expression (Ahuja 1990). The 
enhancing action of ethanol (Kuwano and Kajii 1987) is considered to act through the 
suppression of RNA synthesis, which in tum probably influences the repair capacity 
of the cells (Obe and Ristow 1979). 
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The application of low stringency criteria for FS assignment and the enhancement of 
the effect of aphidicolin via the inhibition of DNA repair would probably lead to 
increased FS expression. This may have been responsible for the divergent results 
arising between studies attempting to correlate specific structural chromosome defects 
recorded in neoplasia with FS, or between breakpoints involved in reciprocal 
translocations and FS (Daniel 1986). 
An association of the localization of common FS with active gene regions has been 
postulated primarily according to their occurrence in the light G-bands (Hecht and 
Hecht 1991). The obvious example supporting this idea is. the expression of the 
common FS Xp22.3 in both homologues in females, whereas the site Xq22.1 is 
expressed only on the active X chromosome (Austin 1991). 
As shown in our study, additional breakpoints occurring on the X chromosome may 
represent active transcription areas, since some of them are present in bands, where 
genes escaping X-inactivation have been found, such as Xp22.l (ZFX), Xpll.2 (UBE 
1, SMeX), and Xq 13 (RPS4X) (Rappold 1993, Disteche 1995). The clustering of FS 
within light G bands, which represents areas of apparent GC richness with a high 
level of gene expression, and their concordance with CpG islands, nuclease-sensitive 
sites, replication origins, zinc fmger protein domains and viral integration sites have 
been demonstrated in many studies (Porfrrio et al. 1989, Ahuya 1990, Tadeschi et al. 
1991, Austin et al. 1991, 1992, Lichter et al. 1992, Nancarrow et al. 1994). Synergy 
seems to occur between adenoviruses and aphidicolin because adenoviruses type 5 
and 12 act at FS sensitive to aphidicolin (Caporossi et al. 1991). 
A histogram giving the distribution of sequences hybridizing with the isochores of the 
G + C-richest H3 family (Saccone et al. 1992) on the human G-banded chromosomes 
is in good agreement with the areas of highest expression of common FS. These 
hybridizing sequences can also be correlated with other breakpoints not currently 
classified as common FS (Tables 2, 3). 
A strong association has been found between bands sensitive to restriction enzymes 
MspI and Hpall and those bands containing common FS (Porfrrio et al. 1989, 
Tedeschi et al. 1991). Recognition sites of the isoschizomeric restriction 
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endonucleases Hpall and MspJ are more frequent in CpG islands than in bulk DNA. 
The high expression of MspJ breakpoints at some bands, which also coincide with FS 
areas, indicates a role for CpG islands in their expression. 
CpG sequences may represent one identifiable subset of DNase-I-hypersensitive sites 
(Elgin 1981). Moreover, agents known preferentially to attack chromatin DNase-l-
hypersensitive sites induce non-randomly distributed chromosomal damage in areas 
showing striking concordance to locations of known common FS (Austin 1991). 
The FS that have been cloned so far are the rare folate-sensitive sites FRAXA 
(Verkerk et al. 1991), FRAXE (Knight et al. 1993), FRAXF (parrish et al. 1994), 
FRA16A (Nancarrow et al. 1994) and FRAIIB (Jones et al. 1995) and all represent 
unstable poly (CCG)n repeats adjacent to CpG islands that become hypermethylated 
when the number of copies of the repeat exceeds certain limits. It has been suggested 
that FS originate at regions in the genome that are not normally associated with 
methylation and that the observed methylation associated with the above mentioned 
sites represents a consequence rather than a cause of FS mutation (Nancarrow et al. 
1994). 
Methylation is associated with imprinting; since both FS and imprinting appear to be 
evolutionary conserved responses and since more than 50% of breakpoints that have 
occurred during chromosome evolution in primates are reported at or close to FS 
(Miro et al. 1987), the possibility of a molecular basis for a link between the processes 
of imprinting and FS formation would clearly be of interest. Parent of origin effects 
have been recorded in relation to TS (Lichter et al. 1995) and as being associated with 
the processes of recombination, late replication and allelic expansion (J. G. Hall 
personal communication). These circumstances represent genetic conditions that can 
be considered as having an effect on FS expression. The possibility exists that FS 
represent a dynamic part of the process of imprinting. 
The localization of FRAIIB within a previously described gene indicates the 
possibility that other poly(CCG)n repeats contained within known genes are also 
associated with folate-sensitive FS expression. The association between FRAIIB and 
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Jacobsen llq-syndrome represents the fIrst evidence and direct link between an 
autosomal FS and chromosome breakage (Jones et al. 1995). 
Several authors have suggested that FS represent an amplifIcation of specifIc DNA 
sequences (Sutherland 1985, Nussbaum 1986) including naturally occurring 
polypurine/polypyrimidine sequences (Sutherland and Hecht 1985). The (CG)n and 
(TG)n repeat families are not highly repetitive in the human genome and seem to be 
clustered. The potential of repeat unit involvement in areas other than rare FS has 
been discussed in connection with their preferential occurrence in promotor areas of 
active genes. 
(TG)n sequence blocks have been shown to have an enhancer function in vitro 
(Hamada et al. 1984) and the potential to adopt a Z-DNA structure (Rich et al. 1984) 
that may attract specifIc nuclear proteins and therefore be able to arrest the DNA 
replication fork (V ogt 1990) or produce a nuclease-sensitive site. Arrest of the DNA 
replication fork coupled with incomplete or aberrant DNA repair may result in FS 
expression and increase the probability of double-strand breaks where daughter 
strands that have just replicated will join with the unreplicated parental strand. When 
replication is completed, the normal ligation process at the junction will generate the 
exchange, which can be visualized as chromatid exchange in metaphase chromosomes 
(Ikushima 1989). 
Although no direct evidence exists for exchange between tandem arrays on sister 
chromatids or homologous chromosomes at minisatellite sequences, the results of 
several studies using simultaneous treatment for sister chromatid differentiation and 
common FS expression support the idea that sister chromatid exchanges on 
chromosomes may preferentially occur in FS regions (Hirsch 1991, Tsuji et al. 1991). 
It will be interesting to determine whether similar mechanisms are involved in rare 
but distinct phenomenon of partial endoreduplication which may originate in common 
FS, as documented in Figure 2. 
The 5' flanking regions of transcriptionally active genes can often be structurally 
distinguished as nucleosome-free zones occupied by non-histone DNA-binding 
proteins (Mitchell and Tjian 1989). Stabilization of these domains is one of the 
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properties of locus control regions (LCR). The LCRs are saturated with DNA-binding 
sequences for transacting factors that enter into cooperative binding interactions to 
keep the promoter free of histones. They guarantee that transcription factor binding is 
stabilized at the replication fork in dividing cells and that it does not dissociate during 
chromatin assembly (Felsenfeld 1992). 
Since DNA replication must be completed prior to initiation of mitosis (Navas et al. 
1995) and since the addition of colcemid to the. cell culture overcomes this important 
checkpoint, delayed or absent replication at the LCR may lead to incomplete 
packaging and collapse of the chromosome stru~ture during metaphase; a process that 
results in FS expression (Sutherland 1988). LCR play an important role in the 
regulation of gene cluster transcription (Craddock et al. 1995). Whether FS localized 
in areas with multiple zinc fmger protein domains (Lichter et al. 1992) are a 
cytogenetic expression of such regulatory regions, or whether increased frequencies 
of common FS in certain cliriically distinguished popUlation groups represent an 
induced response in active genes remains to be solved. 
In conclusion, several lines of information indicate that FS are a manifestation of an 
altered state of genetic activity at areas associated with transcriptional regulation. 
Despite the current lack of molecular evidence, our fmdings and observations from 
routine cytogenetic screening, together with reports published to date, strongly 
support the idea that FS observed under specific culture conditions represent the 
cytogenetic expression of so called chromatin folding code in specific areas (see Vogt 
1990, although the author himself denies any such correlation). If the processes 
described in this paper can be demonstrated to be an important interactive mechanism 
in the expression of genetic diseases, the potential for widespread changes caused by 
FS formation and/or repeat sequence formation could result in. the production of 
variable and complex phenotypes, even within families. This could be responsible for 
disease as well as evolutionary advantageous genetic diversification. If found to be 
true, the mechanisms responsible for producing such divergent outcomes merit further 
study. 
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Figure 2 
A-F Examples oftri-radials produced by chromatid breaks in a previous division, 
followed by nondisjunction of the distal fragment, where the origin of the partial 
duplication corresponds to the area of common FS expression. A. 1 p21, B. 2p24, 
C. 7p13, D. 7qll, E. 9q12, F. 18q12 
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Identification of Genetic Markers Associated with 
Gilles de la Tourette Syndrome in an Afrikaner 
Population 
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University, 1230 York Ave., New York, NY 10021-6399, USA; 3Center for Medical Genetics, 1000 
North Oak Ave., Marshfield, WI 54449, USA 
Summary 
Because gene-mapping efforts, usmg large kindreds and parametric methods of 
analysis, for the neurologic disorder Tourette syndrome have failed, efforts are being 
redirected toward association studies in young, genetically isolated populations. The 
availability of dense marker maps makes it feasible to search for association 
throughout the entire genome. We report the results of such a genome scan using 
DNA samples from Tourette patients and unaffected control subjects from the South 
African Afrikaner population. To optimize mapping efficiency, we chose a two step 
strategy. First we screened pools of DNA samples from both affected and control 
individuals, using a dense collection of 1,167 short tandem-repeat polymorphisms 
distributed throughout the genome. Second, we typed those markers displaying 
evidence of allele frequency-distribution shifts, along with additional tightly linked 
markers, using DNA from each affected and unaffected individual. To reduce false 
positives, we tested two independent groups of case and control subjects. Strongest 
evidence for association (P values 10.2 to 10·s) were obtained for markers within 
chromosomal regions encompassing D2S 1790 near the chromosome 2 centromere, 
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D6S477 on distal 6p, D8S257 on 8q, DllS933 on llq, D14S1003 on proximal 14q, 
D20S1085 on distal20q, and D21S1252 on 21q. 
Introduction 
Gilles de la Tourette syndrome (MIM 137580) is a childhood-onset neurological 
disorder characterized by chronic, involuntary motor and vocal tics. Both twin and 
family studies have indicated a high degree of heritability of Tourette syndrome, 
especially when individuals with chronic motor tics are considered affected (Patel 
1996). Concordance rates, among MZ twins, of 53% and 56% for full-blown Tourette 
syndrome and 77% and 94% for Tourette syndrome plus chronic motor tics have been 
reported (Price et al. 1985). Earlier segregation analyses indicated an autosomal 
dominant mode of inheritance, with reduced penetrance (Comings et al. 1984, Pauls 
and Leckman 1986, Eapen et al. 1993). More-recent studies, however, have indicated 
a more complex mode of inheritance (Hasstedt et al. 1995, Walkup et al. 1996). 
Tourette syndrome has been reported to co segregate with several neuropsychiatric 
disorders. A connection between Tourette syndrome and obsessive-compulsive 
disorder is generally accepted (pauls et al. 1991, 1995). Connection between Tourette 
syndrome and obsessive-compulsive disorder is generally accepted (Pauls et al. 1991, 
1995). Conections between Tourette syndrome and attention deficit disorder and 
between other disorders such as alcoholism, panic attacks, and conduct disorders are 
controversial (Comings and Comings 1988, Pauls et al. 1988, Comings 1994). 
A number of large Tourette kindreds have been identified (Kurian et al. 1986, 
Robertson and Trimble 1991, McMahon et al. 1992, Hasstedt et al. 1995, Heutink et 
al. 1995). Several of these kindreds have undergone whole-genome polymorphism 
screening. Parametric linkage analysis of the resulting data, under the assumption of 
autosomal dominant inheritance, failed to locate genes (pakstis et al. 1991, Wilkie et 
al. 1992, van de Wetering and Heutink 1993). Reasons for the failure are unknown but 
may be related to the wide range of disease severity within Tourette kindreds and/or to 
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misspecification of the mode of inheritance. Associations between three dopamine 
receptor genes and Tourette syndrome have been reported (Comings et al. 1993, 
Nothen et al. 1994, Grice et al. 1996), but replication has not been achieved 
(Hebebrand et al. 1997). 
The South African Afrikaner popUlation arose largely from a small group of 
European, primarily Dutch, immigrants who began settling in Cape Town in 1652 
(Torrington et al. 1984; Jenkins 1990; see also Government Communication and 
Information System [South Africa]). By 1701, there were 1,265 Europeans at the 
Cape. In the 18th century, European immigration to South Africa was small. In the ftrst 
half of the 19th century, particularly in the 1830s, the Afrikaners began the "Great 
Treks," a series of migrations of Europeans away from the coastal areas, to establish 
farming communities in the interior of South Africa. The small number of European 
founders of the Afrikaner population at Cape Town, the lack of large waves of 
European immigration, the Great Treks, and the relatively rapid increase in the 
Afrikaner population, today at ~3 million, all have contributed to the genetic isolation 
and relative homogeneity of this population. Common mutations and/or marker 
haplotypes among Afrikaners have been established for a number of disorders, 
including variegate porphyria, keratolytic winter erythema, hypercholesterolemia, and 
progressive familial heart block (Jenkins 1990, 1996, Meissner et al. 1996, Warnich et 
al. 1996, Starfield et al. 1997, Groenewald et al. 1998). 
We report here our efforts to map Tourette syndrome genes, using Afrikaner patients. 
Starting with a whole-genome screen of > 1,000 polymorphisms, we have identified 
several markers that show significant differences in allele frequency distributions 
between affected and control individuals. 
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Subjects, Material and Methods 
Patients 
Pro bands were selected at random, on consecutive clinic days, from a group of 
existing patients at the Tourette Syndrome Clinic in Pretoria, South Africa. All 
subjects were previously identified as Tourette syndrome patients according to criteria 
of the Diagnostic and Statistical Manual of Mental Disorders. Motor and vocal tics 
were in the moderately severe to severe range in all affected individuals. Tics started 
at <18 years, occurred for ~1 year, and were not absent for any periods >3 months. 
Prior to their recruitment, pro bands and available family members were evaluated 
personally by two educational psychologists for history of tics and presence and 
severity of comorbid problems. The following diagnostic tools were used: a self-report 
form designed by the Tourette Syndrome Association Genetic Consortium (January 
1995 version), the Yale Global Tic Severity Scale (Leckman et al. 1989), 
observation/examination methods for the purpose of excluding other movement or 
neurological disorders and for confirming observable tics typical of those associated 
with Tourette syndrome, and the Stony Brook Psychiatric Exclusion Checklist (Gadow 
and Sprafkin 1998). English language versions of all forms were used, as most 
Afrikaners, including all patients, control subjects, and evaluators, were bilingual. 
Forty Tourette syndrome patients were recruited in the initial phase of the study. For 
the follow up investigations an additional sixty unrelated patients agreed to participate 
(second group). All study subjects spoke Afrikaans and had Afrikaner family names 
but were not known to belong to any Afrikaner subgroup. Individuals of ascertainable 
English descent were excluded. The first and second groups of patients (and control 
subjects) were selected from the same population base. All blood samples were coded 
and made anonymous prior to DNA isolation. Only the information on age, sex, tics 
severity range, and comorbid behavioral problems remained attached to each sample. 
The study was approved by the South African Medical Research Council Review 
Board. 
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Controls 
The Afrikaner individuals (n = 96) included in the control group came from two 
sources: clinic personnel and medical students. Like the patients, all control subjects 
spoke Afrikaans and had Afrikaner family names. Control subjects were required to 
complete the same selfreport form used by the patients and, in addition, were 
personally evaluated by one of us (G.S.G.) for the presence of chronic motor and 
vocal tics. Their blood samples were coded and made anonymous prior to DNA 
isolation. 
Primers 
Primer pairs for the detection of short tandem-repeat polymorphisms (STRPs) were 
obtained from Research Genetics. Approximately 40% of the markers were tri- and 
tetranucleotide-repeat polymorphisms developed within the Cooperative Human 
Linkage Center, and nearly all remaining 60% Genethon dinucleotide-repeat 
polymorphisms. We determined allele sizes, using known genotypes of three CEPH 
individuals: 133101, 133102 and 134702. Marker spacing was determined and close 
flanking markers selected by use of comprehensive sex-averaged genetic maps 
produced by the program CRI-MAP (Lander and Green 1987, Broman et al. [in 
press], see also Center for Medical Genetics). 
Sampling and DNA Pooling 
Genomic DNA was isolated from individual blood samples by standard methods 
(Sambrook et al. 1989). DNA concentrations were measured by spectrophotometric 
readings at OD26o. Pools of template DNA were prepared by combining IJlg of DNA 
from each of 20 individuals from the fIrst group of subjects. Two non-overlapping 
pools were prepared from the affected individuals (AI and A2) and from the controls 
(Cl and C2). The pooled DNA was diluted to a fmal concentration of20nglJll. 
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Amplification ofSTRP markers was performed in 96-well microtiter plates with 45 ng 
of either pooled DNA or individual DNA in a 10-,.Ll volume containing 1.5 mM 
MgCh; 50 mM KCI; 10 mM Tris-HCI, pH 8.3; 0.01 % (w/v) gelatin; 200 ~M each 
dGTP, dATP, and dTTP; 2.5 ~M dCTP; 0.35 ~Ci aC2P]-dCTP (NEN Du Pont; 800 
Cilmmole, 10 ~CiI~I); lOng (-3 pmol) each PCR primer; and 0.3 U AmpliTaq 
polymerase (Boehringer Mannheim). In most cases, two markers were amplified 
simultaneously. Samples were subjected to 27 cycles consisting of 30 sec at 94°, 75 
sec at 55°, and 15 sec at 72°, with a fmal 6 min at 72° after the last cycle. PCR 
products were denatured by adding formamide and by heating for 10 min at 95° prior 
to loading (1~I) onto vertical 6.5% polyacrylamide, 7.7 M urea DNA sequencing gel 
and running at 70 W constant power for -3 hours. Gels were dried on filter paper and 
exposed on X-ray film. 
Statistical analysis 
The following statistics were calculated to compare affected and control allele 
frequency distributions for each polymorhic marker: 
"Heterogeneity" approach. - For the m alleles at a given marker, an m by 2 
contingency table was formed, with columns corresponding to alleles in case and 
control individuals. Rows were ordered by increasing allele size, and rows containing 
cells with expected values <1 were pooled with neighboring rows. From a X2 analysis, 
empirical (two-sided) significance levels were obtained. This approach is expected to 
be powerful when several alleles occur in different frequencies in the case and control 
subjects. 
"Single alleles" approach. - A given allele, i, was selected and all other alleles 
combined into a second category, not i. The resulting 2 by 2 table was analyzed by use 
of Fisher's exact test. The smallest (one-sided) P-value was selected (and the allele 
identified at which it occurred) and adjusted for multiple comparisons by means of a 
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Bonferroni correction. This approach is expected to be powerful when a single allele 
shows association. One-sided P values were used because, when the frequency of a 
given allele is increased in case versus control subjects, some other allele(s) must 
necessarily be decreased. When one allele is tested after another, each allele should 
thus be tested only for positive association. 
"t-test" approach. - Mean allele sizes for case and control subjects were compared 
with use of the t-test. Empirical p-values (two-sided) were calculated numerically. 
This approach is expected to be powerful when allele sizes are shifted in a constant 
direction between case and control subjects. 
Table 1 Chromosomal Breakdown of Markers Used in Whole-Genome 
Screen 
Chromosome NO.ofSTRPs Chromosome NO.ofSTRPs 
1 96 13 41 
2 91 14 48 
3 60 15 31 
4 65 16 35 
5 78 17 41 
6 69 18 47 
7 66 19 24 
8 67 20 32 
9 39 21 14 
10 43 22 17 
11 44 X 52 
12 67 
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Results 
A ftrst group of 40 Afrikaners clearly affected with Tourette syndrome, along with 40 
unaffected Afrikaner controls, were recruited. DNA was pooled from two 
nonoverlapping sets of 20 individuals for both affected (AI and A2) and control (CI 
and C2) subjects. Two sets of pools were chosen, to reduce the false-positive rate due 
to slight differences in DNA concentrations and pipetting inaccuracies. The pooled 
DNA, along with standard DNA from the parents ofCEPH family 1331, was used as 
template in the PCR ampliftcation of 1,167 STRPs distributed throughout the entire 
genome. Chromosomal breakdown of the STRPs is shown in table 1. Sex-averaged 
spacing between STRPs was 3.0 ± 3.2 cM (mean ± SD). Ninety-ftve percent of the 
intervals between markers were <9.0 cM. Fifteen intervals were >15 cM, with the 
very largest at 22 cM. 
Visual examination of the autoradiographic images of pooled PCR products revealed 
51 loci with consistent differences in allele distributions between the two affected and 
'two control DNA pools. Results from six of these loci are displayed in ftgure 1. 
Criteria for selection of the positive loci were (1) consistency of observed differences 
between affected and control subjects as determined by repeat PCR and by use of two 
independent sets of control and affected pools, and (2) prevalence of one allele in 
pooled PCR products from the affected pools (indicated by arrows in fig. 1). 
Ampliftcation of the vast majority of the markers resulted in indistinguishable 
radiographic images between affected and control pools. For a small proportion of 
STRPs, differences between affected and control pools were detected for AIICI or 
A2/C2, but not for both. This may be the consequence of pooling DNA from only 20 
individuals. 
To evaluate the statistical significance of the observed differences in pooled PCR 
products, we subjected the 51 putative positive markers to individual typing, using the 
same group of 40 affected and 40 control DNA samples used for the initial genomic 
screen. We than compared the resulting pairs of allele frequency distributions, using 
three different statistical approaches (see the Subjects, Material, and Methods section). 
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For 15 of the 51 loci, at least one of the calculated statistics showed significance at the 
.05 level (table 2). For the remaining 36 markers, apparent differences between 
affected and control subjects were not confmned at the .05 level. 
In an attempt to reproduce these initial results, a second group of unrelated Afrikaners 
(60 affected and 56 control individuals) were recruited, and their ONA was typed 
individually with the 15 positive markers from the first phase of the study. Results of 
the typings for the second group are also listed in table 2. For the majority of loci, 
evidence for association was not confmned. However, . in four instances (02S 1790, 
06S477, 011S933, 020S1085), the P-values for the second group also reached 
significance and were even lower than those for the first group. For all 15 markers, P 
(heterogeneity) . values from the first and second groups were then combined by 
summing X2 and dfvalues (table 2). This approach of combining results was chosen as 
a safeguard, to eliminate potential effects of sizing alleles differently in the two 
samples. Combining results increased support for association in nearly every case 
relative to the results from either the first or second group of samples. 
To extend these results, we typed a number of markers closely linked to positive 
markers from the whole-genome scan, using both groups of samples jointly. Markers 
at several of these loci gave significant results, including D2S440 adjacent to 
D2S1790, D8S257 and D8S1132 close to D8S1119, DllS1377 adjacent to DllS933, 
020S468 and 020S469, both very close to D20S1085, and GATA45C03 near 
D21S1252 (table 3). Results forDl1S1377 were particularly impressive. In addition, 
two tightly linked markers on chromosome 14 also produced significant results (table 
3). The marker at locus D14S742 was identified in the first stage of the study but did 
not quite yield P values <0.05 for the first set of samples. No additional markers with 
significant allele distribution differences were identified from chromosomes 1,4,5,6, 
12, or 13. Allele frequency distributions for DllS1377 and GATA45C03 are 
displayed in table 4. Note, that for each marker, more than two common alleles were 
enriched in the affected subjects compared with control subjects. 
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Figure 1 
Electrophoretic profiles for markers that demonstrated consistent allele frequency 
distribution between affected and control subjects in the fIrst group. Segments of 
autoradiographs from polyacrylamide gels are displayed for six STRPs at the indicated 
loci. The DNA templates used to generate the amplifIed DNA fragments were in the 
same order for each marker: standard DNA from CEPH family parents 133101 (1) and 
133102 (2), DNA pool from set 1 of unaffected control subjects (CI), DNA pool from 
set 1 of affected subjects (AI), independent amplifIcation of pools CI and AI , DNA 
pool from set 1 of affected subjects (A 1), independent amplifIcation of pools C 1 and 
AI, DNA pool from set 2 of unaffected control subjects (C2), and DNA pool from set 
2 of affected subjects (A2). Arrows mark alleles enriched in the affected subjects. 
Sizes (in nucleotides) for the enriched alleles are listed on the left. 
0251790 
1 2 C1 A1 C1 A1 C2 A2 
296-- .. 
• 
065477 
1 2 C1 A1 C1 A1 C2 A2 
... 
229-- .... 
. 
.... ... . 
0851119 
1 2 C1 A1 C1 A1 C2 A2 
0115933 
1 2 C1 A1 C1 A1 C2 A2 
255-
02051085 
1 2 C1 A1 C1 A1 C2 A2 
173-
02151252 
1 2 C1 A1 C1 A1 C2 A2 
273-
.4; 
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Table 2 
Loci associated with Tourette syndrome in first and second groups of affecteds 
FIRST & SECOND 
FIRST GROUP SECOND GROUP GROUPS 
OF AFFECTEOS OF AFFECTEOS COMBINED 
LOCUS cM P(single P(single 
P(het) alleles) P(t-test) P(het) alleles) P(t-test) P(het) 
001S0485 176.7 0.02 0.005 0.12 0.25 0.24 0.22 0.02 
00181665 136.2 0.01 0.001 0.04 0.12 0.06 0.45 0.008 
00281391 227.9 0.04 0.16 0.41 0.14 0.1 0.29 0.03 
00281790 113.4 0.01 0.04 0.03 0.006 0.01 0.86 0.0006 
00481551 40.7 0.01 0.02 0.12 0.42 0.64 0.34 0.03 
00580666 176.4 0.03 0.02 0.07 0.19 0.62 0.92 0.03 
00680477 9.2 0.005 0.06 0.08 0.02 0.04 0.41 0.0009 
00680470 17.9 0.0006 0.02 0.001 0.43 0.21 0.13 0.004 
00881119 133.4 0.03 0.06 0.66 0.09 0.05 0.82 0.01 
01180933 158.1 0.05 0.006 0.75 0.002 0.009 0.38 0.0009 
01280327 126 0.001 0.1 0.04 0.38 0.3 0.63 0.006 
01380788 50.7 0.005 0.16 0.5 0.56 0.43 0.95 0.02 
02081085 119.7 0.03 0.03 0.65 0.0005 0.0004 0.76 0.0001 
02181252 60.2 0.00001 0.006 0.42 0.07 0.12 0.36 0.000008 
02181435 41.9 0.04 0.05 0.03 0.46 0.17 0.24 0.09 
NOTE. - het = heterogeneity. P values indicate the probability of obtaining a difference as large 
or larger than the one observed if there is no association between disease and marker. 
Values were calculated by means of three different approaches, as described 
in the Subjects, Material, and Methods section. 
I 
I 
J 
00 
........ 
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Table 3 Additional Loci in 8elected Chromosomal Regions Associated 
with Tourette 8yndrome 
P VALUE FOR APPROACH 
LOCU8 cM Heterogeneity 8ingle Alleles t-test 
00280440 113.4 0.002 0.001 0.54 
00880257 145 0.01 0.004 0.74 
00881132 155 0.05 0.1 0.33 
01181377 119.2 <10-6 0.0005 0.01 
01480742 12.5 0.06 0.02 0.03 
01481003 12.5 0.002 0.003 0.00003 
02080468 121.3 0.05 0.06 0.005 
02080469 121.9 0.1 0.06 0.66 
GATA45C03 31.3 0.0004 . 0.004 0.04 
chromosome 21 
NOTE. - Results were obtained with DNA from affected and control individuals in 
both fIrst and second groups. See note for table 2. 
Table 4 Allele Frequency Oistributions for Two Markers with Especially 
Low PValues 
Mfd 316 GATA45C03 
at 01181377 at chromosome 21 
Allele Affected Control Allele Affected Control 
124 1 0 266 0 3 
128 4 0 268 62 66 
130 4 7 286 1 0 
132 2 6 288 10 5 
134 .45 20 289 6 5 
136 62 42 291 32 47 
138 22 52 302 1 3 
140 6 19 305 4 14 
142 16 5 308 15 16 
144 4 9 310 28 19 
146 8 6 312 14 1 
148 0 6 314 3 0 
318 0 1 
NOTE. - Results were obtained with DNA from affected and control individuals in 
both fIrst and second groups. 
88 
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Discussion 
The primary goal -of this study was to identify loci associated with Gilles de la 
Tourette syndrome in the Afrikaner population, using the straightforward comparison 
of polymorphic allele frequency distributions between severely affected probands and 
unaffected control subjects. We believe we have accomplished this goal for the 
I 
markers at the loci listed in tables 2 and 3. 
Several groups have identified linkage disequilibrium over broad chromosomal 
intervals in isolated populations. Disequilibrium has readily been detected over 
intervals ranging up to 15 cM in the Finish population (peltonen and Uusitalo 1997), 
which is likely to be considerably older than the Afrikaners. Among populations 
thought to be similar in age to the Afrikaners (-12 generations), Houwen et al. (1994) 
identified disequilibrium over a 19-cM interval in patients with intrahepatic 
cholestasis from an isolated Netherlands fishing village, and Puffenberger et al. (1994) 
found disequilibrium over at least 10 cM among American Mennonites with 
Hirschsprung disease. Among Afrikaners, Starfield et al. (1997) detected 
disequilibrium over 10 cM for keratolytic winter erythema, and Groenewald et al. 
(1998) recently reported shared haplotypes extending over -17 cM for variegate 
porphyria. Therefore our use of a highly informative marker density of 3.0 cM gave us 
a good chance of successfully detecting association among Afrikaner Tourette 
patients. 
The use of DNA pools in the whole-genome screen dramatically reduced the amount 
of required laboratory work. Allele frequency distributions obtained from pooled 
DNA templates have been found to match, reasonably well, those determined by 
typing individuals (Pacek et al. 1993, Graff et al. 1997). Pooling approaches are 
rapidly becoming standard for the mapping of rare recessive disorders within isolated 
populations (Sheffield et al. 1994, Peltonen and Uusitalo 1997). Although careful 
scanning of the electrophoretic profiles of the amplified fragments might be ideal 
(Barcellos et al. 1997, Graff et al. 1997), visual selection of markers with differences 
in allele frequency distributions is efficient and has worked well for recessive 
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disorders. The fact that only 15 of 51 loci that appeared positive visually were 
confmned by typing individuals indicated that we were generous in our selection of 
candidate loci and that, although false-negative loci cannot be completely ruled out, 
true-positive loci were not easily missed. 
Analysis of the amplified fragments from the DNA pools gave no indication that a 
single predominant Tourette gene exists among the Afrikaners or, that Tourette genes 
were introduced into the Afrikaner population by a single founder. Although specific 
alleles at various loci were clearly enriched in affected versus control subjects, no 
single predominant alleles were found at any loci (see, for example, table 4). 
Therefore, even in the isolated Afrikaner population, several founding Tourette alleles 
at several loci likely exist. 
Since no one yet knows how many Tourette genes exist, how they interact, how many 
Afrikaner founders introduced Tourette genes into this population, or when the genes 
might have been introduced, it is not possible to project how many patients would be 
required to detect association and what P values would be significant (Kruglyak 
1997). It is likewise impossible to completely rule out subtle, undetected population 
differences between the patient and the control groups. Nevertheless, we feel that the 
P-values displayed in tables 2 and 3 are very promising. Given 1,167 markers tested, 
and on the basis of the conservative Bonferroni correction for multiple testing, we 
would by chance expect 0.1 results significant at the 10-4 level. In fact, we found four 
such markers on chromosomes 11, 14, 20, and 2l. Our use of repeat PCR (testing 
pools A 1 and C 1 twice, as shown in the figure) and separate pools of affected and 
control individuals (pools AI, A2, CI, and C2), the confmnation of results using an 
entire separate group of Tourette patients, and the typing of additional STRPs tightly 
linked to the original positives were all designed to reduce the possibility of false 
positives. 
We assert that the only practical route to isolation of Afrikaner Tourette genes is to 
pursue loci that.give strong evidence for association and that eventually are confmned 
by independent studies. In this regard, Leppert and McMahon, in their whole-genome-
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polymorhism screen of unilineal branches of a very large Utah Tourette kindred 
(McMahon et al. 1992), obtained some of their strongest positive LOD scores for 
several markers (including D8S257) in the exact same region of chromosome 8q as 
that identified in this study (unpublished results). Also, Devor and Magee (in press) 
very recently reported a family in which individuals with Tourette syndrome or tics 
showed segregation with a balanced chromosome 1 - 8 translocation 
t[(l:8)(q21.1;q22.l)]. D8S257 is located at or very close to 8q22.l (Bray-Ward et al. 
1996). We plan to continue our efforts among the Afrikaners by collecting parents of 
affected individuals, so that shared haplotypes can be identified, and by collecting 
Tourette families from South African Gereformeerde Church members who are 
themselves a subgroup of Afrikaners (Torrington et al. 1984). 
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CHAPTER 6 
South African Medical Journal (submitted for publication, Jun 1999) 
THE SEARCH FOR TOURETTE SYNDROME GENES: AN 
OVERVIEW 
Simonic I., Gericke G. S. 
Neurogenetics Research Initiative, 1 Soutpansberg Rd., MRC Pretoria 
Clinical description of Tourette syndrome 
By working together in Paris in the 1880s on the classification of movement 
disorders, Jean Martin Charcot, the leading French neurologist at the time and his 
intern Georges Gilles de la Tourette were able to draw attention to a distinguished 
form of movement disorder that is of great interest today (Lajonchere et al. 1996) The 
major features of the disorder as described by Tourette in his 1885 article were 
involuntary movements and sounds, markedly enhanced startle reactions, a tendency 
to repeat both vocalizations (echolalia) and movements (echopraxia), and 
uncontrolable verbal obscenities (coprolalia). Tourette also believed that this 
childhood onset syndrome, later named after him, did not affect the senses or intellect, 
and that the condition was hereditary, variable in severity across the patient's life 
span, and incurable. 
According to the Diagnostic and Statistical Manual of Mental Disorders, 4th ed. 
(DSM-IV) (American Psychiatric Association 1994), the diagnostic criteria for Gilles 
de la Tourette syndrome (GTS) include: 
1. the presence of motor and one or more vocal tics at some time during the illness, 
although not necessarily concurrently; 
2. occurrence of tics throughout a period of> 1 year, with no tic-free period of >3 
consecutive months; 
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3. marked distress or significant impairment m social, occupational, or other 
important areas of functioning; 
4. onset at <18 years of age; 
5. lack of identifiable environmental causes or other contributing medical conditions. 
The primary symptom of GTS - tics - are defmed as sudden, rapid, recurrent, non-
rhythmic, stereotype movements or vocalization (Robertson and Stem 1997) and can 
range in affected individuals from simple tics, often around the eyes, simple clearing 
of the voice, or sniffmg to more complex utterances (Robertson 1989). Although of 
involuntary nature, tics can wax and wane and even be suppressed. Other symptoms 
including echolalia, arithmomania, grunting, and coprolalia may develop, as the 
disease progresses. Although coprolalia is often regarded as the most notorious 
symptom associated with GTS, it has been proven rather infrequent (- 8%) in the 
population of clinic patients (Goldenberg et al. 1994). 
It has been documented that biological relatives of GTS patients more frequently 
exhibit obsessive-compulsive symptoms and chronic tics, than relatives in control 
families (pauls et al. 1991). The rmding supports the hypothesis that obsessive-
compulsive disorder (OCD) and chronic tic disorder (CT) together with GTS are 
representing an alternative manifestation of the same underlying disorder. The 
distribution of OCD symptoms recognized in individuals with GTS (Frankel et al. 
1986, Pauls et al. 1986, Kurlan 1989, Leonard et al. 1992, Swedo and Leonard 1994) 
and those more prevalent in pure OCD patients are, however, different. Moreover, 
comorbid expression of OCD appears to be sex-related with OCD by itself occurring 
more frequently in female relatives ofGTS probands (Eapen et al. 1997a). 
GTS has been observed in all studied populations (Staley et al. 1997) with the vast 
majority of affected individuals being able to lead normal, productive lives, and 
remaining undiagnosed because their symptoms do not require medical attention 
(Leckman et al. 1997). However, with increasing severity of either tics or associated 
behavioral problems such as hyperactivity, temper control, aggressive behavior, and 
obsessive compulsive symptoms, GTS may become a socially and psychologically 
devastating condition. 
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A strong genetic component has been determined for GTS by twin, and family based 
studies (Price et al. 1986, LaBuda et al. 1993) which provoked attempts for the 
elucidation of its genetic basis. So far no biochemical or morphological impairment 
has been consistently associated with GTS. The suspected implication of head of the 
nucleus caudatus in GTS, based on one SPECT tomographical study is currently 
under further investigation. Therefore, the first step in the elucidation of the genetics 
of GTS is the identification of a genetic map location of GTS underlying gene(s). This 
can be done via genome-wide search for linked/associated genetic loci, or via 
candidate gene approach and association of the functional polymorphism in known 
candidate genes with GTS phenotype. 
Genetic models and linkage studies 
The most powerful method in genome wide searches for genetic loci linked to 
a trait is standard lod score (linkage) analysis. However, in order to be successfully 
applied, it requires precise specification of the phenotype (diagnostic criteria) and 
genetic model, including mode of inheritance, penetrance (a proportion of individuals 
with specific genotype that show the expected phenotype), and the population 
prevalence of the condition (Lander and Schork 1994). 
The diagnosis of GTS is a subject of ongoing debate and controversy (Patel 1996). 
Many scientists, attempting to elucidate the genetic basis of GTS expressed 
reservations about the DSM-IV criteria and proposed an alternative classification 
scheme, recognized by the Tourette Syndrome Association (TSA) Genetic Linkage 
., 
Consortium (KurIan 1997). The scheme emphasizes GTS as tic-based dysfunction, 
includes detailed exclusion criteria and a list of clinical features for increasing 
confidence for the diagnosis of GTS. 
In order to specify the mode of inheritance and penetrance, complex segregation 
analysis were carried out in both nuclear families and extended GTS pedigrees. 
Earlier studies supported a mixed model of inheritance for GTS including a major 
semidominant gene with low heritability of the multifactorial background variation 
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(Comings et al. 1984). In later family studies evidence was found for the presence of 
rare, semidominant, incompletely penetrant allele considered to lead to expression of 
the disorder (Devor 1984), autosomal dominant pattern of inheritance (Pauls and 
Leckman 1986) or intermediate pattern of inheritance (Hasstedt et al. 1995). All 
family studies consistently rejected purely polygenic and autosomal recessive models 
, 
of inheritance, with the latest accepted model indicating that the susceptibility for 
GTS is conveyed by an additive major locus in combination with a multifactorial 
background (Walkup et al. 1996). 
When fIrst described, GTS was considered to be rare. Currently, the population 
prevalence of about 4-5 per 10,000 is the most acknowledged estimate (Eapen et al. 
/ 
1997b) with the risks to fIrst-degree relatives of GTS individuals being about 200 
times the population prevalence (Santangelo et al. 1996). The most recent prevalence 
r estimates of GTS in mainstream school population, however, suggest that the mild 
form ofGTS is much more common than previously thought with a prevalence rate of 
almost 3/100 in the age group of 13-14 years (Mason et al. 1998). The reason for such 
differences is based on whether one just considers fully expressing cases versus all 
those that fulfIl diagnostic criteria in the community i.e. outside clinic settings. 
All attempts to link genetic markers with GTS in systematic genome searches to date 
were unsuccessful. The failure, as discussed by number of authors (Devor 1990, Patel 
1996, Robertson and Boardman 1996, Barr and Sandor 1998), could be due to 
ambiguous phenotypic delineation of GTS and, perhaps most importantly, a genetic 
model complicated by equivocal gene frequency, incomplete (reduced) penetrance, 
and bilineal transmission in GTS families (KurIan et al. 1994). Moreover, sex-specifIc 
expression of GTS behaviors and sex-associated differences in genetic transmission 
consistent with possible role of genomic imprinting in phenotypic expression of GTS 
have been documented (Lichter et al. 1995, Eapen et al. 1997c). 
The lack of success usmg a family based linkage approach has recently led 
researchers to the adoption of model-free, non-parametric methods which ignore 
unaffected people, and look for chromosomal segments that are shared by affected 
individuals (e.g. affected sib-pair studies). These methods do not require precise 
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specification of genetic model and concentrate on clearly affected individuals only. 
Another approach currently supported in a search for GIS gene(s) involves linkage 
disequilibrium (LD) mapping in historically isolated populations with greater genetic 
homogeneity . 
Candidate genes and association studies 
Among the human genes that have recently been characterized, no obvious 
candidates for GIS have been identified. Nevertheless, dopamine-receptor genes, 
which are very popular candidates for most neuropsychiatric disorders, because of the 
earlier observations of the therapeutic effects of dopamine inhibitor drugs, have been 
investigated for the association with GIS in numerous studies. An initial positive 
association of the Al allele of the dopamine D2 receptor gene (DRD2) with GIS was 
subsequently disproved in several studies (Devor et al. 1990, Gelender et al. 1994, 
Nothen et al. 1994). Ihe fmding of positive linkage disequilibrium (LD) reported 
between the dopamine D4 receptor allele (DRD4*7R) and GIS (Grice et al. 1996) 
was also not replicated (Barr et al. 1996). All other known dopamine receptor genes 
as well as the dopa,rnine beta hydroxylase gene and the tyrosine hydroxylase gene 
were excluded by classical linkage analysis in large pedigrees from playing a role in 
etiology of GIS (Brett et al. 1995a, Barr et al. 1997, Devor et al. 1998). 
Serotonergic pathway disturbances have also been implicated in number of 
neuropsychiatric disorders including GIS, substance abuse and depression. 
Significantly lower levels of hydroxyphenyl glycol and serotonin have been reported 
after examination of urinary amines and their metabolites in GIS patients (Bomstein 
and Baker 1992) and serotoninergic agents have been successfully used for treatment 
of GIS symptoms, particularly tics (Silvestri et al. 1994). Numerous searches were 
performed in order to defme an association between GIS and some of the variants of 
serotonin receptor genes with no success (Brett et al. 1995b, Gelender et al. 1995). 
Other candidate gene studies led to the exclusion of the whole chromosome regions 
from linkage with GIS (Devor et al. 1991, Brett et al. 1997), or when positive 
awaiting independent confirmation (Gate et al. 1998). 
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Since no sufficient support was found for association of the most obvious candidate 
genes with GTS, and virtually all the genes, expressed in brain, might be good 
candidates, further candidate gene approaches can only be effective if proceeded by 
the identification of suggestive chromosome location of GTS gene(s). Such areas of 
interest may be identified by linkage/association studies, or by identification of a 
chromosomal abnormality co-segregating with disease phenotype in proband and his 
affected family members. 
Chromosome abnormalities reported in probands with GTS 
There are no characteristic chromosome abnormalities associated with GTS. 
Most clinical cases are therefore not referred for cytogenetic analysis. Nevertheless, 
some investigators continue searching for chromosome abnormalities in their GTS 
probands, because such fmding may represent an additional valuable information 
about possible marker areas for genetic loci involved in the susceptibility to the trait. 
Numerous seemingly nonspecific chromosomal abnormalities have been reported in 
GTS families up to date. Among the most significant fmdings is an apparently 
balanced translocation, t(7;18)(q22-q31;q22.1), identified in a proband with GTS and 
, 
several of his relatives presenting various clinical GTS symptoms (Heutink et al. 
1990). Subsequently a proband with GTS and terminal deletion, del (18)(q22.2-qter) 
was identified (Donnai 1987), as a second reported case of chromosome 18q22 
abnormality in conjunction with GTS phenotype. Both fmdings led to the tentative 
assignment of GTS gene locus at 18q21-q22, a region currently subjected to 
molecular cloning (Boghosian-Sell et al. 1996). 
Among the chromosome areas detected more than once in probands with chromosome 
abnormality and GTS phenotype are chromosome 9p, deleted in two GTS probands 
(Sigh et al. 1982, Taylor et al. 1991), and sex chromosome abnormalities, namely 
47,XYY and 47,XXX karyotypes (Marskey 1974, Sigh et al. 1982). 
The GTS symptomatology has also been observed in several individuals with trisomy 
21 (Barabas et al. 1986, Karlinsky et al. 1986, Collacott and Ismail 1988), in a male 
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with Fragile X syndrome, moderate mental retardation and autism (Kerbeshian et al. 
1984), and in probands with Asperger's syndrome (Kerbeshian and Burd 1986, 
Marriage et al. 1993). In one instance a co-occurrence of childhood onset GTS and 
adult onset Huntington disease has been described (Kerbeshian et al. 1991). 
Traditional linkage approaches have not found evidence for a linked marker at most 
of the above chromosomal regions so far. As such, the co-segregation of any 
chromosome translocation, micro-deletion, or -duplication of chromosome region 
with GTS could be coincidental and unrelated to the phenotype, since the population 
frequency of balanced translocation carriers is 111,000 and the prevalence of 
chromosome deleti~ns / duplications is approximately 1110,000 at birth. It IS, 
however, possible that some of the above chromosome variations are causally related 
to the phenotype and their molecular identification will provide valuable insights into 
GTS. 
Similarly, a relatively high incidence of 111,000 live births for sex chromosome 
trisomies and 11800 for trisomy 21 argue against an interrelationship between sex-
chromosome abnormalities and GTS as well as Down syndrome and GTS (Myers and 
Pueschel 1995). 
More recently, a balanced chromosomal translocation, t(1;8)(q21;q22.l), co-
segregating with the GTS affection status in the family was described (Devor and 
Magee, in press). This is a third report associating GTS with the chromosome 8q22.l 
region. A suggestive linkage (=significant at low stringency level) was found between 
GTS and the 8q22 region by Leppert et al. (1996), as well as in a case-control 
association study in the Afrikaner popUlation of South Africa (Simonic et al. 1998). 
The cloning of the chromosome 8 breakpoint in the above family is therefore justified 
and currently well under way (J.L. Weber - personal communication). 
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GTS and environmental factors 
While the role of genetics in GTS etiology is now well documented and 
accepted, the environmental factors influencing penetrance as well as severity of 
phenotypic expression ofGTS gene(s) are in the early stages of investigation. 
Clinical observations and recent results of immunological studies indicate that 
infections with group A beta-hemolytic streptococci, among others, may trigger onset 
or worsening of tics in subset ofGTS pediatric cases (Allen et al. 1995). These cases 
have been identified as pediatric autoimmune neuropsychiatric disorders (OCD and 
TD) associated with streptococcal infections (PANDAS) (Garvey et al. 1998). 
It has been hypothesized that Sydenham's chorea (SC), a major manifestation of 
rheumatic fever (RF), may provid~ a medical model for OCD and GTS. SC is a sequel 
of an untreated Group A B-hemolytic streptococcal infection (GABHS) with the 
pathophysiology probably being due to antibodies to GABHS cross-reacting with 
certain brain regions. The expression of DS/I7, a B-Iymphocyte cell surface antigen, 
which was assigned as trait marker for susceptibility to SC and RF, has been also 
found greater in subset of patients with childhood onset OCD and GTS without 
documented SC or RF (Murphy et al. 1997). Furthermore, significantly higher serum 
levels of antineuronal antibodies against putamen have been demonstrated in children 
and adolescents with GTS than in the controls (Singer et al. 1998). 
Autoimmunity, T-cells and chromosome fragility 
The cells responsible for immune specificity are lymphocytes. During the 
1960s it was discovered that the two major classes of immune responses are mediated 
by different classes of lymphocytes: T - cells, which develop in the thymus, are 
responsible for cell-mediated immunity; B-cells, which in mammals develop in the 
adult bone marrow or the fetal liver, produce antibodies. The majority of T-
lymphocytes playa regulatory role in immunity, acting either to enhance or suppress 
the responses of other white blood cells. These cells are called helper T -cells or Th-
cells. 
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Differentiated Th-cells produce restricted set of lymphokines, allowing their 
subdivision into two major subsets, Thl- and Th2-cells, which led to a new paradigm 
for immunoregulationbased on the ThlITh2 dichotomy (Carter and Dutton 1996). In 
general, Thl cells produce interleukin (IL)-2 and interferon (IFN)-gamma, while Th2 
cells characteristically produce IL-4, IL-5, and IL-6. 
According to the results obtained in different experimental models of autoimmune 
diseases, the Thl-cells contribute to the pathogenesis of several organ-specific 
autoimmune diseases, whereas Th2-cells may inhibit disease development (Charlton 
and Lafferty 1995). There is a general agreement that the different functional subsets 
of Th-cells arise post-thymically from a common pool of precursors and as a 
consequence of antigen activation. However, the factors affecting differentiation of 
Th precursors into Thl or Th2 subsets are still unclear. 
Fragile sites (FS) on human chromosomes which are defmed as vulnerable regions 
where lesions occur spontaneously or after induction with certain break-inducing 
agents, have been divided into two main groups, viz. "rare" and "common" FS 
according to their expression frequencies and mode of induction. Most of the rare FS 
have been cloned by now, while the molecular and biological significance of common 
fragility remains enigmatic (Sutherland and Richards 1999). 
The fmding of increased breakage rates at numerous common FS in two subsequent 
studies (Gericke et al. 1995, 1996) indicate that for unknown reasons, the T-
lymphocyte DNA at the chromosomal level of organization is more sensitive to the 
inhibition of DNA synthesis in GTS individuals than in controls without GTS. Such 
observation may well be a result of different initial cell type ratio (e.g. Thl1Th2) prior 
to mitogen stimulation in two groups of samples and therefore it may prove important 
to investigate the T-Iymphocyte balance (e.g. ThllTh2) in purified T-cell samples 
from GTS vs. non-GTS individuals. Any alterations in such balance would be 
suggestive of the type of candidate genes contributing to the GTS phenotype. 
The relation between the markers for streptococcal infections, higher serum levels of 
specific antineuronal antibodies, increased common chromosome fragility and clinical 
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characteristics of GTS remain unknown. Nevertheless, if proven, autoimmune 
etiology of tics/OCD even in a subset of GTS/OCD patients will have large 
implications for the treatment, prevention (Swedo et al. 1997, 1998), and genetic 
studies ofGTS . 
. Summary 
The attempts to narrow phenotypic defmition of GTS and other 
neurobehavioral and neuropsychiatric traits will undoubtedly continue until genetic 
and environmental factors playing a role in their etiology are elucidated. 
The unsuccessful gene-mapping efforts and number of spurious candidate gene 
association fmdings over the years of searching for GTS loci are by most researchers 
in the field viewed as an argument for pursuing alternative strategies, rather than a 
failure. As a consequence, there is a move towards non-parametric methods of 
analysis, collection :of smaller, less densely affected families as well as analysis of 
large data sets obtained by international collaboration. Candidate gene and candidate 
loci association studies as well have good chances of success, if the results are 
interpreted with caution and are followed by well-designed confirmatory studies. 
It remains important to pursue the genetic studies to fmd a defmitive diagnostic test 
and understand the pathophysiology of a common neurobehavioral disorder which has 
the potential of disrupting the development of children of all population groups. 
Several discoveries in GTS research in recent years deserve further elucidation. One 
is the observation of tic- aggravation following streptococcal infections, offering a 
whole new perspective in understanding ofGTS. The other is a threefold independent 
association of one chromosome region (8q22.l) with GTS. Discoveries of similar 
kind are promise of even more challenging and hopefully successful future 
developments in the search for the GTS gene(s). 
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CHAPTER 7 
American Journal of Human Genetics (submitted for pUblication, July 1999) 
Significant Evidence for Linkage Disequilibrium over a 
5 cM region among Afrikaners 
Derek Gordon1, Ingrid Simonic2, Jurg Ott1 
1 Department of Statistical Genetics, Rockefeller University, New York; lNeurogenetics Research 
Initiative, MRC Pretoria, South Africa 
Abstract 
The extent of disequilibrium on the popUlation level, or background disequilibrium, 
can provide important information regarding complex-trait-mapping study design. 
Therefore, it is vitally important that the extent of background disequilibrium in 
differing popUlations be investigated. In this work, we explore the extent of deviations 
from Hardy-Weinberg equilibrium (HWE) at a marker locus and linkage 
disequilibrium (LD) between pairs of marker loci in the Afrikaner population of South 
Africa. DNA samples were used for genotyping of 24 loci at six chromosomes. The 
samples were collected from 91 healthy unrelated Afrikaner adults. Exact tests were 
used to determine evidence for deviations from HWE at a single marker locus or LD 
between pairs of marker loci. At the 0.05 level of significance, evidence was found 
for deviation from HWE at only one of the 24 loci. At the same level of significance, 
LD was found among 10 of the 38 intra-chromosomal pairs of loci. On chromosome 
21, there was evidence for LD between a pair of loci with an estimated genetic 
distance of5.51 cM (p = 0.0186). On chromosome 2, in which 5 loci were typed, one 
locus showed LD with three of the four other loci. The highest estimated genetic 
distance for pairs of loci with corrected p ~ 0.05 for LD was 5.28 cM (nominal p = 
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0.0019; p = 0.0268, corrected for multiple testing. Our fmdings indicate that 
Afrikaans-speaking Afrikaners represent one of those special populations deemed 
particularly suitable for disequilibrium mapping. This population may also be highly 
suitable for mapping genes underlying complex traits because strong LD is expected 
in the vicinity of disease loci, which can add power to genetic linkage analysis. 
Introduction 
Suitability of a specific population for the localization of disease genes by 
disequilibrium mapping may be assessed by investigating background LD, that is, LD 
among marker loci rather than between a disease and a marker locus (or loci). It has 
been pointed out that "quantifying the degree of such 'background' linkage 
disequilibrium is a crucial undertaking in paving the way for whole genome 
association studies" (Freimer et al. 1997). Studies of background LD have been 
performed in genetically isolated populations (Weir 1992; Peterson et al. 1995; Laan 
and Paabo 1997; Terwilliger et al. 1998); in larger outbred populations (Maiste 1993; 
Maiste and Weir 1995); among human and chimpanzee populations (Crouau-Roy et 
al. 1996); analytically (Terwilliger et al. 1998), and in computer simulations 
(Terwilliger et al. 1998; Kruglyak 1999). To date, we are unaware of any such studies 
in the Afrikaner population of South Africa, although, as described below, this 
population may be a strong candidate for the mapping of complex-trait genes through 
whole-genome association studies. 
The Afrikaner population of South Africa was formed by immigrants from Europe, 
primarily Dutch, German and French, who began settling in Cape Town in 1652 
(Torrington et al. 1984, Jenkins 1990). During the 18th century, the population was 
virtually cut from Europe and expanded from just over 1,000 to 17,000 in 85 years 
(Jenkins 1996). After Great Treks (mass movements of Afrikaners away from Cape in 
the 1830s), geographical isolation of new Afrikaner settlements was also 
accompanied by cultural isolation of the population, mainly due to the afrikaans 
language (derived from Dutch) and religion (Dutch reformed). The lack of larger 
immigration waves from Europe also contributed to the genetic isolation of the 
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Afrikaners, which was partially broken only around the turn of this century. Today 
after an estimated 12 generations since founding, there are about 3 million Afrikaners 
living in South Africa and abroad. Common mutations and/or marker haplotypes 
among Afrikaners have been established for several heritable disorders. Such 
disorders include variegate porphyria, keratolytic winter erythema, 
hypercholesterolemia, and progressive heart block (Jenkins 1990, Jenkins 1996, 
Meissner et al. 1996, Warnich et al. 1996, Starfield et al. 1997) suggesting that this 
recently founded popUlation has maintained its relative genetic homogeneity. The 
extent of conserved haplotypes around disease genes according to the above studies is 
between 8-11 cM, making the Afrikaner population of South Africa exceptionally 
valuable for genetic mapping studies (Groenewald et al. 1998). 
Methods 
Subjects 
Coded and anonymized DNA samples collected for a previous case-control 
association study (Simonic et al. 1998) were used for genotyping of 24 loci (22 
genetic loci and 2 cryptic duplicates) on six chromosomes. The samples were 
collected from paid healthy volunteers coming from two sources: medical students 
and personnel at the Afrikaans University. All study subjects were unrelated, older 
than 18 years, spoke Afrikaans and had Afrikaner family names. The male:female 
ratio in the group was - 1: 1. 
Primers 
24 primer pairs for the detection of short tandem repeat polymorphisms (STRPs) were 
obtained from Research Genetics (Huntsville, AL). 16 of the genetic markers were 
tetra- and trinucleotide repeat polymorphisms developed within the Cooperative 
Human Linkage Center (CHLC) and 6 genetic markers were Genethon dinucleotide 
repeat polymorphisms. Allele sizes were determined utilizing the known genotypes of 
three CEPH individuals: 1331-01, 1331-02 and 134702. Marker spacing was 
determined using comprehensive sex-averaged genetic maps (Broman et al. 1998). A 
list of all markers used may be found in Table 1. 
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Amplification of STRP markers was performed with 45ng of pooled DNA in a 10111 
PCR reaction mixture containing 1.51l1 PCR buffer (1.5mM MgCh, 50mM KCL, 
10mM Tris-HCI, 0.01% w/v gelatin); 200llM each dGTP, dATP, dTTP, 2.51lM dCTP, 
0.351lCi a32P-dCTP:(NEN Du Pont, 800 Cilmmole, 10IlCillll); lOng (about 3 pmoles) 
each PCR primer; and 0.3 U AmpliTaq polymerase (Boehringer Mannheim). Most 
markers were amplified in sets of two markers per amplification reaction in 96-well 
microtiter plate (Techno). Samples were subjected to 27 cycles consisting of 30 sec at 
94°, 75 sec at 55°, 15 sec at 72° and a fmal6 min at 72° after the last cycle. Products 
were denatured at 95° for 10 min, loaded (llll) onto a vertical 6.5% polyacrylamide 
DNA sequencing gel and run at 70 watts constant power for about 3 hours. The 
amplified DNA fragments for each marker were evaluated visually on the 
autoradiographs. 
Table 1 
Markers used in this study and their estimated locations 
Chromosome 1 Chromosome 2 Chromosome 5 
Marker cM Marker cM Marker cM 
GATA26CI2(D1SI648) 101.48 AFMI77xh4(D2S139) 101.56 GATA52AI2(D5S1501) 85.25 
GATA61A06(D1SI665) 102.02 GATA62BlO 103.16 AFM284vdl(D5S641) 92.38 
AFM294wgl(D1S481) 104.23 GATA88G05 103.16 GATA142H05 92.38 
GAATlD09 104.23 16AFM044xal(D2S289) 103.16 GATA91E02(D5S1726) 94.80 
Mfd 337(D2S417) 106.84 GATA69H12 94.80 
Chromosome 11 Chromosome 20 Chromosome 21 
Marker cM Marker cM Marker cM 
Mfd 316(DllS1377) 120.87 GATA45B 1 0(D20S480) 79.91 GATA45C03 31.26 
GATA64D03(DllS4464) 123.00 GATA46C01(D20S1085) 82.07 AFM276za5(D21S1254) 31.26 
GATA140F03 123.00 GGAAIIEI2(D20S469) 84.78 ATA27F01(D21S1440) 36.77 
AFM240yel(Dl1S933) 124.07 
Stellenbosch University  https://scholar.sun.ac.za
117 
Statistical Tests 
There are several statistical methods available for testing deviations from HWE at a 
single locus (Guo and Thompson 1992; Zaykin et al. 1995) or LD among several loci, 
when haplotype information is available (Lazzeroni and Lange 1995; Slatkin 1994; 
Schneider et al. 1997) or not available (Zaykin et al. 1995; Slatkin and Excoffier 
1996; Schneider et al. 1997). Since haplotype information was not available for this 
data set, we used the tests implemented by Zaykin et al. (1995) in their MLD software 
(see Electronic Database Information). 
As outlined below, exact tests were used in all cases. To test for departure from HWE 
at a marker locus, the probability of the set of genotypes in the sample, conditional on 
the allelic counts (Le., the marginals) was calculated from multinomial theory under 
the null hypothesis of HWE (Guo and Thompson 1992; Zaykin et al. 1995). Alleles 
were permuted and, for each permutation, the conditional probability was calculated. 
The proportion of permutations no more probable than the original sample provided 
an estimate for the empirical significance level associated with the test result. Exact 
confidence intervals were computed based on the binomial distribution as 
implemented in the BINOM program (Ott 1999, Electronic Database Information). 
These tests of HWE are implemented in the MLD software program (Electronic 
Database Information), and all reported p-values are determined by use of that 
software. Here, 17000 permutations were selected for each run of MLD on a marker 
locus to narrow the 99 % confidence interval for p-value reported. 
For a given pair of loci, the probability of the set of multi-locus genotypes in the 
sample, conditional on the allelic counts (Le., the marginals) was· calculated from 
multinomial theory under the null hypothesis that each two-locus genotype frequency 
was the product of the respective one-locus genotype frequencies (Zaykin et al. 1995). 
Permutations were implemented by keeping the one-locus genotypes intact and 
permuting these genotypes among individuals at one of the loci (Zaykin et al. 1995). 
An estimate for the empirical significance level was determined as in the one-locus 
case. These tests are also implemented in the MLD software program, and all reported 
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p-values were determined by use of that software. As above, 17000 permutations were 
chosen for each run ofMLD (see Table 3). 
The one-locus test was applied to all markers, while the test for LD among pairs of 
loci was applied to all pairs of markers. Here and elsewhere, the term intra-
chromosomal pair refers to a pair of marker loci on the same chromosome, while 
inter-chromosomal pair refers to a pair of loci on two different chromosomes. Results 
of tests for intra-chromosomal markers are presented in Table 2. 
Results and Discussion 
One-Locus Tests 
Only one marker, D5S1501, had a p-value less than 0.05 when testing for deviations 
from HWE (p = 0.0299). By chance alone we would expect approximately one of 22 
markers (not counting the cryptic duplicates) to show a p-value less than 0.05, even if 
all the markers are in HWE. Thus, no markers showed a significant deviation from 
HWE. 
Two..:Locus Tests 
Table 2 presents those intra-chromosomal marker pairs for which the test for LD 
showed evidence for LD, along with the estimated genetic map distance between the 
markers. The reported distances were computed using Table 1. The p-values 
(uncorrected for multiple testing) for all intra-chromosomal marker pairs may be 
found in Table 3. One can see from Ta.ble 2 that there is evidence for LD in this 
sample between markers D21S1254 and D21S1440 on chromosome 21. The 
estimated genetic distance between these two markers is 5.51 cM. On chromosome 2, 
there is evidence for LD between D2S417 and all other markers (with the exception of 
D2S289). The estimated genetic distance between marker D2S417 and D2S139 is 
5.28 cM. In fact, 6 of the 10 marker pairs in Table 2 have estimated genetic distances 
over 2 cM. 
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Table 2 
Marker Pairs that show evidence for LD in sample of91 Afrikaners. 
Estimated p-value and 99% PeOrT and 99% 
Marker Pair Genetic Chromo- Confidence Interval Confidence Interval 
Distance some (not corrected for (corrected for 
(cM) multiple testing) multiple testing) 
D21S1254 D21S1440 5.51 21 .0186 .2733 
(.0160,.0214) 
D2S417 D2S139 5.28 2 .0016 .0269 
(.0009,.0026) (.0152,.0433) 
D2S417 GATA62B1O 3.68 2 .0004 .0068 
(.0001,.0010) (.0017,.0169) 
D2S417 GATA88G05 3.68 2 .0000 .0000 
(.0000,.0003) (.0000, .0051) 
D20S1085 D20S469 2.71 20 .0461 .5517 
(.0421,.0504) 
D20S480 D20S1085 2.16 20 .0233 .3302 
(.0204,.0264) 
D1S1648 D1S1665 0.54 1 .0021 .0351 
(.0013, .0032) (.0219,.0530) 
GATA62B10 GATA88G05 0.0* 2 .0000 .0000 
* 
(.0000,.0003) (.0000, .0051) 
D5S1726 GATA69H12 0.0* 5 .0000 .0000 
(.0000,.0003) (.0000, .0051) 
D11S4464 GATA140F03 0.0 11 .0104 .1628 
(.0085, .0126) 
indicates that one marker in pair was identified by Marshfield Labs as being a 
"cryptic" duplicate of another marker 
To correct for multiple testing, we applied a form of Bonferroni correction as follows. 
For N markers on a chromosome, we assume that N - 1 independent tests are carried 
out when all pairwise comparisons are considered. Over all chromosomes, this leads 
to 17 independent intra-chromosomal tests. Thus, a corrected empirical significance 
level is given by Peo" = 1-(1- p)17. With this, we observe that all p-values for 
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Chromosome 2 are still significant at the 0.05 level (Table 2). Additional marker pairs 
withPcorr < 0.05 are found on chromosomes 1 and 5. 
We also tested for LD among more than two marker loci jointly as implemented in the 
MLD program (Zaykin et al. 1995). Table 4 reports results for chromosome 2 in 
which the marker set tested includes D2S417 and excludes D2S289, since this marker 
showed no evidence for LD with any other marker. All p-values in Table 4 are 
significant at the 0.05 level, even when using the conservative assumption that 3 
independent tests have been performed (corrected p-value = 1-(1- p )3) . 
Table 3 
Exact Test p-values for all intra-chromosomal pairs 
99% confidence intervals for significant p-values « 0.05) determined by 
BINOM program (Ott 1999) 
Uncorrected for MUltiple Testing 
Chromosome 1 
01S1665 GAATlO09 01S481 
102,02cM 104.23cM 104.23cM 
O1S1648 .0021 .4878 .0885 
101.48cM J.0013, .0032) 
01S1665 .6745 .5837 
102.02cM *** 
GAATlO09 .6679 
104.23cM *** 
Chromosome 2 
GATA62BIO GATA88G05 D28289 D2S417 
103.16cM 103.16cM* 103.16cM 106.84cM 
02S139 .0656 .0856 .1474 .0016 
101.56cM (.0009,.0026) 
GATA62BI0 *** .0000 .6314 .0004 
103.16cM (.0000,.0003) (.0001,.0010) 
GATA88G05 *** .5521 .0000 
103.16cM* (.0000,.0003) 
02S289 *** .1033 
103.16cM 
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Chromosome 5 
D5S641 GATA142H05 D5S1726 GATA69H12 
92.38cM 92.38cM 94.8cM 94.8cM* 
D5S1501 .7798 .8395 .9601 .7597 
85.25cM 
D5S641 *** .7393 .4508 .4648 
92.38cM 
GATA142H05 *** .2444 .4784 
92.38cM 
D5S1726 *** .0000 
94.8cM (.0000,.0003) 
Chromosome 11 
DllS4464 GATA140F03 D11S933 
123.00 cM 123.00cM 124.07cM 
Dll S 1377 .5867 .1154 .3382 
120.87cM 
O11S4464 .0104 .7036 
123.00cM *** (.0085, .0126) 
GATA140F03 .7576 
123.00cM *** 
Chromosome 20 
D20S1085 D20S469 
82.07cM 84.78cM 
D20S480 .0233 .7953 
79.91cM (.0204,.0264) 
D20S1085 *** .0461 
82.07cM (.0421,.0504) 
Chromosome 21 
D21S1254 D21S1440 
31.26cM 36.77cM 
GATA45C03 .4415 .1180 
31.26cM 
D21S1254 *** .0186 
31.26cM (.0160,.0214) 
NOTE. - All map positions detennined by using the Marshfield Website sex-averaged maps 
(www.marshmed.org/genetics/) 
*marker was identified as being a "cryptic" duplicate of another marker 
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Table 4 
Multi-locus Exact-Test p-values for Chromosome 2 using sets of markers that 
include D2S419 and that exclude D2S289. 
3-Locus Tests 
Marker Set P-value Corrected 
P-value 
D2S 139 - GATA62B 1O-D2S417 .0025 .0075 
D2S139 - GATA88G05-D2S417 .0030 .0090 
GATA62BlO-GATA88G05-D2S417 .0000 .0000 
4-Locus Test 
Marker Set P-value 
D2S 139 - GATA62B 1 0-' GATA88G05-D2S417 .0000 
Our fmdings indicate that Afrikaans-speaking Afrikaners represent one of those 
special populations deemed particularly suitable for disequilibrium mapping (Figure 
1). This population may also be highly suitable for mapping genes underlying 
complex traits because "strong LD is expected in the vicinity of disease loci, which can 
add power to genetic linkage analysis. 
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Figure 1 
Evidence for disequilibrium (p-value) in some special 
populations 
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CHAPTERS 
Human Molecular Genetics (submitted for publication, September 1999) 
CONFIRMATION OF GILLES DE LA TOURETTE SYNDROME 
(GTS) SUSCEPTIBILITY LOCI ON CHROMOSOMES 2p11, 8q22 
and 11q23-24IN SOUTH AFRICAN AFRIKANERS 
11. Simonic, 1G.S. Gericke, 20. Nyholt, 20. Gordon, 2 J. Ott, 3 J.L. Weber 
I Neurogenetics Research Initiative, MRC Pretoria, South Africa 
2 Department of Statistical Genetics, Rockefeller University, New York, NY 
3 Center for Medical Ge~etics, Medical Research Foundation, Marshfield, WI 
Summary 
Five genomic regions on chromosomes 2, 8, 11, 20, and 21 that gave evidence for 
association with GTS in previous case-control association studies were investigated 
for linkage and association with GTS utilizing DNA samples from 91 Afrikaner 
nuclear families with one or more affected children. Highly polymorphic markers 
with mean heterozygosity of 0.77 were typed and resulting genotypes evaluated using 
single marker transmission disequilibrium (TDT), single marker haplotype relative 
risk (HRR), and multi-marker 'extended' TDT and HRR methods. Single marker 
TDT analysis showed evidence for linkage or association, with p-values near 0.05, for 
markers D2S139, GATA28F12 and DllS1377 on chromosomes 2pll, 8q22 and 
Ilq23-24, respectively. Extended TDT and HRR analysis provided further evidence 
for linkage or association on chromosome 2 with p values of 0.007 and 0.025, and 
chromosome 8 with p values of 0.059 and 0.013. These results provide strong 
additional evidence for the location ofGTS susceptibility loci. 
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Introduction 
.' 
While the etiology of Gilles de la Tourette syndrome (GTS), a childhood-onset 
neurologic disorder characterized by chronic involuntary movements (either motor, 
vocal, or both at the time of the diagnosis) remains hidden, it has a strong genetic 
component (Price et al. 1985). According to recent complex segregation analyses, the 
susceptibility for GTS is more complicated than previously suggested, conveyed by 
an additive major locus in combination with a multifactorial background (Walkup et 
al. 1996). A failure to identify GTS-linked genetic loci in large, multiple affected 
kindreds motivated the redirection of gene-mapping efforts toward allele-sharing 
methods and linkage disequilibrium (LD) studies in genetically isolated populations. 
Lander and Kruglyak (Lander and Kruglyak 1995) proposed stringent guidelines for 
the assignment of genome-wide significance levels in linkage studies to diminish the 
rates of false positive results. In case-control LD studies, because of the danger of 
spurious associations due to mismatching of controls and population admixture, 
consistent replication may be the best evidence for a true association (Kidd 1993). 
Our previous whole-genome search for association with GTS among Afrikaners 
(Simonic et al. 1998) with 1,167 short tandem repeat polymorphisms, using a cross-
sectional case-control strategy, DNA pooling, and follow-up individual typing of two 
independent sets of case-control samples resulted in identification of 15 markers in 11 
chromosomal regions with significant allele distribution differences between the two 
groups of samples. 
For the reasons outlined above, our current study was designed as an attempt to 
replicate our previous results. Therefore, in this study, we collected additional 
independent affected individuals and their parents from the Afrikaner population. We 
then applied transmission disequilibrium (TDT) and haplotype relative risk (HRR) 
tests to genotype data generated at 5 earlier determined regions of interest, to further 
investigate the significance of our initial fmdings. In three instances, our previous 
results were confirmed (p < 0.05) even after the application of conservative 
Bonferroni cOI:rections for multiple testing. 
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Subjects, Material & Methods 
Patients 
85 randomly selected GTS individuals from 74 independent families (64 singletons, 9 
pairs and 1 affected trio), not participating in our previous studies, were invited 
together with their parents for interviews and blood sample collection. They were 
identified as GTS sufferers at previous visits at the Tourette Syndrome Clinic in 
Pretoria and interviewed for the second time using the criteria of the Tourette 
Syndrome Association Genetic Consortium (Simonic et al. 1998). For 19 individuals 
(including two pairs of siblings), only one parent was available for the study. In 
addition, parental and affected individual blood samples were collected for 22 GTS 
individuals from 17 independent families (12 singletons and 5 affected pairs), whose 
DNA samples were used in our initial genome screen. Our combined material thus 
consisted of 91 families with 107 GTS individuals, 88 with both parental DNA 
samples available, and 19 with one parental DNA only. All families spoke Afrikaans 
and had Afrikaner family names on both maternal and paternal sides. 
Polymorph isms 
In total, 31 short tandem-repeat polymorphisms (STRPs) mapping to 5 genomic 
regions were selected for this replication study (Table 1). The main criteria for 
marker selection were map position (Center for Medical Genetics, Marshfield), 
spacing (-1.5 cM separation on sex-averaged genetic map), and heterozygozity (mean 
0.77) (Broman et al. 1998). Primer pairs were mostly obtained from Research 
Genetics. Primers for CA dinucleotide repeat marker T7-27 were designed from the 
partial sequence of BAC clone 127D17, which contains the MTG8 gene. Allele sizes 
for the markers were determined using known genotypes of two CEPH individuals 
(133101 and l33102). 
Amplification of STRPs was performed in 96 well microtiter plates with 50 ng of 
DNA in a 5 J.lI volume containing 3 mM MgCh; 50 mM KCI; 10 mM Tris-HCI, pH 
8.3; 0.01% (w/v) gelatin; 200 J.lM each dGTP, dCTP, and dTTP; 2.5 J.1M dATP; 0.35 
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JlCi ae3p]-dATP (NEN Du Pont; 800 Ci/mmol, 10 JlCi/JlI); 10 ng (-3 pmol) each 
PCR primer; and OJ U Taq polymerase (Sigma). Samples were subjected to 29 cycles 
consisting of30 sec at 94°C, 75 sec at 55°C, and 30 sec at 72°C, with a fmal6 min at 
72°C after the last cycle. All markers were amplified individually. All genotyping 
was performed in duplicate to minimize errors. PCR products were denatured by 
heating for 10 min at 95°C prior to loading (O.5JlI) onto vertical 6.5% polyacrylamide, 
7.7 M urea DNA sequencing gels and running at 70 W constant power for -2 hours. 
Gels were dried on filter paper and exposed on X-ray film. 
Table 1 
31 markers in five genomic regions were selected for the replication study 
Chr. Marker Locus eM Het. Chr. Marker Locus eM Het. 
2 AFM177xh4 02S139 101.56 0.82 11 OR02 105 0.63 
2 GATA6F08 02S440 103.16 0.68 11 Mfd316 011S1377 120.87 0.78 
2 AFMa126zb1 02S2161 105 0.78 11 AFM331yc5 011S1353 122.47 0.79 
2 Mfd337 02S417 106.84 0.75 11 GATA64003 011S4464 123 0.78 
/ 
11 AFM240ye1 0115933 124.07 0.8 
8 ATA19G07 08S1119 101.01 0.8 11 Mfd251 011S975 126.21 0.79 
8 AFM147yb6 08S1707 101.69 0.7 
8 AFM165yb10 08S271 102.62 0.77 20 GATA45B10 020S480 79.91 0.74 
8 GATA8B01 103.69 0.74 20 GATA46C01 020S1085 82.07 0.86 
8 MTG8* 103.69 0.84 20 AFM276xh1 020S120 83.51 0.85 
8 T7-27** 103.69 0.43 20 GGAA11E12 020S469 84.78 0.79 1 
8 AFM165xh4 08S270 103.69 0.79 
8 GATA28F12 104.33 0.63 21 GATA45C03 31.26 0.7 
8 AFMa052wh1 08S1822 107.97 0.77 21 AFMa086yf9 021S1920 31.99 0.75 
8 GATA23012 08S1129 110.2 0.29 21 AFMb280xd9 021S1895 33.84 0.82 
8 AFM077ya5 08S257 111.68 0.71 21 AFM261zg1 021S1252 35.45 0.8 
8 AFM352td9 08S559 112.42 0.72 
8 AFM333vb9 08S1808 113.16 0.53 
* MTG8 3'UTR microsatetellite polymorphism (Wolford et al. 1998) 
** T7 -27 primers: AGCAT AACA llGCTGCTAGAG and GTT ACTTTGCAGATCTTTGAGC 
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Statistical Analysis 
Several different statistics were used to evaluate marker genotypes (calculation of p-
values is described in paragraph 4 below): 
1. Single marker transmission disequilibrium test (TDT), fIrst proposed by Spielman 
et al. (1996), based on a statistical comparison of the frequencies of transmissions 
and nontransmissions of a marker alleles from heterozygous parents to affected 
offspring. The distribution of transmitted versus nontransmitted alleles were 
compared using the T m (X2) TDT statistic (Bickeboller and Clergot~Darpoux 
1995). 
2. Single marker haplotype relative risk (HRR) method, fIrst proposed by Falk and 
Rubinstein (1987), uses two alleles of the parents (both homo- and heterozygous 
for particular marker alleles) which are not transmitted to their affected offspring 
(only one affected offspring for each pair of parents is used) to create a so called 
"pseudo-control" (Schaid 1998). All case alleles are from the fIrst affected child in 
each pedigree. The control alleles are assigned in relation to the number of typed 
parents, using the following rules: (i) if both parents are typed then the two 
nontransmitted alleles in the parents of the affected children are included in the 
control sample; (ii) if only one parent is typed and there is an unambiguous 
solution (Le., parent and child have different genotypes) then the one remaining 
(nontransmitted) allele is included in the control sample; (iii) if neither parent is 
typed, or if only one parent is typed and has the same genotype as the affected 
child, in which case the probabilities of the transmitted and nontransmitted alleles 
are ambiguous, then no allele(s) is included in the control sample. The association 
of disease with marker alleles was then assessed by a traditional case-control X2 
statistic. 
3. Multipoint TDT and HRR methods were devised to increase meiotic 
informativeness within families. Multi-marker haplotypes were built across two or 
three contiguous markers (i.e., 1-2, 2-3, 3-4 and 1-2-3, 2-3-4, 3-4-5, etc.). A 
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transmitted haplotype consisted of alleles at contiguous loci which could be 
unambiguously detennined to be transmitted by a parent to an affected offspring, 
and non-transmitted haplotypes were defmed analogously. The only case in which 
transmitted haplotypes are ambiguous occurs when both of the typed parents plus 
the affected child are all heterozygous for the same alleles at the same locus, in 
which case these individuals were excluded from the analysis. The frequencies of 
these transmitted and non-transmitted haplotypes were then statistically tested for 
linkage and association using the same methods used for the single marker tests. 
4. Because the large number of allele and haplotype combinations produce large, 
sparse contingency tables, significance for all TDT and HRR tests was detennined 
by exact methods. Associated p-values were approximated by Monte Carlo 
simulation as implemented in the StatXact3 program (CYTEL Software Corp., 
Cambridge, USA) with 10,000 iterations. Also because this is a replication 
analysis focussing on previously identified genomic regions, p-values are reported 
without correction for multiple testing. 
Results 
Genotypes for 4, 13, 6, 4 and 4 markers (Table 1), mapping to the regions on 
chromosomes 2, 8, 11,20 and 21, respectively, previously found to be associated with 
GTS, were tested for linkage and association in 91 independent families. Results of 
single and multiple marker TDT and HRR analyses are summarized in Table 2. Single 
marker TDT analysis showed evidence for linkage or association, producing p-values 
of 0.039, 0.056 and 0.022, for markers D2S139, GATA28FI2 and DIIS1377 on 
chromosomes 2, 8 and 11, respectively. Extended TDT and HRR analysis provided 
further evidence for linkage or association on chromosomes 2 and 8, producing two-
marker p-values of 0.007 and 0.025, and 0.059 and 0.013, respectively. Moreover, 
three-marker HRR analysis on chromosome 8 also showed significant association, 
producing a p-value of 0.011. No evidence, however, was found for linkage or 
association with markers on chromosomes 20 and 21. 
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Table 2 
Results from TOT and HRR Analyses 
I 
Original.Case-Control Study (5) Follow Up Familial TOT and HRR Study 
Extended Haplotypes 
cM i-Locus 2-Locus 2-Locus 3-Locus 
Chromo Locus from p-tel TOT TOT HRR HRR 
Some Jsex-avg) P P P P P 
2 028139 101.56 0.039 0.007 0.025 028440 103.16 0.002 0.734 
028417 106.84 0.160 
8 0881119 101.01 0.01 0.349 
T7-27 103.69 0.835 
088270 103.69 0.823 0.059 0.013 0.011 GATA28F12 104.33 0.056 
088257 111.68 0.01 0.638 
11 01181377 120.87 < 0.000001 0.022 0.109 0.108 01181353 122.47 0.135 
0118933 124.07 0.0009 0.535 
20 020S1085 82.07 0.0001 0.240 
0208469 84.78 0.1 0.411 
21 GATA45C03. 31.26 0.0004 0.221 
02181252 35.45 0.000008 0.279 
Discussion 
Tests for disease-marker association within nuclear families via TDT or HRR are 
generally considered more rigorous than case-control studies. We therefore recruited 
Afrikaner families with affected children in an attempt to confirm our original case-
control GTS results. Although we used a relatively small sample, we were still able to 
confirm 3 out of 5 chromosomal regions identified previously. Regions centered at 
about 2pll, 8q22 and llq23-24 are therefore strengthened as locations of genes 
which influence GTS in the Afrikaner population. 
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There are several potential reasons why we could not conflrm the remaining two 
regions on chromosomes 20 and 21. Instead of true association with disease-
predisposing alleles, the results for these chromosomes could be due to factors such as 
population admixture, slight differences in ancestry between cases and controls, and 
multiple founding alleles. Alternatively, the original fmdings could be true, but 
replication failed because we searched in the wrong locations or selected markers, 
which had particularly high mutation rates or had common alleles associated with the 
disease allele. 
In general, TDT has greater power to detect linkage for a 'recessive' -type model of a 
genetic trait than for a 'dominant' -type. Its power is also higher when there is a 
greater difference in marker allele frequency between disease and normal 
chromosomes and the marker mutation rate is minimal (Xiong and Guo 1998). Given 
these limitations, it is exciting that we were able to conflrm even a fraction of the 
original locations. 
Our fmdings provide an important addition to the molecular genetics of GTS and will 
aid in further studies. For example, our evidence for linkage or association with GTS 
by TDT and HRR analysis, at marker locus GATA28F12, maps proximally to 
D8S257 which has previously been suggestively associated with GTS by us, and 
linked with GTS by Leppert et al. (1996). In addition, D8S257 is distal « 1.5 cM) to 
a breakpoint (unpublished results) in a family with GIS co-segregating with a 
chromosome translocation t(1,8) (q21.1, q22.1) described by Devor and Magee (in 
press). 
In summary, the results from this study represent significant replication and strong 
evidence for the presence of susceptibility loci in some of these genomic regions. In 
particular, the involvement of chromosomes 8q22, 2pll, and llq23-24 as candidate 
regions for GTS susceptibility deserves further study. We plan to continue these 
investigations either by increasing our current sample size; by focusing on historical 
subgroups of Afrikaners and thus escalating the chances for detection of shared 
haplotypes; and ultimately by screening of candidate genes in these regions. 
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CHAPTER 9 
Discussion 
9.1. Contributions made against the background of the current state of 
knowledge concerning the genetics of neuropsychiatric disorders. 
137 
Despite intense international efforts, utilization of classical genetic linkage studies 
and affected sib pair studies have not yielded any strong and consistent leads for any 
major psychiatric disorder such as schizophrenia, bipolar affective disorder, or 
behavioral traits such as the alcoholism. 
Positive fmdings from numerous whole genome scans are scattered throughout the 
genome with no apparent consistency among the results. Some chromosomes have not 
been putatively linked to any psychiatric disease. Others contain large genomic 
regions, with a spread of positive fmdings well over 40 cM, which may contain a 
susceptibility locus to several distinct neuropsychiatric traits. At this stage, however, 
none of the fmdings appear strong enough to be followed by physical cloning and 
sequencing of surrounding regions (Delisi and Crow 1999). 
Views vary widely from the notion that there is one major gene for all psychoses, to a 
single major gene within some families but several different genes within separate 
populations, to the concept that a number of interacting genes are necessary for the 
expression of the disorder within one individual. If the multitude of positive regions 
reported for neuropsychiatric traits by various research teams represent true psychosis 
vulnerability loci, this. would support the latter concept (Delisi and Crow 1999) as 
well as the view that some of the susceptibility loci will have different prevalence 
rates in different popUlations. Under such circumstances coordinated international 
collaboration in genetic mapping of neuropsychiatric traits is essential, including 
sample collection in various populations and integration of all existing and newly 
generated data. 
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A good example of such an international effort is the work of the International 
Tourette Syndrome Genetic Linkage Consortium, created as a result of the Tourette 
Syndrome Association (TSA) initiative. The Consortium has supported international 
collaborative studies for over 10 years, with both administrative and direct research 
funding provided by the TSA. The Consortium includes investigators from 11 centers 
in United States, Canada, United Kingdom, Netherlands, as well as the Neurogenetics 
Research Initiative at the Medical Research Council in Pretoria, South Africa. 
The molecular genetic investigations presented in this study were initiated and 
partially supported by the Tourette Syndrome Genetic Linkage Consortium and 
signify an important step forward in T ourette syndrome gene mapping efforts as well 
as mapping genes for neuropsychiatric illness in general. 
The design and the results achieved throughout the subsequent studies provide 
evidence that initial case-control association fmdings in special populations have the 
potential to be confmned by linkage in the nuclear family design. These studies also 
suggest that several genes at different chromosomal regions shape the susceptibility to 
Tourette syndrome. Even though the initial hypothesis of single founder effect for 
Tourette syndrome in the Afrikaner popUlation was probably incorrect, this type of 
population may still prove to be an extremely valuable source of genetic material for 
mapping complex traits, as documented in this study. 
9.11. The possible significance of cytogenetic findings 
It is sometimes assumed that there is no longer much scope for chromosome studies in 
genetic research because everything is known about phenotypic consequences of 
chromosome abnormalities and also because traditional cytogenetic techniques are 
slowly overtaken by molecular methods (Rutter 1994). Despite these developments, 
further exploration of cytogenetic investigations is needed: 
Stellenbosch University  https://scholar.sun.ac.za
139 
1. in the area of submicroscopic chromosomal deletionlduplication(s) investigations 
in relation to complex phenotypes which are often characterized by comorbidity 
and phenotypic overlaps as exemplified by the contiguous gene syndromes; 
2. in the identification of cytogenetically detectable anomalies in proband(s) which 
may help to accelerate the search for disease gene location, as it was in case of 
neurofibromatosis type 1 or Duchenne muscular dystrophy; 
3. and fmally, in the search for disease-specific chromosome fragile sites, which may 
be expressed in the affected individuals as a consequence of sequence variations, 
such as repeat expansions, at the disease locus. 
Chromosome fragile sites (FS) are regarded as primary targets for environmental 
insults and as such may facilitate subtle DNA changes during prenatal and postnatal 
development resulting in susceptibility/resistance to a large variety of complex 
genetic traits and/or somatic cell mutations involved in malignancy. The role ofFS in 
amplification, loss of heterozygosity (LOH), or gain of function at or near cancer 
related genes is currently well recognized and there are several vague, but intriguing 
indications that a subgroup of chromosome FS may give rise to genetic variations 
involved in the expression of some neurological disorders or may appear 
consequently to such genetic variations. The best known example of such a 
relationship is the rare FS on chromosome X (FRAXA). 
Our fmdings of increased breakage rates at large number of common fragile sites in 
two subsequent case-control studies involving Tourette syndrome probands indicate 
that for unknown reasons their lymphocyte DNA at the chromosomal level of 
organization is more sensitive to the inhibition of DNA synthesis (due to folic acid 
deficiency or aphidicolin treatment). 
The number of FS exhibiting increased expression rates between Tourette syndrome 
and non-Tourette syndrome samples is high and the fragility itself may be influenced 
by numerous sample and culture related conditions, therefore the FS expression 
cannot serve as discriminatory cytogenetic marker for Tourette syndrome and it is 
improbable that the individual FS represent candidate chromosome regions for 
Tourette syndrome loci. 
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Overall, there are several possible explanations for the findings of increased fragility 
rates in several groups ofTourette syndrome probands, two of which are: 
1. As discussed in chapter 6 one possible cause of increased fragility rates may be 
the lack or the presence of distinct T-Iymphocyte type(s) in the Tourette-positive 
group of samples as opposed to controls. This may be a consequence of an 
autoimmune reaction to certain types of bacterial infection, which is considered by 
some researchers associated with phenotypic expression of Tourette syndrome in 
at least a subgroup of cases. 
2. Another alternative, not discussed in Chapter 2, 3 and 6 could relate to a 
prolonged cell cycle in mitogen-stimulated T-Iymphocytes of Tourette syndrome 
probands. Such a prolonged cell cycle could result in the observation of earlier 
metaphase stages, consequently leading to an increased number of gaps and 
breaks in the chromosome structure due to DNA under-replication caused by 
aphidicolin treatment. 
Similar fmdings were documented for the group of genetic conditions known as 
chromosome breakage syndromes, which are characterized by increased breakage 
rates observed in cultured lymphocytes as a result of faulty DNA repair and 
packaging. Completion of DNA replication/repair/packaging is an important check-
point for cytokine induced initiation of mitosis, and if delayed may directly influence 
the duration of the whole cell cycle. 
If an increased FSexpression in Tourette syndrome T-Iymphocyte cultures is a 
function of a prolonged cell cycle, then genes directly or indirectly influencing the 
duration of certain cell cycle stages would be good candidates for Tourette syndrome 
susceptibility. Such candidates must, however, be different from the group of genes 
involved in the expression of chromosome breakage syndromes, which are 
characterized by a high prevalence of childhood cancers. 
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Increased rates of fragile site expression were also found in association with other 
disease states accompanied by neurological and psychiatric disturbances (Petronis and 
Kennedy 1995), e.g. schizophrenia (Garofalo et al. 1993, Chen et al. 1998), type I 
bipolar disorder (Turecki et al. 1995), autism (Arrieta et al. 1996), and Rett syndrome 
(Telvi et al. 1994, Simonic et al. 1997). Increased chromosome breakage was also 
observed in autoimmune disorders, e.g. scleroderma (Emerit et at 1976, 1980), 
rheumatoid polyarthritis (Vincent et al. 1986), and celiac disease (Fundia et al. 1996), 
suggesting that some common underlying mechanisms (certain type of immune 
responses?) playa role in phenotypic expression of all the above conditions including 
Tourette syndrome. In the case of Tourette syndrome, the latter conclusion is 
supported by a growing body of evidence that a subset of Tourette syndrome cases 
could be related to the presence ofD8/17, an immune marker for rheumatic fever. 
9.12. The significance of associationllinkage findings 
For most neurological, psychiatric, or neurobehavioral genetic disorders, the patterns 
of inheritance has proven to be more complicated than previously thought. Examples 
include schizophrenia, bipolar affective disorder, alcohol dependence, autism, 
obsessive compUlsive disorder (OCD), attention deficit hyperactivity disorder 
(ADHD), Tourette syndrome, conduct disorder, etc., where disease-associated 
psychopathologies presumably develop due to mUltiplicative and/or additive 
interactions of several genes rather than a single major gene. The interplay of several 
genes as well as unknown environmental factors could well explain other common 
features of this group of complex traits, such as clinical heterogeneity and 
comorbidity. These factors together with high phenocopy rates in the populations and 
frequent bilineal transmissions of susceptibility factors in families contribute to 
overall resistance of the traits to gene-mapping efforts. 
Heutink et al. (1995) performed an extensive computer simulation study in -order to 
investigate the best strategy for mapping Tourette syndrome gene(s) with respect to 
data collection and diagnostic classification of the disease. Their results suggested, 
that the scenario of multiple tests that included various Tourette syndrome diagnostic 
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models (narrow, mild, and broad) gives much higher probability for detecting linkage 
than does the use of a single test including narrowly defmed phenotype. However, 
classical linkage studies using large pedigrees with multiple affected relatives have 
not produced unambiguous results under the assumption of a single dominant model 
of inheritance, despite incorporating different diagnostic models into data analysis. On 
the contrary, the implementation of classical linkage methods resulted in exclusion of 
>90% of the genome for harboring Tourette syndrome genes. 
Complexities arising with more complicated models of inheritance cannot be assumed 
when parametric methods, such as classical linkage methods, are used for data 
analysis. Therefore, a great deal of hope in current Tourette syndrome gene-mapping 
efforts is focused on the notion that non-parametric methods, such as the affected sib-
pair method (ASP), which do not require assumptions with regard to a specific genetic 
model will provide a more powerful tool for genetic mapping. As a result, the 
International Tourette Syndrome Genetic Linkage Consortium has initiated a 
preliminary ASP genome-wide linkage study using hundred affected siblings 
collected at several sites in Canada, United States, United Kingdom and Netherlands. 
The results of single and multipoint maximum likelihood score (MLS) analyses were 
recently submitted for a publication in Am J Hum Genet (Aug 1999). 
The ASP approach is expected to have sufficient power for detection of linkage with 
complex traits only when extensive samples are subjected to statistical analysis, 
requiring about 200 to probably a thousand or more affected siblings. A similar 
situation with respect to robustness accounts for other analytical approaches based on 
nuclear family or case-control data collection. To overcome this problem, sequential 
approaches to data collection/generation/analysis have been proposed, based on 
subsequent follow-up studies using smaller sets of samples. Moreover, to avoid 
shortcomings of each different statistical method, combined semi parametric methods 
for mapping complex traits were established via linkage/linkage disequilibrium (LD) 
analysis. 
Two critical tasks regarding sequential and combined approaches in study designs are 
the selection of genetic markers with respect to their average genetic map spacing and 
Stellenbosch University  https://scholar.sun.ac.za
143 
their mean heterozygosity, as well as the interpretation of the results and statistically 
generated significance levels. With this regard, a number of general rules were 
established: 
1. The average spacing of the markers in the whole genome searches has been 
recommended as < 0.5 cM for LD mapping efforts in heterogeneous populations 
and between 5-10 cM in young « 20 generations) genetically isolated 
populations. An efficient strategy in scanning the chromosomes for linkagelLD 
with disease genes also involves typing markers along sparse map, throughout the 
genome, and then following up on promising areas from the initial scan with a 
dense array of markers, to extract the full inheritance information (Durham and 
Feingold 1997). 
2. Historically, most methods for detecting LD (in particular) were designed for use 
with diallelic marker loci, for which the analysis is straightforward. These 
analytical methods have now been extended for use of polymorphic markers with 
many alleles, leading to an increase of the number of observations and 
corresponding loss of power. Altemativelly, multiallelic systems were reduced to 
diallelic systems by selecting one allele believed to be associated with the trait and 
collapsing the other alleles, leading to the introduction of substantial bias into the 
analysis (Terwilliger 1995). Ott and Rabinowitz (1997) examined the relationship 
between marker heterozygosity and the power to detect LD and concluded that, 
despite the penalties for multiple testing incurred with mUltiple alleles, in general 
greater heterozygosity of markers results in greater power. 
3. In interpreting linkagelLD fmdings, consistent significant results are usually 
considered suggestive for the identification of a candidate gene locus. However, 
inconsistent fmdings with positive linkage results and negative LD results could 
have several different interpretations: a/ markers significantly linked with disease 
locus may still be located far away from the actual disease locus, reSUlting in 
linkage-equilibrium; bl linked markers identify the disease locus, but may have 
multiple disease-causing mutations, diminishing the allelic association with 
closely spaced markers; 31 the linkage signals could be false-positive. On the other 
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hand, an inconsistent fmding with positive LD and negative linkage is likely to 
suggest that LD resulted from population-based forces other than co-segregation 
of disease and marker alleles. Finally, a consistent negative result between LD and 
linkage analyses provides a strong support that the corresponding region is less 
likely to include any major disease locus (Zhao et al. 1999). 
4. The interpretation of significance levels resulting from multi-locus analysis 
(particularly genome-wide) is matter of current debate and persistent controversy. 
Therefore, repeated replication of statistically significant or suggestive linkagelLD 
fmdings from several independent experiments is still regarded as the best 
evidence for candidate disease gene location. 
The study design, presented in this thesis, attempted to identify candidate gene 
location(s) for Tourette syndrome based on a modified sequential and semi-parametric 
model of analysis. Several independent studies were performed including an initial 
whole-genome search for association (case-control design), a confirmatory LD study 
with denser marker maps in regions of interest and two independent non-overlapping 
groups of case-control samples, and fmally the confirmatory linkage/association study 
of case-control data based on nuclear family design using TDT and HRR statistics. 
Throughout the study an attempt was made to comply with all the recommendations· 
discussed earlier with respect to marker density and heterozygosity, as well as the 
interpretation of the results. 
To date, three genetic regions were identified on chromosomes 8q22.1-q22.3, 
llq23-24, and 2pll during this study, as being suggestive for Tourette syndrome 
candidate loci. 
The chromosome 8q22 region was found to manifest a translocation breakpoint in a 
family with a cytogenetically balanced chromosome translocation co-segregating with 
T ourette syndrome. The breakpoint at 8q22 was found in close proximity to the 
marker D8S257, associated with Tourette syndrome in our study, and the MI'G8 gene 
(Weber, unpublished), also known as the CDR/ETO gene (MIM 133435). The 
'myeloid translocation gene on 8q22 (MI'G8), is juxtaposed to the acute myeloid 
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leukemia (AMLJ) gene, which is the most frequent target for the AML associated 
chromosome translocation t(8;21). The MI'G8 gene encodes a protein with two 
putative zinc fmger motifs and several proline-rich regions, and is presumed to 
., 
function as a transcription factor (Kitabayashi et al. 1998). The MI'G8 mRNA is 
abundantly expressed in human adipose tissue, skeletal muscle and neural cells 
(Sacchi et al. 1998) and as such might be a good candidate for Tourette syndrome 
gene. 
Several other genes have been mapped at or near the 8q22 region, e.g. the tsBN51 
gene (MIM 187280), encoding for a temperature sensitivity complementation protein 
with cell cycle-specific expression. The mutations in the tsBN5 J gene lead to a block 
in progression through the G 1 phase of the cell cycle at non-permissive temperatures. 
Another interesting gene mapped to the region is GEM (MIM 600164), a GTP-
binding mitogen-induced T-cell protein, which is transiently overexpressed in human 
peripheral blood cells after the mitogen induction. The product of the gene has been 
found to be overexpressed in skeletal muscle and in individuals with type II diabetes 
mellitus. Both the above genes might be good candidates for Tourette syndrome, 
particularly from the standpoint of chromosomal fragility fmdings viewed earlier in 
this thesis. 
It is of interest, that the search for shared haplotypes at the 8q22 region among 
Tourette syndrome probands based on Afrikaner nuclear family data revealed only 
two individuals who shared an haplotype identical by state (IBS) throughout the 
investigated region (Appendix, Table 3). By narrowing the region towards marker 
GATA28FI2, which yielded the highest P-value with TDT statistics, the number of 
individuals sharing an IBS haplotype increased [Note, that two alleles 12 and 13 were 
pooled for the MTG8 polymorphism (Table 3). The reason is a high mutation rate of 
the marker, in which case clustering of neighboring alleles is common even in 
statistical analyses for linkagelLD. The Afrikaner haplotyping data have not been 
statistically evaluated and Table 3 is included in appendices for illustration purposes 
only.] However, significant values for haplotype sharing among affected individuals 
were not reached as one would expect from assuming a single founder effect for 
Tourette syndrome among Afrikaners. Without detailed genealogical study of the 
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ancestry of families sharing IBS haplotypes at 8q22, it is hard to predict whether 
identified regions are also identical by descent (IBD), and if so, whether they are 
linked to rourette syndrome or simply occur as a result of the background kinship in 
our study population. 
The region on chromosome llq23, suggestively linked to rourette syndrome 
throughout this study (Chapter 5 and 8), has previously been extensively investigated 
by others particularly because it harbors the dopamine D2 receptor (DRD2) gene. The 
initial positive association rmding between rourette syndrome and the Al allele of the 
DRD2 (MIMI26450) gene has been repeatedly disproved by linkage studies in large 
pedigrees. Due to the genetic location of the markers DllS933 and DllS1377 
(Chapter 5) mapped distal to the DRD2 locus (-15.l cM), transmission of one out of 
three allelic polymorhisms identified within DRD2 gene was investigated in Afrikaner 
nuclear families. The investigation did not yield any significant distortion of allelic 
transmission patterns in the group of samples used for the study reported in this thesis 
(Appendix, Table 5) which leads to the conclusion, that if there is a gene playing a 
significant role in susceptibility to Tourette syndrome at the llq23 region, it is 
probably distinct from the DRD2 gene and most likely located distal to the DRD2 
locus. 
Another obvious candidate for the rourette syndrome gene at the llq23.l-q23.2 
region is the 5-hydroxytryptamine (serotonin) receptor-3 gene (HTR3, MIM182139), 
which has not been investigated for association with rourette syndrome before. 
It is of interest, that the ASP study of the Tourette Syndrome Genetic Linkage 
Consortium identified marker DllS912 as one of 18 markers, which yielded positive 
single- and multipoint maximum likelihood scores (MLS) in their whole genome 
screen. Marker DllS912 is located distal from marker DllS1377 (-11 cM) and 
marker DllS933 (-7 cM away). 
The search for a common haplotype across the 11q23 region in South African patients 
did not reveal any IBS region present in > 4 individuals. It is, however, of interest, 
that a rare allele (236) of marker DllS975 present only four times across the entire 
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sample of >200 individuals (Appendix, Table 5), has been transmitted to affected 
probands three times, each time on the same background (IBS) haplotype (Appendix, 
Table 4). Only in one case was the allele not transmitted to the affected proband, in 
i 
which case it resided on a different background haplotype. A denser map of markers 
has to be typed at chromosome IIq23 to see whether this particular IBS haplotype 
also demonstrates IBD haplotype. 
There have been no prevIous reports of Tourette syndrome linkage with the 
chromosome 2p II region. As illustrated in Fig.1 (Appendix) several markers along 
the whole length of the chromosome 2 were identified in the initial Afrikaner genome· 
screen (Chapter 5) with consistent differences in marker allele distribution between 
affected and control pools. However, only two loci have subsequently been confirmed 
for association by individual typings (Appendix, Table I and 2). Increased haplotype 
sharing identified by extended HRR analysis among the markers at the 2pll region 
may either reflect the association with a putative Tourette syndrome gene locus, or 
may alternatively represent high levels of background LD in the region,. which has 
been documented for the same region in the Afrikaner background LD study 
(Appendix, Figure 2). Such high levels of LD may be explained by centromeric 
chromosomal location of the region, a site, which is usually characterized by lower 
recombination rates. 
There have been no obvious candidates for Tourette syndrome mapped to the 2qll 
region, however, genes important with respect to immune responses, such as CD8 
antigen, alpha polypeptide (CD8A, MIMI8691O), and immunoglobulin kappa light 
chain gene cluster (IGK@),been mapped to the region. 
A gene, such as transcriptional factor-9 (TCF9, MIMI89901), which binds GC-rich 
sequences (common fragile sites cluster in GC-rich chromosome regions), and maps 
to 2p 11.2-p 11.1, may also serve as a candidate gene in future studies with attempt to 
elucidate the genetics ofTourette syndrome. 
It is intriguing, that the 2q 12-q 11 region has also been associated with alcohol 
dependence in genome-wide linkage investigation of the Collaborative Study on the 
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Genetics of Alcoholism (COGA), with one of two largest lod scores in the region 
being achieved with marker D2S 1790 (Reich et al. 1998), positively associated with 
Tourette syndrome in the Afrikaner study. 
The regions on chromosome 20q and 21q21, associated with Tourette syndrome 
throughout the case-control study (Chapter 5), have not been confirmed for linkage by 
subsequent nuclear family study design (Chapter 8). The high original P-values for 
the markers in the region most likely resulted from spurious associations detected in a 
rather small initial group of samples (Appendix, Table 1 and 2). 
The remaining 10 regions associated with Tourette syndrome in earlier case-control 
study (Chapter 5) have yet to be subjected to confirmatory studies. Particularly the 
region on chromosome 1 p is of interest, where two markers (D 1 S485 and DIS 1665) 
span a -34 cM region harboring marker D1S1728, which also yielded a suggestive 
single point MLS value in the genome-wide ASP study of the Tourette Syndrome 
Genetic Linkage Consortium. The region has also been suggestively linked to 
schizophrenia in several recent studies (Shaw et al. 1998), bipolar disorder (Rice et al. 
1997), and alcohol dependence (Reich et al. 1998). 
The chromosome 6p22-p24 region has been subjected to extensive linkage and ASP 
analyses in connection with common psychoses, since the report by Straub et al. 
(1995) of linkage to schizophrenia. While markers which yielded suggestive 
association results throughout the Afrikaner study, D6S477 and D6S470 (Appendix, 
Table 1 and 2), map to the 6p24-p25 region, a. marker identified by the Tourette 
Syndrome Genetic Linkage Consortium in the ASP study with a positive (> 1) single 
point MLS value (D6SI053) maps proximal to the region (55.17 cM) in the HLA and 
dyslexia gene region (Grigorenko et al. 1997, Fischer et al. 1999, Gayan et al. 1999). 
Wide-spread positive linkage fmdings throughout the 6p region (-40 cM) are 
documented in the search for schizophrenia genes and may also become common in 
the search for Tourette syndrome genes as more linkage/association studies using 
non-parametric methods of analysis are performed. The HLA antigens (HLA-A, B, C, 
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and DR) have been excluded from linkage with Tourette syndrome in earlier studies 
(Caine et al. 1985). 
Chromosomes 12, and 14 markers associated with Tourette syndrome in the initial 
genome scan (Appendix, Table 1 and 2), have not been repeatedly associated with 
either Tourette syndrome or other major neurological or psychiatric traits (Detera-
Wadleigh 1999, Craddock and Lendon 1999). 
Chromosome 5q and 13q regions including markers D5S666 and D13S788 
(Appendix, Table 1 and 2) have been suggestively linked to schizophrenia and bipolar 
disorder respectively (Crowe and Vieland 1999, Barden and Morissette 1999). 
One of the potentially important areas also includes the Xpl1.4-p21 region, where 
differences were observed in marker allele distributions for two markers in the initial 
genome scan with DNA pools from affected and control males only (Appendix, 
Figure 1). These initial fmdings could not be conftrmed with subsequent evaluation of 
individual genotyping data (Appendix, Table 1 and 2). However, because of the fact 
that the male- to female-ratio in the prevalence of Tourette syndrome as well as other 
childhood onset neurological disorders (e.g. autism, ADHD) is distorted, our initial 
fmding may still be of importance because of the possibility of imprinted 
susceptibility loci at the Xp chromosome region. 
Further investigations are necessary to support this claim, e.g. by separate 
investigations of marker allele transmissions from fathers and mothers to affected 
probands in nuclear families. 
9.2. Future research strategies 
The localization and characterization of genes important for the expression of the 
Tourette syndrome phenotype would represent a major advance in the understanding 
of the pathogenesis of this disorder and would also provide a model for the study of 
other developmental disorders. Furthermore, once genes conferring susceptibility to 
Tourette syndrome and associated behaviors have been characterized, further research 
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will allow the identification of additional non-genetic factors important for the 
manifestation as well as amelioration of the symptoms of the disorders (pauls, 1990). 
It is generally accepted that co-segregation of a chromosomal abnormality with a 
disease phenotype, even in the case of common complex trait, may represent 
additional valuable information about the genetic locus or character of the gene 
product responsible for the susceptibility to the trait. Therefore, it is important, that at 
least until the genes responsible for Tourette syndrome are found, researchers will 
continue to search for chromosomal abnormalities in Tourette syndrome cases. 
Further research is needed to fmalize and confirm the molecular data generated 
throughout this study: 
1. Confirmatory linkagelLD studies in the remaining 10 loci identified during the 
initial whole genome screen (Chapter 5) are of immediate importance. 
2. A second complete genome scan on the Afrikaner Tourette syndrome nuclear 
families, which would allow replication and extension of the initial case-control 
association results. 
3. Further examination of current chromosomal areas of interest, based on the 
identification of regions that are shared identical by descent (lBD) among 
Tourette syndrome patients. These must preferably be drawn from genealogically 
well-characterized and presumably more genetically isolated sub-population of 
Afrikaners. 
4. The follow-up on the initial Xp association fmdings by linkagelLD analysis using 
nuclear families. Particularly differences in the parental marker allele 
transmissions (paternal vs. maternal transmissions) would be of interest in light of 
distorted male:female ratio among affected individuals and observed imprinting 
effects as a part of the inheritance pattern of certain Tourette syndrome-associated 
pathologies (e.g. tics vs. OCD). 
In agreement with the current goals of the Tourette Syndrome Genetic Mapping 
Consortium, the recommended gene-mapping designs for further exploration of the 
existing and newly generated data will incorporate extensive clinical information 
about the study participants for future quantitative trait loci analysis (QTL). E.g. tics 
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plus associated psychopathologies (either OeD or ADHD, etc.) vs. tics only may 
serve as one discriminatory factor for QTL analysis, the presence/expression vs. non-
presence of DS/17 antibody in Tourette syndrome probands may serve as another 
discriminatory factor. 
The co-localization of some of the currently identified genetic regions of interest for 
Tourette syndrome with regions linked to other psychoses (schizophrenia, bipolar 
affective disorder) 'or neurobehavioral traits (alcohol dependence) may also serve as 
an alternative basis for further investigations aiming to identify susceptibility genes 
for this intriguing condition. 
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APPENDICES 
Figure 1 
Electrophoretic profiles for additional markers (see Chapter 5) that demonstrated 
consistent allele frequency distribution between affected and control subjects in the 
fIrst group. Segments of autoradiographs from polyacrylamide gels are displayed for 
six STRPs at the indicated loci. The DNA templates used to generate the amplifIed 
DNA fragments were in the same order for each marker: standard DNA from CEPH 
family parents 133101 (1) and 133lO2 (2), DNA pool from set 1 of unaffected control 
subjects (CI), DNA pool from set 1 of affected subjects (AI), independent 
amplifIcation of pools CI and AI, DNA pool from set 1 of affected subjects (AI), 
independent amplifIcation of pools CI and AI, DNA pool from set 2 of unaffected 
control subjects (C2), and DNA pool from set 2 of affected subjects (A2). Arrows 
mark alleles enriched in the affected subjects. 
0181665 028293 
2 C1 A1 C1 A1 C2 A2 2 C1 A1 C1 A1 C2 A2 
028410 0281326 
1 2 C1 A1 C1 A1 C2A2 1 2 C1 A1 C1 A1 C2A2 
~ 
• 
~ 
.- ~.~ 
,. !I 
.t!i ~ 
• 
0481551 0281391 
1 2 C1 A1 C1 A1 C2A2 1 2 C1 A1 C1 A1 C2A2 
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Figure 1 (Continued) 
058641 0581505 
2 C1 A1 C1 A1 C2 A2 1 2 C1 A1 C1 A1 C2 A2 
0781804 0881132 
1 2 C1 A1 C1 A1 C2 A2 1 2 C1 A1 C1 A1 C2 A2 
01282078 0138788 
1 2 C1 A1 C1 A1 C2 A2 1 2 C1 A1 C1 A1 C2 A2 
0148742 0208470 
1 2 C1 A1 C1 A1 C2 A2 1 2 C1 A1 C1 A1 C2 A2 
GATA31 010 GATA72E05 
1 2 C1 A1 C2 A2 2 C1 A1 C2 A2 
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Table 1 
Statistical analysis of the marker allele frequencies at the loci investigated in the fIrst 
set of samples (-40 cases,-40 controls). "2p(chi-sq)" refers to the (twr-sided) P-value 
of the chi-square test when all alleles are distinguished in an 2-by-n c0ntingency table 
(2 affection classes, n alleles); alleles with expected values smaller than 1 were 
suitably pooled. "Allele" is the marker allele most strongly (in terms of P-value) 
associated with disease (or control). "P(assoc)" refers to the (one-sided) P-value for 
Fisher's test in a 2-by-2 table, given allele versus all other alleles, cases versus 
controls. One such table was calculated for each allele. The value reported is the 
smallest P-value, adjusted for mUltiple testing using the Bonferroni correction. "t" and 
"df' refers to the t-test for a difference in mean allele sizes between cases and 
controls. Positive t-values mean larger allele sizes in the group of cases (affected 
individuals). The t-test is expected to be powerful when marker alleles generally are 
shifted in the length in cases versus controls (Chapter 5). 
Chr. Marker 2P(chi-sq) Allele P(assoc) t df 
1 01S485 0.017664 177 0.005112* -1.5556 178 
1 0181665 0.009487* 231 0.001256* 2.0439 180 
2 028410 0.237736 152 0.222738 -2.5914 180 
2 0281326 0.106139 236 0.075417 -1.3403 180 
2 0281360 0.066787 152 0.29132 1.3521 182 
2 0281391 0.04229 109 0.155708 -0.8236 178 
2 0281790 0.012772 324 0.034551 -2.1946 170 
3 0381261 0.217071 213 0.338027 -1.5857 176 
3 0381286 0.05662 141 0.47967 0.7068 180 
4 0481551 0.009769* 178 0.025258 1.5437 182 
4 0481613 0.234327 261 0.358959 -0.4513 172 
4 0481647 0.037058 152 0.012706 1.5706 180 
5 058666 0.025713 249 0.022373 -1.8311 182 
6 068274 0.124564 182 0.086487 -2.3028 180 
6 068277 0.433172 116 0.262028 1.3867 172 
6 068344 0.855934 141 0.692204 -1.8502 172 
6 06S429 0.216727 230 0.505481 0.9265 176 
6 068439 0.535595 284 0.63383 -0.499 174 
6 068470 0.000621** 134 0.022729 3.3466** 180 
6 06S477 0.004796* 229 0.06495 1.6926 178 
8 0881119 0.025608 182 0.057083 -0.4463 180 
8 0881128 0.453483 244 0.312992 -0.4471 178 
8 0881130 0.019856 148 0.076935 3.6133** 178 
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Table 1 
Continued 
Chr. Marker 2P(chi-sq) Allele P(assoc) t df 
8 0881145 0.111139 261 0.257379 -2.2015 180 
8 0881477 0.136501 159 0.088622 -0.3253 182 
9 098910 0.496543 105 0.504005 -0.2093 178 
9 098922 0.262896 255 0.218491 -1.95 150 
9 098925 0.369299 171 0.225581 1.2767 170 
10 0108186 0.001720* 155 0.000181** 0.3809 176 
10 0108198 0.8642 187 0.583652 0.5003 172 
10 01081432 0.254791 181 0.149307 0.097 180 
11 0118933 0.049813 255 0.005541* -0.3139 180 
12 0128327 0.001229* 196 0.101758 -2.0964 182 
12 0128356 0.360483 217 0.355306 0.749 182 
12 0128358 0.082245 256 0.024513 -0.0065 180 
13 0138788 0.005115* 258 0.163327 -0.6732 170 
13 01381493 0.227108 135 0.041064 -0.7115 174 
16 0168771 0.532954 253 0.694941 -0.2014 168 
16 01683253 0.289044 187 0.221844 -1.1191 170 
20 0208478 0.34899 263 0.31646 1.6931 180 
20 0208604 0.44301 127 0.331024 0.6893 174 
20 GATA46C01 0.027842 189 0.028089 0.4601 172 
20 GGAA7E02 0.088129 266 0.111662 1.3189 176 
21 02181252 0.000005** 243 0.006422* 0.8027 152 
21 02181435 0.04453 171 0.046633 -2.2074 180 
X(m) OX81218 0.312308 263 0.172211 1.9379 62 
X(m) OX81221 0.575005 155 0.304773 -0.6525 63 
X(m) OX86799 0.866395 257 0.692356 -0.3485 61 
X(m) OX86800 0.076792 197 0.100052 1.9878 60 
X(m) OX86810 0.159977 223 0.09872 -1.6041 61 
X(m) OX87132 0.304675 287 0.184667 -1.4221 61 
m - investigated in the male samples only 
* results with P = 0.01 or smaller 
** results with P = 0.001 or smaller 
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Table 2 
Statistical analysis of the marker allele frequencies at the loci investigated with the 
second set of samples (-60 cases, -60 controls). 
* results with P = 0.01 or smaller 
** results with P = 0.001 or smaller 
Chr. Marker 2P(chi-sq) Allele P(assoc) t df 
1 01S1665 0.120449 239 0.057488 -0.7509 200 
1 01S485 0.245221 173 0.242315 -1.2204 194 
1 GATA124802 0.722764 198 0.463694 0.6729 396 
1 01S495 0.415392 146 0.454405 0.6122 386 
2 02S428 0.244404 158 0.138064 -1.3824 420 
2 GATA6E12 0.512984 264 0.631871 0.7613 412 
2 GATA5807 0.930603 192 0.758404 -0.5789 410 
2 02S1396 0.158605 130 0.286638 -0.6296 376 
2 02S435 0.222442 215 0.079522 -0.9384 424 
2 02S440 0.001505* 207 0.001086** -0.6062 426 
2 02S1790 0.006018* 324 0.012406 -0.1754 198 
2 GATA62810 0.392579 161 0.740326 -0.7276 410 
2 02S1391 0.141234 133 0.103959 1.0698 179 
3 03S1286 0.777862 145 0.211394 1.326 200 
3 GATA123C09 0.156317 169 0.138956 -1.5572 386 
3 GATA8C11 0.909997 124 0.691808 -0.5488 406 
4 04S1551 0.416725 176 0.639875 -0.9522 189 
5 05S666 0.189512 233 0.624466 -0.1008 186 
6 06S477 0.02357 237 0.040963 0.8224 422 
6 ATA109H09 0.178322 203 0.204661 -0.2115 416 
6 06S470 0.434915 130 0.206133 -1.5249 242 
8 08S1130 0.42089 136 0.422439 -0.8546 210 
8 08S1138 0.238189 260 0.105402 1.3155 420 
8 08S273 0.130718 137 0.164897 -1.3345 420 
8 08S257 0.013695 118 0.003529* -0.3329 393 
8 Mfd45 0.164226 84 0.31805 1.5887 422 
8 08S0271 0.752514 271 0.750539 -0.4636 414 
8 08S1119 0.088352 182 0.052879 0.2282 409 
10 010S1222 0.27078 118 0.200439 -1.0616 212 
13 013S788 0.562724 270 0.429572 0.0673 196 
13 ATA17C06 0.92774 213 0.794166 -0.7704 374 
13 GATA148801 0.453457 188 0.533182 0.3577 428 
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Continued 
Chr. Marker 2P(chi-sq) Allele 
14 0148742 0.060972 399 
14 0148275 0.79853 201 
14 0148283 0.691032 133 
14 Mfd130 0.842671 180 
14 01481003 0.001486* 163 
20 0208913 0.613341 252 
20 020S1085 0.000462** 181 
20 ACT1A04 0.053424 194 
20 ATA7B01 0.543936 110 
20 0208469 0.097633 215 
21 0218260 I 0.150657 269 
21 ATA22G04 0.747804 320 
21 02181252 0.072452 249 
21 02181435 0.461993 179 
21 GATA116E08 0.360294 230 
21 021S1255 0.081902 118 
X(m) GATA186006 0.861824 204 
X(m) ATA70F04 0.371436 140 
X(m) OX81 068 0.379466 251 
X(f) GATA186006 0.040756 212 
X(f) ATA70F07 0.114496 140 
X(f) OX81 068 0.663063 249 
m - investigated in the male samples only 
f - investigated in the female samples only 
Thresholds for "t" values (absolute values) 
P(assoc) 
0.018396 
0.663896 
0.836835 
0.524172 
0.002918* 
0.46292 
0.000401** 
0.060856 
0.510919 
0.06269 
0.108757 
0.464855 
0.121975 
0.174308 
0.203998 
0.223159 
0.867496 
0.566302 
0.197329 
0.019096 
0.11832 
0.593089 
df P=O.OI P = 0.001 
120 2.617 3.373 
2.576 3.291 
171 
t df 
-2.1493 410 
-0.0732 392 
-0.3339 382 
-0.6704 396 
3.9910* 402 
-0.8893 396 
-0.3111 196 
2.8233 394 
-0.101 412 
-0.4355 420 
-0.3152 374 
0.3443 192 
-0.9262 189 
-1.1872 196 
0.7338 402 
-1.126 194 
-0.474 135 
1.7733 92 
-0.6172 117 
1.5016 132 
2.025 106 
-0.0499 136 
P=O.OOO 
4.025 
3.891 
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Figure 2 
Chromosomal regions investigated for the extent of the background LD in the 
Afrikaner population (Chapter 7). 
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Table 3 
Marker 
0881119 
0881707 
088271 
GATA8B01 
T7-27 
088270 
MTG8 
GATA28F12 
0881822 
0881129 
088257 
088559 
0881808 
Table 4 
IB8 haplotype sharing among unrelated Tourette syndrome probands on chromosome 8q22 (see Chapter 8,9) 
Tourette syndrome probands 
cM 2-3 7-3 16-3 18-323-324-333-338-341-344-346-349-350-357-361-3 69-3 79-381-305-308-3013-3016-4019-3020-3023-3 025-3 
.101.01 
101.69 107 
102.62 267 
103.69234 234 234 234 
103.69 4 4 4 4 4 4 
103.69 191 191 191 191 191 191 
103.69 13 13 13 13 13 12 
104.33 286 286 286 286 
107.97 14 14 
110.2 144 
111.68 110 
112.42 
113.16 
218 
174 
9 9 9 
107 107 107 
267 267 267 267 
234 234 234 234 234 234 234 234 234 234 234 234 234 234 234 234 
44444444444444444444 
191 191 191 191 191 191 191 191 191 191 191 191 191 191 191 191 191 191 191 191 
13 13 13 13 12 12 13 13 12 12 13 13 12 13 13 12 13 12 12 13 
286 286 286 286 286 286 286 286 286 286 286 286 286 286 286 286 
14 14 14 14 14 14 14 14 14 14 
144 144 144 144 144 144 144 
110 110 
218 218 
174 174 
IB8 haplotype sharing among unrelated Nontransmitted haplotype 
Tourette syndrome probands on chromosome 11q23 
Tourette syndrome probands 
Marker cM' 8-3 13-3 49-3 
01181377 120.87 136 136 
01181353 ·122.47 202 202 202 
01184464 123 4 4 4 
0118933 124.07 255 255 255 
0118975 126.21 236 236 236 
associated with the allele 236 (0118975) 
4-2 
136/136 
200/200 
2/5 
247/259 
224/236 
-l w 
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Table 5 
Actual numbers of transmitted (T) versus non-transmitted (Nn alleles 
for investigated markers (Chapter 8) subjected to TOT and HRR statistics . 
. Only informative nuclear families for particular marker-allele are included. 
, . 
174 
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0851119 0851707 085271 GATA8B01 MTG8 
Alelle T NT Alelle T NT Alelle T NT Alelle T NT Alelle T NT 
1 0 1 107 40 39 272 1 1 258 0 1 19 2 1 
2 18 13 105 27 29 269 6 7 254 3 4 17 7 10 
3 14 23 103 7 11 267 40 36 250 7 5 16 17 17 
4 6 6 99 47 42 265 6 10 246 20 12 15 11 13 
5 12 17 263 21 22 242 7 16 14 10 4 
6 53 48 GATA28F12 261 8 2 238 29 18 13 28 32 
7 5 1 Alelle T NT 259 29 30 236 0 1 12 28 27 
9 26 25 298 2 1 257 35 37 ' 234 38 46 11 19 27 
294 2 2 253 0 1 230 5 8 10 20 30 
290 22 41 226 4 2 9 10 9 
286 44 28 8 3 6 
282 9 9 7 2 0 
274 4 2 5 1 0 
2 1 0 
,,,->t:!!I.!Is:tWtEt£&,,,,,%Z'~~,g9·.J.~.o-.W: ~,;....:::!2I1£:ee ... !i" • ."...a __ ~! 
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T7-27 085270 0851822 0851129 085257 
Alelle T NT Alelle T NT Alelle T NT Alelle T NT Alelle T NT 
11 26 26 197 3 4 2 0 1 148 3 4 122 0 1 
10 4 4 195 7 5 3 3 1 144 . 19 17 118 1 1 
6 5 1 193 28 24 4 1 1 140 6 8 116 14 19 
5 1 2 191 49 43 5 4 7 136 4 3 114 44 54 
4 35 35 189 12 18 6 10 13 130 7 7 112 37 31 
3 2 5 187 2 4 7 4 0 110 32 23 
2 1 1 185 1 2 8 12 13 108 1 i 
183 5 10 9 2 7 106 1 0 
-181 31 27 10 42 34 
179 1 1 12 4 2 
175 0 1 13 4 5 
14 41 43 
15 14 14 
MWd$:l$!&J..::. .... tfiCiSt!&\iAl~ 
085559 0851808 OR02 01151377 01151353 
Alelle T NT Alelle T NT Alelle T NT Alelle T NT Alelle T NT 
238 1 0 176 1 0 1 1 3 146 8 6 214 0 1 
232 1 0 174 9 6 2 31 31 144 3 5 208 6 3 
230 4 6 172 6 11 3 49 43 142 19 8 206 34 38 
228 7 7 170 38 49 4 19 32 141 0 1 204 28 29 
226 30 29 168 51 39 5 24 14 140 10 19 203 5 0 
224 16 20 6 1 2 138 17 27 202 15 24 
222 5 9 136 26 37 200 33 28 
220 42 40 134 37 23 196 3 1 
218 24 19 132 8 2 
216 0 1 130 3 1 
212 1 0 128 5 7 
,....~,..,."'."'" '- . ~ 
--- -~ ....... 7'>r"'.~ ~,-.. - . . ,.,.. "< • .....,~ ........... ,~ ~ ......... _= ~. 
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Table 5 
Continued 
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Alelle T NT Alelle T NT Alelle T NT Alelle T NT Alelle T NT 
1 10 4 267 1 3 240 1 8 201 1 2 211 4 2 
2 13 20 265 3 1 238 0 1 199 1 2 207 8 8 
3 38 33 263 8 3 236 3 1 197 7 11 203 18 21 
4 38 43 261 3 4 234 11 14 195 30 27 199 44 39 
5 15 12 259 11 7 232 43 51 193 16 29 195 43 42 
6 8 10 257 31 37 230 6 1 191 13 9 191 12 16 
255 37 41 228 6 9 189 0 1 187 1 0 
253 6 7 226 3 1 187 0 3 183 0 2 
251 34 26 224 22 11 183 0 2 
249 3 3 222 36 33 181 29 32 
247 4 9 216 6 7 177 4 1 
175 43 25 
~'\.l'w.o;r.~. ~~~~. ~~ m!~~~~~~ ~~~,,~~ 
0282161 028417 0208480 0201085 0208469 
Alelle T NT Alelle T NT Alelle T NT Alelle T NT Alelle T NT 
204 3 4 213 0 2 308 2 3 199 2 0 239 2 0 
202 4 7 211 6 5 304 4 10 195 1 2 235 1 0 
200 8 7 209 13 13 300 33 27 193 0 2 231 8 4 
198 9 16 207 32 23 296 36 31 191 8 8 229 0 1 
196 13 7 205 36 51 292 32 37 189 4 6 227 3 2 
194 33 42 203 47 34 288 13 12 188 2 1 223 8 3 
192 29 21 201 '. 1 4 284 2 2 187 20 22 219 15 17 
190 11 4 199 0 1 185 20 19 215 6 10 
188 3 5 197 7 9 184 6 2 211 32 41 
184 3 2 183 16 33 207 17 14 
180 1 0 181 20 25 203 1 1 
176 0 3 180 21 14 
172 1 0 179 5 4 
177 15 9 
176 14 9 
173 3 3 
171 2 0 
.~~~~~~ ~~.,glli£I'j;:;.i!!w!WiJiiM" ... ~ r· ': ~:gg;ssn.-"",~JU.~;(1!";x:;:;;;g..;,:,,,.~ 
0208120 GATA45C03 02181920 02181895 02181252 
Alelle T NT Alelle T NT Alelle T NT Alelle T NT Alelle T NT 
249 0 1 1 1 2 234 2 2 280 1 1 253 1 4 
247 0 1 2 0 2 232 23 22 278 10 8 251 2 3 
245 1 2 3 13 13 230 25 27 276 8 15 249 11 10 
243 8 7 4 19 18 228 9 8 274 18 17 247 21 22 
241 8 8 5 16 9 226 29 27 272 12 16 245 9 17 
239 27 19 6 2 2 224 33 39 270 27 27 243 5 0 
237 43 28 7 1 2 222 4 1 268 17 11 241 3 2 
235 12 15 8 32 33 220 11 10 266 11 22 239 25 23 
233 19 28 9 10 2 264 46 31 237 42 32 
231 20 23 10 2 2 262 3 4 233 2 2 
229 0 2 12 0 1 260 0 1 231 20 27 
223 0 1 16 1 1 227 1 0 
221 1 1 
219 6 11 
217 1 1 
213 8 6 
........... ' . .,. "'~-""'-~...,., " ....... 
_ . 
..... ,..,..,. 
..... """"~, .- . .' . ~,~ b.= 
. -. -- ..",.,,...."" ... 
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